{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:42:13Z","timestamp":1793727733932,"version":"4.6.1"},"reference-count":601,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T00:00:00Z","timestamp":1733702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T00:00:00Z","timestamp":1733702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Immunol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1038\/s41577-024-01104-7","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T09:28:04Z","timestamp":1733736484000},"page":"321-352","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":618,"title":["Neuroinflammation in Alzheimer disease"],"prefix":"10.1038","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8766-6224","authenticated-orcid":false,"given":"Michael T.","family":"Heneka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiesje M.","family":"van der Flier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Jessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Hoozemanns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1036-1075","authenticated-orcid":false,"given":"Dietmar Rudolf","family":"Thal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5884-130X","authenticated-orcid":false,"given":"Delphine","family":"Boche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3137-7516","authenticated-orcid":false,"given":"Frederic","family":"Brosseron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4061-0837","authenticated-orcid":false,"given":"Charlotte","family":"Teunissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas H.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6551-2002","authenticated-orcid":false,"given":"Paul","family":"Edison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4991-763X","authenticated-orcid":false,"given":"Alfredo","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Cruchaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0829-7817","authenticated-orcid":false,"given":"Jean-Charles","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2633-2495","authenticated-orcid":false,"given":"Agustin Ruiz","family":"Laza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9292-8521","authenticated-orcid":false,"given":"Jose Vicente","family":"Sanchez-Mut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8546-1161","authenticated-orcid":false,"given":"Andre","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1581-474X","authenticated-orcid":false,"given":"Sergio","family":"Castro-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thor D.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3309-6856","authenticated-orcid":false,"given":"Luca","family":"Kleineidam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2589-6440","authenticated-orcid":false,"given":"Michael","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas J.","family":"Neher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colm","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sim K.","family":"Singhrao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0349-1955","authenticated-orcid":false,"given":"Marco","family":"Prinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher K.","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes C. M.","family":"Schlachetzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg","family":"Butovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kilian","family":"Kleemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8057-2505","authenticated-orcid":false,"given":"Philip L.","family":"De Jaeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Scheiblich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3610-1730","authenticated-orcid":false,"given":"Guy C.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8808-424X","authenticated-orcid":false,"given":"Gary","family":"Landreth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0525-9145","authenticated-orcid":false,"given":"Miguel","family":"Moutinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5000-243X","authenticated-orcid":false,"given":"Jaime","family":"Grutzendler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5316-2682","authenticated-orcid":false,"given":"Diego","family":"Gomez-Nicola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6896-0302","authenticated-orcid":false,"given":"R\u00f3is\u00edn M.","family":"McManus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8391-4155","authenticated-orcid":false,"given":"Katrin","family":"Andreasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7267-3488","authenticated-orcid":false,"given":"Christina","family":"Ising","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Karabag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren J.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0840-1437","authenticated-orcid":false,"given":"Shane A.","family":"Liddelow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2592-9898","authenticated-orcid":false,"given":"Alexei","family":"Verkhratsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1719-4708","authenticated-orcid":false,"given":"Malu","family":"Tansey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4888-7865","authenticated-orcid":false,"given":"Alon","family":"Monsonego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1653-8046","authenticated-orcid":false,"given":"Ludwig","family":"Aigner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5763-3632","authenticated-orcid":false,"given":"Guillaume","family":"Doroth\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8724-9666","authenticated-orcid":false,"given":"Klaus-Armin","family":"Nave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8978-3539","authenticated-orcid":false,"given":"Gabriela","family":"Constantin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neta","family":"Rosenzweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5459-6207","authenticated-orcid":false,"given":"Alberto","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0145-8641","authenticated-orcid":false,"given":"Gabor C.","family":"Petzold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3714-517X","authenticated-orcid":false,"given":"Jonathan","family":"Kipnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Venegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5222-4987","authenticated-orcid":false,"given":"Marco","family":"Colonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4678-2912","authenticated-orcid":false,"given":"Jochen","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3000-024X","authenticated-orcid":false,"given":"Andrea J.","family":"Tenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1246-3363","authenticated-orcid":false,"given":"M. Kerry","family":"O\u2019Banion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joern R.","family":"Steinert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas L.","family":"Feinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8931-6316","authenticated-orcid":false,"given":"Magdalena","family":"Sastre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6064-8106","authenticated-orcid":false,"given":"Kiran","family":"Bhaskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5744-4871","authenticated-orcid":false,"given":"Soyon","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy P.","family":"Schafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Golde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0175-6910","authenticated-orcid":false,"given":"Richard M.","family":"Ransohoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1224-7476","authenticated-orcid":false,"given":"David","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Breitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7046-3348","authenticated-orcid":false,"given":"Renzo","family":"Mancuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6933-9174","authenticated-orcid":false,"given":"Sean-Patrick","family":"Riechers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,9]]},"reference":[{"key":"1104_CR1","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41583-018-0054-8","volume":"19","author":"J Gotz","year":"2018","unstructured":"Gotz, J., Bodea, L. G. & Goedert, M. Rodent models for Alzheimer disease. Nat. Rev. Neurosci. 19, 583\u2013598 (2018).","journal-title":"Nat. Rev. Neurosci."},{"key":"1104_CR2","doi-asserted-by":"publisher","first-page":"807473","DOI":"10.3389\/fnins.2022.807473","volume":"16","author":"H Sasaguri","year":"2022","unstructured":"Sasaguri, H. et al. Recent advances in the modeling of Alzheimer\u2019s disease. Front. Neurosci. 16, 807473 (2022).","journal-title":"Front. Neurosci."},{"key":"1104_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1126\/science.abb8575","volume":"370","author":"A Sierksma","year":"2020","unstructured":"Sierksma, A., Escott-Price, V. & De Strooper, B. Translating genetic risk of Alzheimer\u2019s disease into mechanistic insight and drug targets. Science 370, 61\u201366 (2020).","journal-title":"Science"},{"key":"1104_CR4","first-page":"146","volume":"64","author":"A Alzheimer","year":"1907","unstructured":"Alzheimer, A. Uber eine eigenartige Erkrankung der Hirnrinde. Allg. Z. Psychiatr. 64, 146\u2013148 (1907).","journal-title":"Allg. Z. Psychiatr."},{"key":"1104_CR5","first-page":"208","volume":"17","author":"E Redlich","year":"1898","unstructured":"Redlich, E. Uber miliare Sklerose der hirnrinde bei seniler Atrophie. Jahrb. Psychiatry Neurol. 17, 208\u2013216 (1898).","journal-title":"Jahrb. Psychiatry Neurol."},{"key":"1104_CR6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00685397","volume":"57","author":"P Eikelenboom","year":"1982","unstructured":"Eikelenboom, P. & Stam, F. C. Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study. Acta Neuropathol. 57, 239\u2013242 (1982).","journal-title":"Acta Neuropathol."},{"key":"1104_CR7","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/00005072-199503000-00014","volume":"54","author":"WS Griffin","year":"1995","unstructured":"Griffin, W. S., Sheng, J. G., Roberts, G. W. & Mrak, R. E. Interleukin-1 expression in different plaque types in Alzheimer\u2019s disease: significance in plaque evolution. J. Neuropathol. Exp. Neurol. 54, 276\u2013281 (1995).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1104_CR8","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1016\/j.neuron.2021.08.003","volume":"109","author":"VN Lagomarsino","year":"2021","unstructured":"Lagomarsino, V. N. et al. Stem cell-derived neurons reflect features of protein networks, neuropathology, and cognitive outcome of their aged human donors. Neuron 109, 3402\u20133420.e9 (2021).","journal-title":"Neuron"},{"key":"1104_CR9","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0304-3940(87)90696-3","volume":"79","author":"PL McGeer","year":"1987","unstructured":"McGeer, P. L., Itagaki, S., Tago, H. & McGeer, E. G. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci. Lett. 79, 195\u2013200 (1987).","journal-title":"Neurosci. Lett."},{"key":"1104_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/00005072-199703000-00007","volume":"56","author":"JG Sheng","year":"1997","unstructured":"Sheng, J. G., Mrak, R. E. & Griffin, W. S. Glial-neuronal interactions in Alzheimer disease: progressive association of IL-1alpha+ microglia and S100beta+ astrocytes with neurofibrillary tangle stages. J. Neuropathol. Exp. Neurol. 56, 285\u2013290 (1997).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1104_CR11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0304-3940(89)90843-4","volume":"107","author":"PL McGeer","year":"1989","unstructured":"McGeer, P. L., Akiyama, H., Itagaki, S. & McGeer, E. G. Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci. Lett. 107, 341\u2013346 (1989).","journal-title":"Neurosci. Lett."},{"key":"1104_CR12","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0197-4580(88)80079-4","volume":"9","author":"J Rogers","year":"1988","unstructured":"Rogers, J., Luber-Narod, J., Styren, S. D. & Civin, W. H. Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer\u2019s disease. Neurobiol. Aging 9, 339\u2013349 (1988).","journal-title":"Neurobiol. Aging"},{"key":"1104_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0014-4886(90)90054-V","volume":"110","author":"SD Styren","year":"1990","unstructured":"Styren, S. D., Civin, W. H. & Rogers, J. Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer\u2019s disease brain. Exp. Neurol. 110, 93\u2013104 (1990).","journal-title":"Exp. Neurol."},{"key":"1104_CR14","doi-asserted-by":"publisher","first-page":"7611","DOI":"10.1073\/pnas.86.19.7611","volume":"86","author":"WS Griffin","year":"1989","unstructured":"Griffin, W. S. et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl Acad. Sci. USA 86, 7611\u20137615 (1989).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1104_CR15","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41583-018-0055-7","volume":"19","author":"MT Heneka","year":"2018","unstructured":"Heneka, M. T., McManus, R. M. & Latz, E. Inflammasome signalling in brain function and neurodegenerative disease. Nat. Rev. Neurosci. 19, 610\u2013621 (2018).","journal-title":"Nat. Rev. Neurosci."},{"key":"1104_CR16","first-page":"223","volume":"66","author":"S Strauss","year":"1992","unstructured":"Strauss, S. et al. Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer\u2019s disease patients. Lab. Invest. 66, 223\u2013230 (1992).","journal-title":"Lab. Invest."},{"key":"1104_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00401-022-02528-y","volume":"145","author":"S Moonen","year":"2023","unstructured":"Moonen, S. et al. Pyroptosis in Alzheimer\u2019s disease: cell type-specific activation in microglia, astrocytes and neurons. Acta Neuropathol. 145, 175\u2013195 (2023).","journal-title":"Acta Neuropathol."},{"key":"1104_CR18","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0197-4580(98)00090-6","volume":"19","author":"DR Thal","year":"1998","unstructured":"Thal, D. R. et al. Progression of neurofibrillary changes and PHF-tau in end-stage Alzheimer\u2019s disease is different from plaque and cortical microglial pathology. Neurobiol. Aging 19, 517\u2013525 (1998).","journal-title":"Neurobiol. Aging"},{"key":"1104_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1180-y","volume":"15","author":"BDC Boon","year":"2018","unstructured":"Boon, B. D. C. et al. Neuroinflammation is increased in the parietal cortex of atypical Alzheimer\u2019s disease. J. Neuroinflammation 15, 170 (2018).","journal-title":"J. Neuroinflammation"},{"key":"1104_CR20","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1093\/brain\/awt210","volume":"136","author":"E Zotova","year":"2013","unstructured":"Zotova, E. et al. Inflammatory components in human Alzheimer\u2019s disease and after active amyloid-\u03b242 immunization. Brain 136, 2677\u20132696 (2013).","journal-title":"Brain"},{"key":"1104_CR21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0140-6736(00)03589-3","volume":"357","author":"Neuropathology Group. Medical Research Council Cognitive Function and Aging Study.","year":"2001","unstructured":"Neuropathology Group. Medical Research Council Cognitive Function and Aging Study. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 357, 169\u2013175 (2001).","journal-title":"Lancet"},{"key":"1104_CR22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s40478-019-0828-x","volume":"7","author":"DK Franco-Bocanegra","year":"2019","unstructured":"Franco-Bocanegra, D. K. et al. Microglial motility in Alzheimer\u2019s disease and after A\u03b242 immunotherapy: a human post-mortem study. Acta Neuropathol. Commun. 7, 174 (2019).","journal-title":"Acta Neuropathol. Commun."},{"key":"1104_CR23","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/nan.12642","volume":"46","author":"D Boche","year":"2020","unstructured":"Boche, D. & Nicoll, J. A. R. Invited review \u2014 understanding cause and effect in Alzheimer\u2019s pathophysiology: implications for clinical trials. Neuropathol. Appl. Neurobiol. 46, 623\u2013640 (2020).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"1104_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0601-z","volume":"13","author":"T Minett","year":"2016","unstructured":"Minett, T. et al. Microglial immunophenotype in dementia with Alzheimer\u2019s pathology. J. Neuroinflammation 13, 135 (2016).","journal-title":"J. Neuroinflammation"},{"key":"1104_CR25","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00401-020-02198-8","volume":"140","author":"BDC Boon","year":"2020","unstructured":"Boon, B. D. C. et al. The coarse-grained plaque: a divergent A\u03b2 plaque-type in early-onset Alzheimer\u2019s disease. Acta Neuropathol. 140, 811\u2013830 (2020).","journal-title":"Acta Neuropathol."},{"key":"1104_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s40478-019-0791-6","volume":"7","author":"L Jakel","year":"2019","unstructured":"Jakel, L., Boche, D., Nicoll, J. A. R. & Verbeek, M. M. A\u03b243 in human Alzheimer\u2019s disease: effects of active A\u03b242 immunization. Acta Neuropathol. Commun. 7, 141 (2019).","journal-title":"Acta Neuropathol. Commun."},{"key":"1104_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40478-017-0505-x","volume":"6","author":"ML Moro","year":"2018","unstructured":"Moro, M. L. et al. Pyroglutamate and isoaspartate modified amyloid-beta in ageing and Alzheimer\u2019s disease. Acta Neuropathol. Commun. 6, 3 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"1104_CR28","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1097\/01.jnen.0000240466.10758.ce","volume":"65","author":"JA Nicoll","year":"2006","unstructured":"Nicoll, J. A. et al. A\u03b2 species removal after a\u03b242 immunization. J. Neuropathol. Exp. Neurol. 65, 1040\u20131048 (2006).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1104_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13195-020-00619-0","volume":"12","author":"G Tondo","year":"2020","unstructured":"Tondo, G. et al. The combined effects of microglia activation and brain glucose hypometabolism in early-onset Alzheimer\u2019s disease. Alzheimers Res. Ther. 12, 50 (2020).","journal-title":"Alzheimers Res. Ther."},{"key":"1104_CR30","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/0197-4580(94)90026-4","volume":"15","author":"T Pirttila","year":"1994","unstructured":"Pirttila, T., Mehta, P. D., Frey, H. & Wisniewski, H. M. \u03b11-Antichymotrypsin and IL-1\u03b2 are not increased in CSF or serum in Alzheimer\u2019s disease. Neurobiol. Aging 15, 313\u2013317 (1994).","journal-title":"Neurobiol. Aging"},{"key":"1104_CR31","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1136\/jnnp-2017-316201","volume":"88","author":"KSP Lai","year":"2017","unstructured":"Lai, K. S. P. et al. Peripheral inflammatory markers in Alzheimer\u2019s disease: a systematic review and meta-analysis of 175 studies. J. Neurol. Neurosurg. Psychiatry 88, 876\u2013882 (2017).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1104_CR32","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","volume":"68","author":"W Swardfager","year":"2010","unstructured":"Swardfager, W. et al. A meta-analysis of cytokines in Alzheimer\u2019s disease. Biol. Psychiatry 68, 930\u2013941 (2010).","journal-title":"Biol. Psychiatry"},{"key":"1104_CR33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13195-018-0353-3","volume":"10","author":"F Brosseron","year":"2018","unstructured":"Brosseron, F. et al. Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer\u2019s disease. Alzheimers Res. Ther. 10, 25 (2018).","journal-title":"Alzheimers Res. Ther."},{"key":"1104_CR34","doi-asserted-by":"publisher","first-page":"4828","DOI":"10.1002\/alz.13066","volume":"19","author":"M Chatterjee","year":"2023","unstructured":"Chatterjee, M. et al. C1q is increased in cerebrospinal fluid-derived extracellular vesicles in Alzheimer\u2019s disease: a multi-cohort proteomics and immuno-assay validation study. Alzheimers Dement. 19, 4828\u20134840 (2023).","journal-title":"Alzheimers Dement."},{"key":"1104_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42834-x","volume":"14","author":"W Feng","year":"2023","unstructured":"Feng, W. et al. NULISA: a proteomic liquid biopsy platform with attomolar sensitivity and high multiplexing. Nat. Commun. 14, 7238 (2023).","journal-title":"Nat. Commun."},{"key":"1104_CR36","doi-asserted-by":"publisher","first-page":"100629","DOI":"10.1016\/j.mcpro.2023.100629","volume":"22","author":"CE Teunissen","year":"2023","unstructured":"Teunissen, C. E. et al. Methods to discover and validate biofluid-based biomarkers in neurodegenerative dementias. Mol. Cell Proteom. 22, 100629 (2023).","journal-title":"Mol. Cell Proteom."},{"key":"1104_CR37","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.biopsych.2010.08.025","volume":"68","author":"R Craig-Schapiro","year":"2010","unstructured":"Craig-Schapiro, R. et al. YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer\u2019s disease. Biol. Psychiatry 68, 903\u2013912 (2010).","journal-title":"Biol. Psychiatry"},{"key":"1104_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13024-016-0071-x","volume":"11","author":"A Heslegrave","year":"2016","unstructured":"Heslegrave, A. et al. Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer\u2019s disease. Mol. Neurodegener. 11, 3 (2016).","journal-title":"Mol. Neurodegener."},{"key":"1104_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/BF00314423","volume":"233","author":"R Crols","year":"1986","unstructured":"Crols, R., Saerens, J., Noppe, M. & Lowenthal, A. Increased GFAp levels in CSF as a marker of organicity in patients with Alzheimer\u2019s disease and other types of irreversible chronic organic brain syndrome. J. Neurol. 233, 157\u2013160 (1986).","journal-title":"J. Neurol."},{"key":"1104_CR40","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.3390\/cells12091309","volume":"12","author":"KY Kim","year":"2023","unstructured":"Kim, K. Y., Shin, K. Y. & Chang, K. A. GFAP as a potential biomarker for Alzheimer\u2019s disease: a systematic review and meta-analysis. Cells 12, 1309 (2023).","journal-title":"Cells"},{"key":"1104_CR41","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13024-023-00647-y","volume":"18","author":"K Chiotis","year":"2023","unstructured":"Chiotis, K. et al. Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer\u2019s disease with multi-modal PET and plasma GFAP. Mol. Neurodegener. 18, 60 (2023).","journal-title":"Mol. Neurodegener."},{"key":"1104_CR42","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","volume":"26","author":"ECB Johnson","year":"2020","unstructured":"Johnson, E. C. B. et al. Large-scale proteomic analysis of Alzheimer\u2019s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat. Med. 26, 769\u2013780 (2020).","journal-title":"Nat. Med."},{"key":"1104_CR43","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41531-020-00147-6","volume":"7","author":"FL Anderson","year":"2021","unstructured":"Anderson, F. L. et al. Plasma-borne indicators of inflammasome activity in Parkinson\u2019s disease patients. NPJ Parkinsons Dis. 7, 2 (2021).","journal-title":"NPJ Parkinsons Dis."},{"key":"1104_CR44","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.3390\/ijms21134674","volume":"21","author":"XO Scott","year":"2020","unstructured":"Scott, X. O. et al. The inflammasome adaptor protein ASC in mild cognitive impairment and Alzheimer\u2019s disease. Int. J. Mol. Sci. 21, 4674 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1104_CR45","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41582-023-00915-x","volume":"20","author":"KA Ravichandran","year":"2024","unstructured":"Ravichandran, K. A. & Heneka, M. T. Inflammasomes in neurological disorders \u2014 mechanisms and therapeutic potential. Nat. Rev. Neurol. 20, 67\u201383 (2024).","journal-title":"Nat. Rev. Neurol."},{"key":"1104_CR46","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1038\/jcbfm.2012.53","volume":"32","author":"AH Jacobs","year":"2012","unstructured":"Jacobs, A. H. & Tavitian, B.; INMiND Consortium.Noninvasive molecular imaging of neuroinflammation. J. Cereb. Blood Flow Metab. 32, 1393\u20131415 (2012).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"1104_CR47","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3390\/diagnostics13061029","volume":"13","author":"F Corica","year":"2023","unstructured":"Corica, F. et al. PET imaging of neuro-inflammation with tracers targeting the translocator protein (TSPO), a systematic review: from bench to bedside.Diagnostics 13, 1029 (2023).","journal-title":"Diagnostics"},{"key":"1104_CR48","doi-asserted-by":"publisher","first-page":"5400","DOI":"10.7150\/thno.25572","volume":"8","author":"A Villa","year":"2018","unstructured":"Villa, A. et al. Identification of new molecular targets for PET imaging of the microglial anti-inflammatory activation state. Theranostics 8, 5400\u20135418 (2018).","journal-title":"Theranostics"},{"key":"1104_CR49","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3389\/fimmu.2016.00544","volume":"7","author":"ES Wohleb","year":"2016","unstructured":"Wohleb, E. S. Neuron-microglia interactions in mental health disorders: \u201cFor Better, and For Worse\u201d. Front. Immunol. 7, 544 (2016).","journal-title":"Front. Immunol."},{"key":"1104_CR50","doi-asserted-by":"publisher","first-page":"468","DOI":"10.2967\/jnumed.108.058669","volume":"50","author":"F Chauveau","year":"2009","unstructured":"Chauveau, F. et al. Comparative evaluation of the translocator protein radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a rat model of acute neuroinflammation. J. Nucl. Med. 50, 468\u2013476 (2009).","journal-title":"J. Nucl. Med."},{"key":"1104_CR51","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1093\/brain\/awt145","volume":"136","author":"WC Kreisl","year":"2013","unstructured":"Kreisl, W. C. et al. In vivo radioligand binding to translocator protein correlates with severity of Alzheimer\u2019s disease. Brain 136, 2228\u20132238 (2013).","journal-title":"Brain"},{"key":"1104_CR52","first-page":"2740","volume":"141","author":"M Dani","year":"2018","unstructured":"Dani, M. et al. Microglial activation correlates in vivo with both tau and amyloid in Alzheimer\u2019s disease. Brain 141, 2740\u20132754 (2018).","journal-title":"Brain"},{"key":"1104_CR53","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1093\/brain\/awx151","volume":"140","author":"WC Kreisl","year":"2017","unstructured":"Kreisl, W. C. Discerning the relationship between microglial activation and Alzheimer\u2019s disease. Brain 140, 1825\u20131828 (2017).","journal-title":"Brain"},{"key":"1104_CR54","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1093\/brain\/aww017","volume":"139","author":"L Hamelin","year":"2016","unstructured":"Hamelin, L. et al. Early and protective microglial activation in Alzheimer\u2019s disease: a prospective study using 18F-DPA-714 PET imaging. Brain 139, 1252\u20131264 (2016).","journal-title":"Brain"},{"key":"1104_CR55","doi-asserted-by":"publisher","first-page":"e1331","DOI":"10.1212\/WNL.0000000000007133","volume":"92","author":"GD Femminella","year":"2019","unstructured":"Femminella, G. D. et al. Microglial activation in early Alzheimer trajectory is associated with higher gray matter volume. Neurology 92, e1331\u2013e1343 (2019).","journal-title":"Neurology"},{"key":"1104_CR56","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1093\/brain\/awy079","volume":"141","author":"L Hamelin","year":"2018","unstructured":"Hamelin, L. et al. Distinct dynamic profiles of microglial activation are associated with progression of Alzheimer\u2019s disease. Brain 141, 1855\u20131870 (2018).","journal-title":"Brain"},{"key":"1104_CR57","first-page":"792","volume":"140","author":"Z Fan","year":"2017","unstructured":"Fan, Z., Brooks, D. J., Okello, A. & Edison, P. An early and late peak in microglial activation in Alzheimer\u2019s disease trajectory. Brain 140, 792\u2013803 (2017).","journal-title":"Brain"},{"key":"1104_CR58","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","volume":"63","author":"M Gatz","year":"2006","unstructured":"Gatz, M. et al. Role of genes and environments for explaining Alzheimer disease. Arch. Gen. Psychiatry 63, 168\u2013174 (2006).","journal-title":"Arch. Gen. Psychiatry"},{"key":"1104_CR59","doi-asserted-by":"publisher","first-page":"200.e13","DOI":"10.1016\/j.neurobiolaging.2016.02.024","volume":"41","author":"PG Ridge","year":"2016","unstructured":"Ridge, P. G. et al. Assessment of the genetic variance of late-onset Alzheimer\u2019s disease. Neurobiol. Aging 41, 200.e13\u2013200.e20 (2016).","journal-title":"Neurobiol. Aging"},{"key":"1104_CR60","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1038\/s41380-023-02076-1","volume":"28","author":"JC Lambert","year":"2023","unstructured":"Lambert, J. C., Ramirez, A., Grenier-Boley, B. & Bellenguez, C. Step by step: towards a better understanding of the genetic architecture of Alzheimer\u2019s disease. Mol. Psychiatry 28, 2716\u20132727 (2023).","journal-title":"Mol. Psychiatry"},{"key":"1104_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22491-8","volume":"12","author":"I de Rojas","year":"2021","unstructured":"de Rojas, I. et al. Common variants in Alzheimer\u2019s disease and risk stratification by polygenic risk scores. Nat. Commun. 12, 3417 (2021).","journal-title":"Nat. Commun."},{"key":"1104_CR62","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1038\/s41588-022-01208-7","volume":"54","author":"H Holstege","year":"2022","unstructured":"Holstege, H. et al. Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer\u2019s disease. Nat. Genet. 54, 1786\u20131794 (2022).","journal-title":"Nat. Genet."},{"key":"1104_CR63","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3233\/JAD-2010-100018","volume":"20","author":"JC Lambert","year":"2010","unstructured":"Lambert, J. C. et al. Implication of the immune system in Alzheimer\u2019s disease: evidence from genome-wide pathway analysis. J. Alzheimers Dis. 20, 1107\u20131118 (2010).","journal-title":"J. Alzheimers Dis."},{"key":"1104_CR64","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez, C. et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat. Genet. 54, 412\u2013436 (2022).","journal-title":"Nat. Genet."},{"key":"1104_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21823-y","volume":"12","author":"G Novikova","year":"2021","unstructured":"Novikova, G. et al. Integration of Alzheimer\u2019s disease genetics and myeloid genomics identifies disease risk regulatory elements and genes. Nat. Commun. 12, 1610 (2021).","journal-title":"Nat. Commun."},{"key":"1104_CR66","first-page":"245","volume":"8","author":"AK Hodges","year":"2021","unstructured":"Hodges, A. K., Piers, T. M., Collier, D., Cousins, O. & Pocock, J. M. Pathways linking Alzheimer\u2019s disease risk genes expressed highly in microglia. Neuroimmunol. Neuroinflamm. 8, 245 (2021).","journal-title":"Neuroimmunol. Neuroinflamm."},{"key":"1104_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-023-00687-4","volume":"19","author":"L Wang","year":"2024","unstructured":"Wang, L. et al. Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer\u2019s disease. Mol. Neurodegener. 19, 1 (2024).","journal-title":"Mol. Neurodegener."},{"key":"1104_CR68","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/385729a0","volume":"385","author":"RA Black","year":"1997","unstructured":"Black, R. A. et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-\u03b1 from cells. Nature 385, 729\u2013733 (1997).","journal-title":"Nature"},{"key":"1104_CR69","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bcp.2009.02.009","volume":"78","author":"L Verstrepen","year":"2009","unstructured":"Verstrepen, L., Carpentier, I., Verhelst, K. & Beyaert, R. ABINs: A20 binding inhibitors of NF-\u03baB and apoptosis signaling. Biochem. Pharmacol. 78, 105\u2013114 (2009).","journal-title":"Biochem. Pharmacol."},{"key":"1104_CR70","doi-asserted-by":"publisher","first-page":"101775","DOI":"10.1016\/j.isci.2020.101775","volume":"23","author":"C Spitz","year":"2020","unstructured":"Spitz, C. et al. Non-canonical shedding of TNF\u03b1 by SPPL2a is determined by the conformational flexibility of its transmembrane helix. iScience 23, 101775 (2020).","journal-title":"iScience"},{"key":"1104_CR71","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1126\/science.1199214","volume":"332","author":"W Tang","year":"2011","unstructured":"Tang, W. et al. The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science 332, 478\u2013484 (2011).","journal-title":"Science"},{"key":"1104_CR72","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2302720120","volume":"120","author":"Y Le Guen","year":"2023","unstructured":"Le Guen, Y. et al. Multiancestry analysis of the HLA locus in Alzheimer\u2019s and Parkinson\u2019s diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes. Proc. Natl Acad. Sci. USA 120, e2302720120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1104_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19317-4","volume":"11","author":"H Trzeciakiewicz","year":"2020","unstructured":"Trzeciakiewicz, H. et al. An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline. Nat. Commun. 11, 5522 (2020).","journal-title":"Nat. Commun."},{"key":"1104_CR74","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising, C. et al. NLRP3 inflammasome activation drives tau pathology. Nature 575, 669\u2013673 (2019).","journal-title":"Nature"},{"key":"1104_CR75","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00401-020-02138-6","volume":"139","author":"L Kleineidam","year":"2020","unstructured":"Kleineidam, L. et al. PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment. Acta Neuropathol. 139, 1025\u20131044 (2020).","journal-title":"Acta Neuropathol."},{"key":"1104_CR76","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201910606","volume":"12","author":"A Sierksma","year":"2020","unstructured":"Sierksma, A. et al. Novel Alzheimer risk genes determine the microglia response to amyloid-\u03b2 but not to TAU pathology. EMBO Mol. Med. 12, e10606 (2020).","journal-title":"EMBO Mol. Med."},{"key":"1104_CR77","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nature14252","volume":"518","author":"E Gjoneska","year":"2015","unstructured":"Gjoneska, E. et al. Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer\u2019s disease. Nature 518, 365\u2013369 (2015).","journal-title":"Nature"},{"key":"1104_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24243-0","volume":"12","author":"B Hu","year":"2021","unstructured":"Hu, B. et al. Neuronal and glial 3D chromatin architecture informs the cellular etiology of brain disorders. Nat. Commun. 12, 3968 (2021).","journal-title":"Nat. Commun."},{"key":"1104_CR79","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/s41588-022-01149-1","volume":"54","author":"R Kosoy","year":"2022","unstructured":"Kosoy, R. et al. Genetics of the human microglia regulome refines Alzheimer\u2019s disease risk loci. Nat. Genet. 54, 1145\u20131154 (2022).","journal-title":"Nat. Genet."},{"key":"1104_CR80","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1126\/science.aay0793","volume":"366","author":"A Nott","year":"2019","unstructured":"Nott, A. et al. Brain cell type-specific enhancer-promoter interactome maps and disease-risk association. Science 366, 1134\u20131139 (2019).","journal-title":"Science"},{"key":"1104_CR81","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1016\/j.molcel.2021.08.004","volume":"81","author":"TD Troutman","year":"2021","unstructured":"Troutman, T. D., Kofman, E. & Glass, C. K. Exploiting dynamic enhancer landscapes to decode macrophage and microglia phenotypes in health and disease. Mol. Cell 81, 3888\u20133903 (2021).","journal-title":"Mol. Cell"},{"key":"1104_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07548-5","volume":"9","author":"A Shemer","year":"2018","unstructured":"Shemer, A. et al. Engrafted parenchymal brain macrophages differ from microglia in transcriptome, chromatin landscape and response to challenge. Nat. Commun. 9, 5206 (2018).","journal-title":"Nat. Commun."},{"key":"1104_CR83","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-018-0023-4","volume":"556","author":"AC Wendeln","year":"2018","unstructured":"Wendeln, A. C. et al. Innate immune memory in the brain shapes neurological disease hallmarks. Nature 556, 332\u2013338 (2018).","journal-title":"Nature"},{"key":"1104_CR84","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13112","volume":"33","author":"M Montalbano","year":"2023","unstructured":"Montalbano, M., Majmundar, L., Sengupta, U., Fung, L. & Kayed, R. Pathological tau signatures and nuclear alterations in neurons, astrocytes and microglia in Alzheimer\u2019s disease, progressive supranuclear palsy, and dementia with Lewy bodies. Brain Pathol. 33, e13112 (2023).","journal-title":"Brain Pathol."},{"key":"1104_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2016.07.006","volume":"47","author":"SM Matt","year":"2016","unstructured":"Matt, S. M., Lawson, M. A. & Johnson, R. W. Aging and peripheral lipopolysaccharide can modulate epigenetic regulators and decrease IL-1\u03b2 promoter DNA methylation in microglia. Neurobiol. Aging 47, 1\u20139 (2016).","journal-title":"Neurobiol. Aging"},{"key":"1104_CR86","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.neuroscience.2021.05.027","volume":"468","author":"BA McGregor","year":"2021","unstructured":"McGregor, B. A. et al. Alpha-synuclein-induced DNA methylation and gene expression in microglia. Neuroscience 468, 186\u2013198 (2021).","journal-title":"Neuroscience"},{"key":"1104_CR87","doi-asserted-by":"publisher","DOI":"10.1101\/2022.08.04.502805","author":"AM Xavier","year":"2022","unstructured":"Xavier, A. M. et al. Systematic delineation of signaling and epigenomic mechanisms underlying microglia inflammatory activity in acute and chronic brain pathologies. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2022.08.04.502805 (2022).","journal-title":"bioRxiv"},{"key":"1104_CR88","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/s41593-018-0192-3","volume":"21","author":"P Ayata","year":"2018","unstructured":"Ayata, P. et al. Epigenetic regulation of brain region-specific microglia clearance activity. Nat. Neurosci. 21, 1049\u20131060 (2018).","journal-title":"Nat. Neurosci."},{"key":"1104_CR89","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cdd.2013.159","volume":"21","author":"Y Tang","year":"2014","unstructured":"Tang, Y. et al. Jmjd3 is essential for the epigenetic modulation of microglia phenotypes in the immune pathogenesis of Parkinson\u2019s disease. Cell Death Differ. 21, 369\u2013380 (2014).","journal-title":"Cell Death Differ."},{"key":"1104_CR90","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.bbi.2018.09.019","volume":"74","author":"G Rigillo","year":"2018","unstructured":"Rigillo, G. et al. LPS-induced histone H3 phospho(Ser10)-acetylation(Lys14) regulates neuronal and microglial neuroinflammatory response. Brain Behav. Immun. 74, 277\u2013290 (2018).","journal-title":"Brain Behav. Immun."},{"key":"1104_CR91","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.cmet.2022.02.013","volume":"34","author":"RY Pan","year":"2022","unstructured":"Pan, R. Y. et al. Positive feedback regulation of microglial glucose metabolism by histone H4 lysine 12 lactylation in Alzheimer\u2019s disease. Cell Metab. 34, 634\u2013648.e6 (2022).","journal-title":"Cell Metab."},{"key":"1104_CR92","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.neurobiolaging.2019.06.005","volume":"82","author":"A Ansari","year":"2019","unstructured":"Ansari, A. et al. miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer\u2019s disease. Neurobiol. Aging 82, 102\u2013109 (2019).","journal-title":"Neurobiol. Aging"},{"key":"1104_CR93","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202013659","volume":"13","author":"MR Islam","year":"2021","unstructured":"Islam, M. R. et al. A microRNA signature that correlates with cognition and is a target against cognitive decline. EMBO Mol. Med. 13, e13659 (2021).","journal-title":"EMBO Mol. Med."},{"key":"1104_CR94","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3390\/genes2030449","volume":"2","author":"A Nagy","year":"2011","unstructured":"Nagy, A. et al. Reassessing domain architecture evolution of metazoan proteins: major impact of gene prediction errors. Genes 2, 449\u2013501 (2011).","journal-title":"Genes"},{"key":"1104_CR95","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3389\/fnins.2018.00636","volume":"12","author":"SM Matt","year":"2018","unstructured":"Matt, S. M. et al. Inhibition of DNA methylation with zebularine alters lipopolysaccharide-induced sickness behavior and neuroinflammation in mice. Front. Neurosci. 12, 636 (2018).","journal-title":"Front. Neurosci."},{"key":"1104_CR96","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s11064-018-2532-9","volume":"43","author":"FZ Jiao","year":"2018","unstructured":"Jiao, F. Z. et al. Histone deacetylase 2 inhibitor CAY10683 alleviates lipopolysaccharide induced neuroinflammation through attenuating TLR4\/NF-\u03baB signaling pathway. Neurochem. Res. 43, 1161\u20131170 (2018).","journal-title":"Neurochem. Res."},{"key":"1104_CR97","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13024-021-00496-7","volume":"16","author":"H Walgrave","year":"2021","unstructured":"Walgrave, H., Zhou, L., De Strooper, B. & Salta, E. The promise of microRNA-based therapies in Alzheimer\u2019s disease: challenges and perspectives. Mol. Neurodegener. 16, 76 (2021).","journal-title":"Mol. Neurodegener."},{"key":"1104_CR98","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.1523\/JNEUROSCI.3474-17.2018","volume":"38","author":"P Periyasamy","year":"2018","unstructured":"Periyasamy, P. et al. Epigenetic promoter DNA methylation of miR-124 promotes HIV-1 tat-mediated microglial activation via MECP2-STAT3 axis. J. Neurosci. 38, 5367\u20135383 (2018).","journal-title":"J. Neurosci."},{"key":"1104_CR99","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.celrep.2019.09.013","volume":"29","author":"A Carrillo-Jimenez","year":"2019","unstructured":"Carrillo-Jimenez, A. et al. TET2 regulates the neuroinflammatory response in microglia. Cell Rep. 29, 697\u2013713.e8 (2019).","journal-title":"Cell Rep."},{"key":"1104_CR100","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.immuni.2018.02.016","volume":"48","author":"M Datta","year":"2018","unstructured":"Datta, M. et al. Histone deacetylases 1 and 2 regulate microglia function during development, homeostasis, and neurodegeneration in a context-dependent manner. Immunity 48, 514\u2013529.e6 (2018).","journal-title":"Immunity"},{"key":"1104_CR101","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1523\/JNEUROSCI.2939-14.2015","volume":"35","author":"SH Cho","year":"2015","unstructured":"Cho, S. H. et al. SIRT1 deficiency in microglia contributes to cognitive decline in aging and neurodegeneration via epigenetic regulation of IL-1\u03b2. J. Neurosci. 35, 807\u2013818 (2015).","journal-title":"J. Neurosci."},{"key":"1104_CR102","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201911227","volume":"12","author":"K Schlepckow","year":"2020","unstructured":"Schlepckow, K. et al. Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region. EMBO Mol. Med. 12, e11227 (2020).","journal-title":"EMBO Mol. Med."},{"key":"1104_CR103","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3389\/fncel.2018.00243","volume":"12","author":"M Cheray","year":"2018","unstructured":"Cheray, M. & Joseph, B. Epigenetics control microglia plasticity. Front. Cell Neurosci. 12, 243 (2018).","journal-title":"Front. Cell Neurosci."},{"key":"1104_CR104","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","volume":"110","author":"RC Paolicelli","year":"2022","unstructured":"Paolicelli, R. C. et al. Microglia states and nomenclature: a field at its crossroads. Neuron 110, 3458\u20133483 (2022).","journal-title":"Neuron"},{"key":"1104_CR105","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/j.celrep.2016.04.063","volume":"15","author":"F Denk","year":"2016","unstructured":"Denk, F., Crow, M., Didangelos, A., Lopes, D. M. & McMahon, S. B. Persistent alterations in microglial enhancers in a model of chronic pain. Cell Rep. 15, 1771\u20131781 (2016).","journal-title":"Cell Rep."},{"key":"1104_CR106","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.bbi.2015.03.013","volume":"48","author":"W Schaafsma","year":"2015","unstructured":"Schaafsma, W. et al. Long-lasting pro-inflammatory suppression of microglia by LPS-preconditioning is mediated by RelB-dependent epigenetic silencing. Brain Behav. Immun. 48, 205\u2013221 (2015).","journal-title":"Brain Behav. Immun."},{"key":"1104_CR107","doi-asserted-by":"publisher","first-page":"17835","DOI":"10.1523\/JNEUROSCI.3297-11.2011","volume":"31","author":"JM Schwarz","year":"2011","unstructured":"Schwarz, J. M., Hutchinson, M. R. & Bilbo, S. D. Early-life experience decreases drug-induced reinstatement of morphine CPP in adulthood via microglial-specific epigenetic programming of anti-inflammatory IL-10 expression. J. Neurosci. 31, 17835\u201317847 (2011).","journal-title":"J. Neurosci."},{"key":"1104_CR108","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1001\/jamaneurol.2018.0815","volume":"75","author":"DE Barnes","year":"2018","unstructured":"Barnes, D. E. et al. Association of mild traumatic brain injury with and without loss of consciousness with dementia in US military veterans. JAMA Neurol. 75, 1055\u20131061 (2018).","journal-title":"JAMA Neurol."},{"key":"1104_CR109","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3233\/JAD-220069","volume":"87","author":"A Graham","year":"2022","unstructured":"Graham, A., Livingston, G., Purnell, L. & Huntley, J. Mild traumatic brain injuries and future risk of developing alzheimer\u2019s disease: systematic review and meta-analysis. J. Alzheimers Dis. 87, 969\u2013979 (2022).","journal-title":"J. Alzheimers Dis."},{"key":"1104_CR110","doi-asserted-by":"publisher","first-page":"afab194","DOI":"10.1093\/ageing\/afab194","volume":"51","author":"KK Leung","year":"2022","unstructured":"Leung, K. K., Carr, F. M., Russell, M. J., Bremault-Phillips, S. & Triscott, J. A. C. Traumatic brain injuries among veterans and the risk of incident dementia: a systematic review & meta-analysis. Age Ageing 51, afab194 (2022).","journal-title":"Age Ageing"},{"key":"1104_CR111","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1001\/jamaneurol.2016.1948","volume":"73","author":"PK Crane","year":"2016","unstructured":"Crane, P. K. et al. Association of traumatic brain injury with late-life neurodegenerative conditions and neuropathologic findings. JAMA Neurol. 73, 1062\u20131069 (2016).","journal-title":"JAMA Neurol."},{"key":"1104_CR112","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.jalz.2018.12.015","volume":"15","author":"MA Sugarman","year":"2019","unstructured":"Sugarman, M. A. et al. Failure to detect an association between self-reported traumatic brain injury and Alzheimer\u2019s disease neuropathology and dementia. Alzheimers Dement. 15, 686\u2013698 (2019).","journal-title":"Alzheimers Dement."},{"key":"1104_CR113","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1159\/000355478","volume":"37","author":"EL Abner","year":"2014","unstructured":"Abner, E. L. et al. Self-reported head injury and risk of late-life impairment and AD pathology in an AD center cohort. Dement. Geriatr. Cogn. Disord. 37, 294\u2013306 (2014).","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"1104_CR114","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.9311","volume":"5","author":"S Agrawal","year":"2022","unstructured":"Agrawal, S. et al. Association of traumatic brain injury with and without loss of consciousness with neuropathologic outcomes in community-dwelling older persons. JAMA Netw. Open 5, e229311 (2022).","journal-title":"JAMA Netw. Open"},{"key":"1104_CR115","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/brain\/aws307","volume":"136","author":"AC McKee","year":"2013","unstructured":"McKee, A. C. et al. The spectrum of disease in chronic traumatic encephalopathy. Brain 136, 43\u201364 (2013).","journal-title":"Brain"},{"key":"1104_CR116","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/ana.25611","volume":"87","author":"J Mez","year":"2020","unstructured":"Mez, J. et al. Duration of American football play and chronic traumatic encephalopathy. Ann. Neurol. 87, 116\u2013131 (2020).","journal-title":"Ann. Neurol."},{"key":"1104_CR117","first-page":"1147","volume":"74","author":"JR Hay","year":"2015","unstructured":"Hay, J. R., Johnson, V. E., Young, A. M., Smith, D. H. & Stewart, W. Blood-brain barrier disruption is an early event that may persist for many years after traumatic brain injury in humans. J. Neuropathol. Exp. Neurol. 74, 1147\u20131157 (2015).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1104_CR118","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/jnen\/nlac122","volume":"82","author":"D Kirsch","year":"2023","unstructured":"Kirsch, D. et al. Vascular injury is associated with repetitive head impacts and tau pathology in chronic traumatic encephalopathy. J. Neuropathol. Exp. Neurol. 82, 127\u2013139 (2023).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1104_CR119","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-02036-4","volume":"17","author":"JD Cherry","year":"2020","unstructured":"Cherry, J. D. et al. CCL2 is associated with microglia and macrophage recruitment in chronic traumatic encephalopathy. J. Neuroinflammation 17, 370 (2020).","journal-title":"J. Neuroinflammation"},{"key":"1104_CR120","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s40478-016-0382-8","volume":"4","author":"JD Cherry","year":"2016","unstructured":"Cherry, J. D. et al. Microglial neuroinflammation contributes to tau accumulation in chronic traumatic encephalopathy. Acta Neuropathol. Commun. 4, 112 (2016).","journal-title":"Acta Neuropathol. Commun."},{"key":"1104_CR121","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.3171\/jns.2003.98.5.1072","volume":"98","author":"DH Smith","year":"2003","unstructured":"Smith, D. H., Chen, X. H., Iwata, A. & Graham, D. I. Amyloid \u03b2 accumulation in axons after traumatic brain injury in humans. J. Neurosurg. 98, 1072\u20131077 (2003).","journal-title":"J. Neurosurg."},{"key":"1104_CR122","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1177\/0271678X221119288","volume":"42","author":"A Drieu","year":"2022","unstructured":"Drieu, A. et al. Persistent neuroinflammation and behavioural deficits after single mild traumatic brain injury. J. Cereb. Blood Flow. Metab. 42, 2216\u20132229 (2022).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"1104_CR123","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1089\/neu.2015.3970","volume":"33","author":"O Kokiko-Cochran","year":"2016","unstructured":"Kokiko-Cochran, O. et al. Altered neuroinflammation and behavior after traumatic brain injury in a mouse model of Alzheimer\u2019s disease. J. Neurotrauma 33, 625\u2013640 (2016).","journal-title":"J. Neurotrauma"},{"key":"1104_CR124","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/glia.20638","volume":"56","author":"Y Nadler","year":"2008","unstructured":"Nadler, Y. et al. Increased expression of the \u03b3-secretase components presenilin-1 and nicastrin in activated astrocytes and microglia following traumatic brain injury. Glia 56, 552\u2013567 (2008).","journal-title":"Glia"},{"key":"1104_CR125","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/jnr.24419","volume":"98","author":"E Gabande-Rodriguez","year":"2020","unstructured":"Gabande-Rodriguez, E., Keane, L. & Capasso, M. Microglial phagocytosis in aging and Alzheimer\u2019s disease. J. Neurosci. Res. 98, 284\u2013298 (2020).","journal-title":"J. Neurosci. Res."},{"key":"1104_CR126","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1016\/j.cell.2021.03.032","volume":"184","author":"MK Shin","year":"2021","unstructured":"Shin, M. K. et al. Reducing acetylated tau is neuroprotective in brain injury. Cell 184, 2715\u20132732.e23 (2021).","journal-title":"Cell"},{"key":"1104_CR127","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3389\/fimmu.2018.00672","volume":"9","author":"ON Kokiko-Cochran","year":"2018","unstructured":"Kokiko-Cochran, O. N. & Godbout, J. P. The inflammatory continuum of traumatic brain injury and Alzheimer\u2019s disease. Front. Immunol. 9, 672 (2018).","journal-title":"Front. Immunol."},{"key":"1104_CR128","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/jnen\/nly065","volume":"77","author":"JW Adams","year":"2018","unstructured":"Adams, J. W. et al. Lewy body pathology and chronic traumatic encephalopathy associated with contact sports. J. Neuropathol. Exp. Neurol. 77, 757\u2013768 (2018).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1104_CR129","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00401-023-02539-3","volume":"145","author":"R Nicks","year":"2023","unstructured":"Nicks, R. et al. Repetitive head impacts and chronic traumatic encephalopathy are associated with TDP-43 inclusions and hippocampal sclerosis. Acta Neuropathol. 145, 395\u2013408 (2023).","journal-title":"Acta Neuropathol."},{"key":"1104_CR130","doi-asserted-by":"publisher","first-page":"101045","DOI":"10.1016\/j.arr.2020.101045","volume":"64","author":"G Grande","year":"2020","unstructured":"Grande, G., Qiu, C. & Fratiglioni, L. Prevention of dementia in an ageing world: evidence and biological rationale. Ageing Res. Rev. 64, 101045 (2020).","journal-title":"Ageing Res. Rev."},{"key":"1104_CR131","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","volume":"390","author":"G Livingston","year":"2017","unstructured":"Livingston, G. et al. Dementia prevention, intervention, and care. Lancet 390, 2673\u20132734 (2017).","journal-title":"Lancet"},{"key":"1104_CR132","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.mayocp.2016.04.024","volume":"91","author":"A Santos-Lozano","year":"2016","unstructured":"Santos-Lozano, A. et al. Physical activity and Alzheimer disease: a protective association. Mayo Clin. Proc. 91, 999\u20131020 (2016).","journal-title":"Mayo Clin. Proc."},{"key":"1104_CR133","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1093\/gerona\/glaa268","volume":"76","author":"T Yoneda","year":"2021","unstructured":"Yoneda, T. et al. The importance of engaging in physical activity in older adulthood for transitions between cognitive status categories and death: a coordinated analysis of 14 longitudinal studies. J. Gerontol. A Biol. Sci. Med. Sci. 76, 1661\u20131667 (2021).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"1104_CR134","doi-asserted-by":"publisher","first-page":"112141","DOI":"10.1016\/j.exger.2023.112141","volume":"175","author":"S Ayari","year":"2023","unstructured":"Ayari, S., Abellard, A., Carayol, M., Guedj, E. & Gavarry, O. A systematic review of exercise modalities that reduce pro-inflammatory cytokines in humans and animals\u2019 models with mild cognitive impairment or dementia. Exp. Gerontol. 175, 112141 (2023).","journal-title":"Exp. Gerontol."},{"key":"1104_CR135","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1136\/bjsports-2016-095999","volume":"51","author":"MV Fedewa","year":"2017","unstructured":"Fedewa, M. V., Hathaway, E. D. & Ward-Ritacco, C. L. Effect of exercise training on C reactive protein: a systematic review and meta-analysis of randomised and non-randomised controlled trials. Br. J. Sports Med. 51, 670\u2013676 (2017).","journal-title":"Br. J. Sports Med."},{"key":"1104_CR136","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1523\/JNEUROSCI.1483-21.2021","volume":"42","author":"KB Casaletto","year":"2022","unstructured":"Casaletto, K. B. et al. Microglial correlates of late life physical activity: relationship with synaptic and cognitive aging in older adults. J. Neurosci. 42, 288\u2013298 (2022).","journal-title":"J. Neurosci."},{"key":"1104_CR137","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/cns.12790","volume":"24","author":"M Cao","year":"2018","unstructured":"Cao, M. et al. Enriched physical environment reverses spatial cognitive impairment of socially isolated APPswe\/PS1dE9 transgenic mice before amyloidosis onset. CNS Neurosci. Ther. 24, 202\u2013211 (2018).","journal-title":"CNS Neurosci. Ther."},{"key":"1104_CR138","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3389\/fncel.2018.00224","volume":"12","author":"C Grinan-Ferre","year":"2018","unstructured":"Grinan-Ferre, C. et al. Environmental enrichment improves cognitive deficits, AD hallmarks and epigenetic alterations presented in 5xFAD mouse model. Front. Cell Neurosci. 12, 224 (2018).","journal-title":"Front. Cell Neurosci."},{"key":"1104_CR139","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3390\/cells8070691","volume":"8","author":"O Mee-Inta","year":"2019","unstructured":"Mee-Inta, O., Zhao, Z. W. & Kuo, Y. M. Physical exercise inhibits inflammation and microglial activation. Cells 8, 691 (2019).","journal-title":"Cells"},{"key":"1104_CR140","doi-asserted-by":"publisher","first-page":"100149","DOI":"10.1016\/j.bbih.2020.100149","volume":"9","author":"M Nakano","year":"2020","unstructured":"Nakano, M. et al. An enriched environment prevents cognitive impairment in an Alzheimer\u2019s disease model by enhancing the secretion of exosomal microRNA-146a from the choroid plexus. Brain Behav. Immun. Health 9, 100149 (2020).","journal-title":"Brain Behav. Immun. Health"},{"key":"1104_CR141","doi-asserted-by":"publisher","first-page":"9041","DOI":"10.1523\/JNEUROSCI.1023-16.2016","volume":"36","author":"H Xu","year":"2016","unstructured":"Xu, H. et al. Environmental enrichment potently prevents microglia-mediated neuroinflammation by human amyloid \u03b2-protein oligomers. J. Neurosci. 36, 9041\u20139056 (2016).","journal-title":"J. Neurosci."},{"key":"1104_CR142","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.neuroscience.2019.04.015","volume":"408","author":"KE Stuart","year":"2019","unstructured":"Stuart, K. E. et al. Late-life environmental enrichment preserves short-term memory and may attenuate microglia in male APP\/PS1 mice. Neuroscience 408, 282\u2013292 (2019).","journal-title":"Neuroscience"},{"key":"1104_CR143","doi-asserted-by":"publisher","first-page":"167","DOI":"10.15252\/embj.201797021","volume":"37","author":"S Ziegler-Waldkirch","year":"2018","unstructured":"Ziegler-Waldkirch, S. et al. Seed-induced A\u03b2 deposition is modulated by microglia under environmental enrichment in a mouse model of Alzheimer\u2019s disease. EMBO J. 37, 167\u2013182 (2018).","journal-title":"EMBO J."},{"key":"1104_CR144","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/jhn.12139","volume":"27","author":"A Alhazmi","year":"2014","unstructured":"Alhazmi, A., Stojanovski, E., McEvoy, M. & Garg, M. L. The association between dietary patterns and type 2 diabetes: a systematic review and meta-analysis of cohort studies. J. Hum. Nutr. Diet. 27, 251\u2013260 (2014).","journal-title":"J. Hum. Nutr. Diet."},{"key":"1104_CR145","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1001\/jama.2022.7408","volume":"328","author":"CD Patnode","year":"2022","unstructured":"Patnode, C. D., Redmond, N., Iacocca, M. O. & Henninger, M. Behavioral counseling interventions to promote a healthy diet and physical activity for cardiovascular disease prevention in adults without known cardiovascular disease risk factors: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 328, 375\u2013388 (2022).","journal-title":"JAMA"},{"key":"1104_CR146","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.immuni.2019.09.020","volume":"51","author":"A Christ","year":"2019","unstructured":"Christ, A., Lauterbach, M. & Latz, E. Western diet and the immune system: an inflammatory connection. Immunity 51, 794\u2013811 (2019).","journal-title":"Immunity"},{"key":"1104_CR147","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","volume":"25","author":"D Furman","year":"2019","unstructured":"Furman, D. et al. Chronic inflammation in the etiology of disease across the life span. Nat. Med. 25, 1822\u20131832 (2019).","journal-title":"Nat. Med."},{"key":"1104_CR148","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2018101064","volume":"38","author":"D Tejera","year":"2019","unstructured":"Tejera, D. et al. Systemic inflammation impairs microglial A\u03b2 clearance through NLRP3 inflammasome. EMBO J. 38, e101064 (2019).","journal-title":"EMBO J."},{"key":"1104_CR149","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.bbi.2023.07.006","volume":"113","author":"Y Yang","year":"2023","unstructured":"Yang, Y. et al. LPS priming before plaque deposition impedes microglial activation and restrains A\u03b2 pathology in the 5xFAD mouse model of Alzheimer\u2019s disease. Brain Behav. Immun. 113, 228\u2013247 (2023).","journal-title":"Brain Behav. Immun."},{"key":"1104_CR150","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/s41380-023-01975-7","volume":"28","author":"MR Duggan","year":"2023","unstructured":"Duggan, M. R. et al. Plasma proteins related to inflammatory diet predict future cognitive impairment. Mol. Psychiatry 28, 1599\u20131609 (2023).","journal-title":"Mol. Psychiatry"},{"key":"1104_CR151","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-02940-5","volume":"21","author":"Y Shi","year":"2023","unstructured":"Shi, Y. et al. Association of pro-inflammatory diet with increased risk of all-cause dementia and Alzheimer\u2019s dementia: a prospective study of 166,377 UK Biobank participants. BMC Med. 21, 266 (2023).","journal-title":"BMC Med."},{"key":"1104_CR152","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/alz.12685","volume":"19","author":"D Melo Van Lent","year":"2023","unstructured":"Melo Van Lent, D. et al. Higher dietary inflammatory index scores are associated with brain MRI markers of brain aging: results from the Framingham Heart Study offspring cohort. Alzheimers Dement. 19, 621\u2013631 (2023).","journal-title":"Alzheimers Dement."},{"key":"1104_CR153","doi-asserted-by":"publisher","first-page":"e2920","DOI":"10.1212\/WNL.0000000000012067","volume":"96","author":"T Ballarini","year":"2021","unstructured":"Ballarini, T. et al. Mediterranean diet, Alzheimer disease biomarkers and brain atrophy in old age. Neurology 96, e2920\u2013e2932 (2021).","journal-title":"Neurology"},{"key":"1104_CR154","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.3390\/jcm10204642","volume":"10","author":"N Garcia-Casares","year":"2021","unstructured":"Garcia-Casares, N. et al. Alzheimer\u2019s disease, mild cognitive impairment and Mediterranean diet. A systematic review and dose-response meta-analysis. J. Clin. Med. 10, 4642 (2021).","journal-title":"J. Clin. Med."},{"key":"1104_CR155","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S1474-4422(18)30338-7","volume":"17","author":"N Scarmeas","year":"2018","unstructured":"Scarmeas, N., Anastasiou, C. A. & Yannakoulia, M. Nutrition and prevention of cognitive impairment. Lancet Neurol. 17, 1006\u20131015 (2018).","journal-title":"Lancet Neurol."},{"key":"1104_CR156","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.numecd.2014.03.003","volume":"24","author":"L Schwingshackl","year":"2014","unstructured":"Schwingshackl, L. & Hoffmann, G. Mediterranean dietary pattern, inflammation and endothelial function: a systematic review and meta-analysis of intervention trials. Nutr. Metab. Cardiovasc. Dis. 24, 929\u2013939 (2014).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"1104_CR157","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/advances\/nmaa116","volume":"12","author":"PY Wu","year":"2021","unstructured":"Wu, P. Y., Chen, K. M. & Tsai, W. C. The Mediterranean dietary pattern and inflammation in older adults: a systematic review and meta-analysis. Adv. Nutr. 12, 363\u2013373 (2021).","journal-title":"Adv. Nutr."},{"key":"1104_CR158","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","volume":"385","author":"T Ngandu","year":"2015","unstructured":"Ngandu, T. et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 385, 2255\u20132263 (2015).","journal-title":"Lancet"},{"key":"1104_CR159","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41582-021-00579-5","volume":"17","author":"BM Bettcher","year":"2021","unstructured":"Bettcher, B. M., Tansey, M. G., Dorothee, G. & Heneka, M. T. Publisher correction: peripheral and central immune system crosstalk in Alzheimer disease \u2014 a research prospectus. Nat. Rev. Neurol. 17, 724 (2021).","journal-title":"Nat. Rev. Neurol."},{"key":"1104_CR160","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/S1473-3099(21)00144-4","volume":"21","author":"PN Sipila","year":"2021","unstructured":"Sipila, P. N. et al. Hospital-treated infectious diseases and the risk of dementia: a large, multicohort, observational study with a replication cohort. Lancet Infect. Dis. 21, 1557\u20131567 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"1104_CR161","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neuron.2010.08.023","volume":"68","author":"K Bhaskar","year":"2010","unstructured":"Bhaskar, K. et al. Regulation of tau pathology by the microglial fractalkine receptor. Neuron 68, 19\u201331 (2010).","journal-title":"Neuron"},{"key":"1104_CR162","doi-asserted-by":"publisher","first-page":"8843","DOI":"10.1523\/JNEUROSCI.2868-05.2005","volume":"25","author":"M Kitazawa","year":"2005","unstructured":"Kitazawa, M., Oddo, S., Yamasaki, T. R., Green, K. N. & LaFerla, F. M. Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer\u2019s disease. J. Neurosci. 25, 8843\u20138853 (2005).","journal-title":"J. Neurosci."},{"key":"1104_CR163","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1111\/j.1582-4934.2012.01556.x","volume":"16","author":"H Sarlus","year":"2012","unstructured":"Sarlus, H. et al. Allergy influences the inflammatory status of the brain and enhances tau-phosphorylation. J. Cell Mol. Med. 16, 2401\u20132412 (2012).","journal-title":"J. Cell Mol. Med."},{"key":"1104_CR164","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1212\/WNL.0b013e3181b6bb95","volume":"73","author":"C Holmes","year":"2009","unstructured":"Holmes, C. et al. Systemic inflammation and disease progression in Alzheimer disease. Neurology 73, 768\u2013774 (2009).","journal-title":"Neurology"},{"key":"1104_CR165","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.it.2019.02.001","volume":"40","author":"JJ Neher","year":"2019","unstructured":"Neher, J. J. & Cunningham, C. Priming microglia for innate immune memory in the brain. Trends Immunol. 40, 358\u2013374 (2019).","journal-title":"Trends Immunol."},{"key":"1104_CR166","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1161\/STROKEAHA.117.018675","volume":"48","author":"KA Walker","year":"2017","unstructured":"Walker, K. A. et al. Midlife systemic inflammation, late-life white matter integrity, and cerebral small vessel disease: the atherosclerosis risk in communities study. Stroke 48, 3196\u20133202 (2017).","journal-title":"Stroke"},{"key":"1104_CR167","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","volume":"20","author":"MG Netea","year":"2020","unstructured":"Netea, M. G. et al. Defining trained immunity and its role in health and disease. Nat. Rev. Immunol. 20, 375\u2013388 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1104_CR168","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1002\/alz.12341","volume":"17","author":"AB Lopez-Rodriguez","year":"2021","unstructured":"Lopez-Rodriguez, A. B. et al. Acute systemic inflammation exacerbates neuroinflammation in Alzheimer\u2019s disease: IL-1\u03b2 drives amplified responses in primed astrocytes and neuronal network dysfunction. Alzheimers Dement. 17, 1735\u20131755 (2021).","journal-title":"Alzheimers Dement."},{"key":"1104_CR169","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3233\/JAD-200064","volume":"75","author":"MA Beydoun","year":"2020","unstructured":"Beydoun, M. A. et al. Clinical and bacterial markers of periodontitis and their association with incident all-cause and Alzheimer\u2019s disease dementia in a large national survey. J. Alzheimers Dis. 75, 157\u2013172 (2020).","journal-title":"J. Alzheimers Dis."},{"key":"1104_CR170","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.14219\/jada.archive.2007.0046","volume":"138","author":"PS Stein","year":"2007","unstructured":"Stein, P. S., Desrosiers, M., Donegan, S. J., Yepes, J. F. & Kryscio, R. J. Tooth loss, dementia and neuropathology in the Nun study. J. Am. Dent. Assoc. 138, 1314\u20131322 (2007).","journal-title":"J. Am. Dent. Assoc."},{"key":"1104_CR171","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1369-5274(99)00046-6","volume":"3","author":"B Beutler","year":"2000","unstructured":"Beutler, B. Endotoxin, toll-like receptor 4, and the afferent limb of innate immunity. Curr. Opin. Microbiol. 3, 23\u201328 (2000).","journal-title":"Curr. Opin. Microbiol."},{"key":"1104_CR172","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nrmicro2873","volume":"10","author":"G Hajishengallis","year":"2012","unstructured":"Hajishengallis, G., Darveau, R. P. & Curtis, M. A. The keystone-pathogen hypothesis. Nat. Rev. Microbiol. 10, 717\u2013725 (2012).","journal-title":"Nat. Rev. Microbiol."},{"issue":"Suppl. 20","key":"1104_CR173","first-page":"S1","volume":"45","author":"JG Caton","year":"2018","unstructured":"Caton, J. G. et al. A new classification scheme for periodontal and peri-implant diseases and conditions \u2014 introduction and key changes from the 1999 classification. J. Clin. Periodontol. 45 (Suppl. 20), S1\u2013S8 (2018).","journal-title":"J. Clin. Periodontol."},{"key":"1104_CR174","doi-asserted-by":"publisher","first-page":"eaau3333","DOI":"10.1126\/sciadv.aau3333","volume":"5","author":"SS Dominy","year":"2019","unstructured":"Dominy, S. S. et al. Porphyromonas gingivalis in Alzheimer\u2019s disease brains: evidence for disease causation and treatment with small-molecule inhibitors. Sci. Adv. 5, eaau3333 (2019).","journal-title":"Sci. Adv."},{"key":"1104_CR175","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3233\/JAD-121918","volume":"36","author":"S Poole","year":"2013","unstructured":"Poole, S., Singhrao, S. K., Kesavalu, L., Curtis, M. A. & Crean, S. Determining the presence of periodontopathic virulence factors in short-term postmortem Alzheimer\u2019s disease brain tissue. J. Alzheimers Dis. 36, 665\u2013677 (2013).","journal-title":"J. Alzheimers Dis."},{"key":"1104_CR176","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3233\/ADR-180080","volume":"2","author":"SK Singhrao","year":"2018","unstructured":"Singhrao, S. K. & Olsen, I. Are Porphyromonas gingivalis outer membrane vesicles microbullets for sporadic Alzheimer\u2019s disease manifestation? J. Alzheimers Dis. Rep. 2, 219\u2013228 (2018).","journal-title":"J. Alzheimers Dis. Rep."},{"key":"1104_CR177","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3233\/JAD-170304","volume":"60","author":"F Rokad","year":"2017","unstructured":"Rokad, F. et al. Cerebral oxidative stress and microvasculature defects in TNF-\u03b1 expressing transgenic and Porphyromonas gingivalis-infected ApoE-\/- mice. J. Alzheimers Dis. 60, 359\u2013369 (2017).","journal-title":"J. Alzheimers Dis."},{"key":"1104_CR178","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3389\/fnins.2020.00658","volume":"14","author":"Y Hu","year":"2020","unstructured":"Hu, Y. et al. Periodontitis induced by P. gingivalis-LPS is associated with neuroinflammation and learning and memory impairment in Sprague-Dawley rats. Front. Neurosci. 14, 658 (2020).","journal-title":"Front. Neurosci."},{"key":"1104_CR179","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204941","volume":"13","author":"V Ilievski","year":"2018","unstructured":"Ilievski, V. et al. Chronic oral application of a periodontal pathogen results in brain inflammation, neurodegeneration and amyloid beta production in wild type mice. PLoS One 13, e0204941 (2018).","journal-title":"PLoS One"},{"key":"1104_CR180","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3233\/JAD-140315","volume":"43","author":"S Poole","year":"2015","unstructured":"Poole, S. et al. Active invasion of Porphyromonas gingivalis and infection-induced complement activation in ApoE-\/- mice brains. J. Alzheimers Dis. 43, 67\u201380 (2015).","journal-title":"J. Alzheimers Dis."},{"key":"1104_CR181","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-1052-x","volume":"15","author":"J Zhang","year":"2018","unstructured":"Zhang, J. et al. Porphyromonas gingivalis lipopolysaccharide induces cognitive dysfunction, mediated by neuronal inflammation via activation of the TLR4 signaling pathway in C57BL\/6 mice. J. Neuroinflammation 15, 37 (2018).","journal-title":"J. Neuroinflammation"},{"key":"1104_CR182","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3390\/toxins12050333","volume":"12","author":"Z Memedovski","year":"2020","unstructured":"Memedovski, Z. et al. Classical and alternative activation of rat microglia treated with ultrapure Porphyromonas gingivalis lipopolysaccharide in vitro. Toxins 12, 333 (2020).","journal-title":"Toxins"},{"key":"1104_CR183","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/glia.10161","volume":"40","author":"UK Hanisch","year":"2002","unstructured":"Hanisch, U. K. Microglia as a source and target of cytokines. Glia 40, 140\u2013155 (2002).","journal-title":"Glia"},{"key":"1104_CR184","doi-asserted-by":"publisher","first-page":"4916","DOI":"10.1093\/brain\/awad303","volume":"69","author":"S Grabrucker","year":"2023","unstructured":"Grabrucker, S. et al. Microbiota from Alzheimer\u2019s patients induce deficits in cognition and hippocampal neurogenesis. Brain 69, 4916\u20134934 (2023).","journal-title":"Brain"},{"key":"1104_CR185","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1136\/gutjnl-2018-317431","volume":"69","author":"MS Kim","year":"2020","unstructured":"Kim, M. S. et al. Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer\u2019s disease animal model. Gut 69, 283\u2013294 (2020).","journal-title":"Gut"},{"key":"1104_CR186","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.3390\/microorganisms9122548","volume":"9","author":"F Valeri","year":"2021","unstructured":"Valeri, F. et al. Impact of the age of cecal material transfer donors on Alzheimer\u2019s disease pathology in 5xFAD mice. Microorganisms 9, 2548 (2021).","journal-title":"Microorganisms"},{"key":"1104_CR187","doi-asserted-by":"publisher","first-page":"114473","DOI":"10.1016\/j.expneurol.2023.114473","volume":"367","author":"P Upadhyay","year":"2023","unstructured":"Upadhyay, P. & Gupta, S. Dual mode of Triphala in the reversal of cognition through gut restoration in antibiotic mediated prolonged dysbiosis condition in 5XFAD mice. Exp. Neurol. 367, 114473 (2023).","journal-title":"Exp. Neurol."},{"key":"1104_CR188","doi-asserted-by":"publisher","first-page":"1118529","DOI":"10.3389\/fmicb.2023.1118529","volume":"14","author":"K Kasarello","year":"2023","unstructured":"Kasarello, K., Cudnoch-Jedrzejewska, A. & Czarzasta, K. Communication of gut microbiota and brain via immune and neuroendocrine signaling. Front. Microbiol. 14, 1118529 (2023).","journal-title":"Front. Microbiol."},{"key":"1104_CR189","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.brainres.2018.03.015","volume":"1693","author":"P Strandwitz","year":"2018","unstructured":"Strandwitz, P. Neurotransmitter modulation by the gut microbiota. Brain Res. 1693, 128\u2013133 (2018).","journal-title":"Brain Res."},{"key":"1104_CR190","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0434-1","volume":"12","author":"WA Banks","year":"2015","unstructured":"Banks, W. A. et al. Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit. J. Neuroinflammation 12, 223 (2015).","journal-title":"J. Neuroinflammation"},{"key":"1104_CR191","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.bbi.2009.09.001","volume":"24","author":"WA Banks","year":"2010","unstructured":"Banks, W. A. & Robinson, S. M. Minimal penetration of lipopolysaccharide across the murine blood-brain barrier. Brain Behav. Immun. 24, 102\u2013109 (2010).","journal-title":"Brain Behav. Immun."},{"key":"1104_CR192","doi-asserted-by":"publisher","first-page":"263ra158","DOI":"10.1126\/scitranslmed.3009759","volume":"6","author":"V Braniste","year":"2014","unstructured":"Braniste, V. et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci. Transl. Med. 6, 263ra158 (2014).","journal-title":"Sci. Transl. Med."},{"key":"1104_CR193","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/nn.4030","volume":"18","author":"D Erny","year":"2015","unstructured":"Erny, D. et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci. 18, 965\u2013977 (2015).","journal-title":"Nat. Neurosci."},{"key":"1104_CR194","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.4049\/jimmunol.173.6.3916","volume":"173","author":"JK Olson","year":"2004","unstructured":"Olson, J. K. & Miller, S. D. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 173, 3916\u20133924 (2004).","journal-title":"J. Immunol."},{"key":"1104_CR195","doi-asserted-by":"publisher","first-page":"114908","DOI":"10.1016\/j.celrep.2024.114908","volume":"43","author":"AF Lloyd","year":"2024","unstructured":"Lloyd, A. F. et al. Deep proteomic analysis of microglia reveals fundamental biological differences between model systems. Cell Rep. 43, 114908 (2024).","journal-title":"Cell Rep."},{"key":"1104_CR196","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s40478-020-00988-5","volume":"8","author":"C Mezo","year":"2020","unstructured":"Mezo, C. et al. Different effects of constitutive and induced microbiota modulation on microglia in a mouse model of Alzheimer\u2019s disease. Acta Neuropathol. Commun. 8, 119 (2020).","journal-title":"Acta Neuropathol. Commun."},{"key":"1104_CR197","doi-asserted-by":"publisher","first-page":"eadd1236","DOI":"10.1126\/science.add1236","volume":"379","author":"DO Seo","year":"2023","unstructured":"Seo, D. O. et al. ApoE isoform- and microbiota-dependent progression of neurodegeneration in a mouse model of tauopathy. Science 379, eadd1236 (2023).","journal-title":"Science"},{"key":"1104_CR198","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.bbi.2020.11.032","volume":"92","author":"N Sun","year":"2021","unstructured":"Sun, N. et al. Antibiotic-induced microbiome depletion in adult mice disrupts blood-brain barrier and facilitates brain infiltration of monocytes after bone-marrow transplantation. Brain Behav. Immun. 92, 102\u2013114 (2021).","journal-title":"Brain Behav. Immun."},{"key":"1104_CR199","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.bbi.2016.02.020","volume":"56","author":"EE Frohlich","year":"2016","unstructured":"Frohlich, E. E. et al. Cognitive impairment by antibiotic-induced gut dysbiosis: analysis of gut microbiota-brain communication. Brain Behav. Immun. 56, 140\u2013155 (2016).","journal-title":"Brain Behav. Immun."},{"key":"1104_CR200","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.apsb.2019.07.001","volume":"10","author":"X Yang","year":"2020","unstructured":"Yang, X., Yu, D., Xue, L., Li, H. & Du, J. Probiotics modulate the microbiota-gut-brain axis and improve memory deficits in aged SAMP8 mice. Acta Pharm. Sin. B 10, 475\u2013487 (2020).","journal-title":"Acta Pharm. Sin. B"},{"key":"1104_CR201","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.immuni.2013.08.003","volume":"39","author":"T Zelante","year":"2013","unstructured":"Zelante, T. et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39, 372\u2013385 (2013).","journal-title":"Immunity"},{"key":"1104_CR202","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41586-018-0119-x","volume":"557","author":"V Rothhammer","year":"2018","unstructured":"Rothhammer, V. et al. Microglial control of astrocytes in response to microbial metabolites. Nature 557, 724\u2013728 (2018).","journal-title":"Nature"},{"key":"1104_CR203","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/nm.4106","volume":"22","author":"V Rothhammer","year":"2016","unstructured":"Rothhammer, V. et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat. Med. 22, 586\u2013597 (2016).","journal-title":"Nat. Med."},{"key":"1104_CR204","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1146\/annurev-immunol-101320-014237","volume":"40","author":"LW Yu","year":"2022","unstructured":"Yu, L. W., Agirman, G. & Hsiao, E. Y. The gut microbiome as a regulator of the neuroimmune landscape. Annu. Rev. Immunol. 40, 143\u2013167 (2022).","journal-title":"Annu. Rev. Immunol."},{"key":"1104_CR205","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/jnc.13243","volume":"135","author":"M McMillin","year":"2015","unstructured":"McMillin, M. et al. TGR5 signaling reduces neuroinflammation during hepatic encephalopathy. J. Neurochem. 135, 565\u2013576 (2015).","journal-title":"J. Neurochem."},{"key":"1104_CR206","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-11-50","volume":"11","author":"N Yanguas-Casas","year":"2014","unstructured":"Yanguas-Casas, N., Barreda-Manso, M. A., Nieto-Sampedro, M. & Romero-Ramirez, L. Tauroursodeoxycholic acid reduces glial cell activation in an animal model of acute neuroinflammation. J. Neuroinflammation 11, 50 (2014).","journal-title":"J. Neuroinflammation"},{"key":"1104_CR207","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1002\/jcp.25742","volume":"232","author":"N Yanguas-Casas","year":"2017","unstructured":"Yanguas-Casas, N., Barreda-Manso, M. A., Nieto-Sampedro, M. & Romero-Ramirez, L. TUDCA: an agonist of the bile acid receptor GPBAR1\/TGR5 with anti-inflammatory effects in microglial cells. J. Cell Physiol. 232, 2231\u20132245 (2017).","journal-title":"J. Cell Physiol."},{"key":"1104_CR208","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.immuni.2016.10.009","volume":"45","author":"C Guo","year":"2016","unstructured":"Guo, C. et al. Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome. Immunity 45, 944 (2016).","journal-title":"Immunity"},{"key":"1104_CR209","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s12035-012-8256-y","volume":"45","author":"AF Nunes","year":"2012","unstructured":"Nunes, A. F. et al. TUDCA, a bile acid, attenuates amyloid precursor protein processing and amyloid-\u03b2 deposition in APP\/PS1 mice. Mol. Neurobiol. 45, 440\u2013454 (2012).","journal-title":"Mol. Neurobiol."},{"key":"1104_CR210","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/ni.3423","volume":"17","author":"T Goldmann","year":"2016","unstructured":"Goldmann, T. et al. Origin, fate and dynamics of macrophages at central nervous system interfaces. Nat. Immunol. 17, 797\u2013805 (2016).","journal-title":"Nat. Immunol."},{"key":"1104_CR211","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.immuni.2018.01.011","volume":"48","author":"D Mrdjen","year":"2018","unstructured":"Mrdjen, D. et al. High-dimensional single-cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging, and disease. Immunity 48, 380\u2013395.e6 (2018).","journal-title":"Immunity"},{"key":"1104_CR212","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/s41593-019-0393-4","volume":"22","author":"H Van Hove","year":"2019","unstructured":"Van Hove, H. et al. A single-cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment. Nat. Neurosci. 22, 1021\u20131035 (2019).","journal-title":"Nat. Neurosci."},{"key":"1104_CR213","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/s41583-019-0201-x","volume":"20","author":"K Kierdorf","year":"2019","unstructured":"Kierdorf, K., Masuda, T., Jordao, M. J. C. & Prinz, M. Macrophages at CNS interfaces: ontogeny and function in health and disease. Nat. Rev. Neurosci. 20, 547\u2013562 (2019).","journal-title":"Nat. Rev. Neurosci."},{"key":"1104_CR214","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41586-019-0924-x","volume":"566","author":"T Masuda","year":"2019","unstructured":"Masuda, T. et al. Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution. Nature 566, 388\u2013392 (2019).","journal-title":"Nature"},{"key":"1104_CR215","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1146\/annurev-immunol-093019-110159","volume":"39","author":"M Prinz","year":"2021","unstructured":"Prinz, M., Masuda, T., Wheeler, M. A. & Quintana, F. J. Microglia and central nervous system-associated macrophages-from origin to disease modulation. Annu. Rev. Immunol. 39, 251\u2013277 (2021).","journal-title":"Annu. Rev. Immunol."},{"key":"1104_CR216","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann, S. et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity 47, 566\u2013581.e9 (2017).","journal-title":"Immunity"},{"key":"1104_CR217","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169, 1276\u20131290.e17 (2017).","journal-title":"Cell"},{"key":"1104_CR218","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/nn.4597","volume":"20","author":"TF Galatro","year":"2017","unstructured":"Galatro, T. F. et al. Transcriptomic analysis of purified human cortical microglia reveals age-associated changes. Nat. Neurosci. 20, 1162\u20131171 (2017).","journal-title":"Nat. Neurosci."},{"key":"1104_CR219","doi-asserted-by":"publisher","first-page":"eaal3222","DOI":"10.1126\/science.aal3222","volume":"356","author":"D Gosselin","year":"2017","unstructured":"Gosselin, D. et al. An environment-dependent transcriptional network specifies human microglia identity. Science 356, eaal3222 (2017).","journal-title":"Science"},{"key":"1104_CR220","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19737-2","volume":"11","author":"M Olah","year":"2020","unstructured":"Olah, M. et al. Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer\u2019s disease. Nat. Commun. 11, 6129 (2020).","journal-title":"Nat. Commun."},{"key":"1104_CR221","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1038\/s41593-019-0532-y","volume":"22","author":"R Sankowski","year":"2019","unstructured":"Sankowski, R. et al. Mapping microglia states in the human brain through the integration of high-dimensional techniques. Nat. Neurosci. 22, 2098\u20132110 (2019).","journal-title":"Nat. Neurosci."},{"key":"1104_CR222","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00401-021-02372-6","volume":"143","author":"AM Smith","year":"2022","unstructured":"Smith, A. M. et al. Diverse human astrocyte and microglial transcriptional responses to Alzheimer\u2019s pathology. Acta Neuropathol. 143, 75\u201391 (2022).","journal-title":"Acta Neuropathol."},{"key":"1104_CR223","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.celrep.2020.107843","volume":"31","author":"K Srinivasan","year":"2020","unstructured":"Srinivasan, K. et al. Alzheimer\u2019s patient microglia exhibit enhanced aging and unique transcriptional activation. Cell Rep. 31, 107843 (2020).","journal-title":"Cell Rep."},{"key":"1104_CR224","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/nbt.2858","volume":"32","author":"A Rongvaux","year":"2014","unstructured":"Rongvaux, A. et al. Development and function of human innate immune cells in a humanized mouse model. Nat. Biotechnol. 32, 364\u2013372 (2014).","journal-title":"Nat. Biotechnol."},{"key":"1104_CR225","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.neuron.2019.07.002","volume":"103","author":"J Hasselmann","year":"2019","unstructured":"Hasselmann, J. et al. Development of a chimeric model to study and manipulate human microglia in vivo. Neuron 103, 1016\u20131033.e10 (2019).","journal-title":"Neuron"},{"key":"1104_CR226","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1038\/s41593-019-0525-x","volume":"22","author":"R Mancuso","year":"2019","unstructured":"Mancuso, R. et al. Stem-cell-derived human microglia transplanted in mouse brain to study human disease. Nat. Neurosci. 22, 2111\u20132116 (2019).","journal-title":"Nat. Neurosci."},{"key":"1104_CR227","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19227-5","volume":"11","author":"A McQuade","year":"2020","unstructured":"McQuade, A. et al. Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer\u2019s disease. Nat. Commun. 11, 5370 (2020).","journal-title":"Nat. Commun."},{"key":"1104_CR228","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13024-021-00473-0","volume":"16","author":"C Claes","year":"2021","unstructured":"Claes, C. et al. Plaque-associated human microglia accumulate lipid droplets in a chimeric model of Alzheimer\u2019s disease. Mol. Neurodegener. 16, 50 (2021).","journal-title":"Mol. Neurodegener."},{"key":"1104_CR229","doi-asserted-by":"publisher","first-page":"104511","DOI":"10.1016\/j.ebiom.2023.104511","volume":"90","author":"SJ Andrews","year":"2023","unstructured":"Andrews, S. J. et al. The complex genetic architecture of Alzheimer\u2019s disease: novel insights and future directions. EBioMedicine 90, 104511 (2023).","journal-title":"EBioMedicine"},{"key":"1104_CR230","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23111-1","volume":"12","author":"A Grubman","year":"2021","unstructured":"Grubman, A. et al. Transcriptional signature in microglia associated with A\u03b2 plaque phagocytosis. Nat. Commun. 12, 3015 (2021).","journal-title":"Nat. Commun."},{"key":"1104_CR231","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41593-018-0296-9","volume":"22","author":"S Parhizkar","year":"2019","unstructured":"Parhizkar, S. et al. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nat. Neurosci. 22, 191\u2013204 (2019).","journal-title":"Nat. Neurosci."},{"key":"1104_CR232","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41590-021-00913-5","volume":"22","author":"Y Huang","year":"2021","unstructured":"Huang, Y. et al. Microglia use TAM receptors to detect and engulf amyloid \u03b2 plaques. Nat. Immunol. 22, 586\u2013594 (2021).","journal-title":"Nat. Immunol."},{"key":"1104_CR233","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/78682","volume":"6","author":"F Bard","year":"2000","unstructured":"Bard, F. et al. Peripherally administered antibodies against amyloid \u03b2-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat. Med. 6, 916\u2013919 (2000).","journal-title":"Nat. Med."},{"key":"1104_CR234","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/s43587-022-00281-1","volume":"2","author":"B Dejanovic","year":"2022","unstructured":"Dejanovic, B. et al. Complement C1q-dependent excitatory and inhibitory synapse elimination by astrocytes and microglia in Alzheimer\u2019s disease mouse models. Nat. Aging 2, 837\u2013850 (2022).","journal-title":"Nat. Aging"},{"key":"1104_CR235","doi-asserted-by":"publisher","first-page":"4954","DOI":"10.1172\/JCI138179","volume":"130","author":"M Gratuze","year":"2020","unstructured":"Gratuze, M. et al. Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegeneration. J. Clin. Invest. 130, 4954\u20134968 (2020).","journal-title":"J. Clin. Invest."},{"key":"1104_CR236","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1002\/glia.24318","volume":"71","author":"AS Popescu","year":"2023","unstructured":"Popescu, A. S. et al. Alzheimer\u2019s disease-associated R47H TREM2 increases, but wild-type TREM2 decreases, microglial phagocytosis of synaptosomes and neuronal loss. Glia 71, 974\u2013990 (2023).","journal-title":"Glia"},{"key":"1104_CR237","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2204306119","volume":"119","author":"Y Huang","year":"2022","unstructured":"Huang, Y. & Lemke, G. Early death in a mouse model of Alzheimer\u2019s disease exacerbated by microglial loss of TAM receptor signaling. Proc. Natl Acad. Sci. USA 119, e2204306119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1104_CR238","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/j.celrep.2018.07.072","volume":"24","author":"J Brelstaff","year":"2018","unstructured":"Brelstaff, J., Tolkovsky, A. M., Ghetti, B., Goedert, M. & Spillantini, M. G. Living neurons with tau filaments aberrantly expose phosphatidylserine and are phagocytosed by microglia. Cell Rep. 24, 1939\u20131948.e4 (2018).","journal-title":"Cell Rep."},{"key":"1104_CR239","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/jnc.14940","volume":"154","author":"K Pampuscenko","year":"2020","unstructured":"Pampuscenko, K. et al. Extracellular tau induces microglial phagocytosis of living neurons in cell cultures. J. Neurochem. 154, 316\u2013329 (2020).","journal-title":"J. Neurochem."},{"key":"1104_CR240","doi-asserted-by":"publisher","first-page":"110148","DOI":"10.1016\/j.celrep.2021.110148","volume":"37","author":"M Puigdellivol","year":"2021","unstructured":"Puigdellivol, M. et al. The microglial P2Y6 receptor mediates neuronal loss and memory deficits in neurodegeneration. Cell Rep. 37, 110148 (2021).","journal-title":"Cell Rep."},{"key":"1104_CR241","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.biopsych.2017.10.007","volume":"83","author":"C Condello","year":"2018","unstructured":"Condello, C., Yuan, P. & Grutzendler, J. Microglia-mediated neuroprotection, TREM2, and Alzheimer\u2019s disease: evidence from optical imaging. Biol. Psychiatry 83, 377\u2013387 (2018).","journal-title":"Biol. Psychiatry"},{"key":"1104_CR242","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7176","volume":"6","author":"C Condello","year":"2015","unstructured":"Condello, C., Yuan, P., Schain, A. & Grutzendler, J. Microglia constitute a barrier that prevents neurotoxic protofibrillar A\u03b242 hotspots around plaques. Nat. Commun. 6, 6176 (2015).","journal-title":"Nat. Commun."},{"key":"1104_CR243","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000211873","volume":"22","author":"O Fischer","year":"1907","unstructured":"Fischer, O. Miliare Nekrosen mit drusigen Wucherungen der Neuro-fibrillen, eine regelm\u00e4ssige Ver\u00e4nderung der Hirnrinde bei. Monatsschr. Psychiatr. Neurol. 22, 361 (1907).","journal-title":"Monatsschr. Psychiatr. Neurol."},{"key":"1104_CR244","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s41586-022-05491-6","volume":"612","author":"P Yuan","year":"2022","unstructured":"Yuan, P. et al. PLD3 affects axonal spheroids and network defects in Alzheimer\u2019s disease. Nature 612, 328\u2013337 (2022).","journal-title":"Nature"},{"key":"1104_CR245","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.neuron.2016.05.003","volume":"90","author":"P Yuan","year":"2016","unstructured":"Yuan, P. et al. TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron 90, 724\u2013739 (2016).","journal-title":"Neuron"},{"key":"1104_CR246","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1084\/jem.20151948","volume":"213","author":"Y Wang","year":"2016","unstructured":"Wang, Y. et al. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J. Exp. Med. 213, 667\u2013675 (2016).","journal-title":"J. Exp. Med."},{"key":"1104_CR247","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1016\/j.cell.2022.09.030","volume":"185","author":"H Ennerfelt","year":"2022","unstructured":"Ennerfelt, H. et al. SYK coordinates neuroprotective microglial responses in neurodegenerative disease. Cell 185, 4135\u20134152.e22 (2022).","journal-title":"Cell"},{"key":"1104_CR248","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1016\/j.cell.2022.09.033","volume":"185","author":"S Wang","year":"2022","unstructured":"Wang, S. et al. TREM2 drives microglia response to amyloid-\u03b2 via SYK-dependent and -independent pathways. Cell 185, 4153\u20134169.e19 (2022).","journal-title":"Cell"},{"key":"1104_CR249","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.neuron.2022.10.021","volume":"111","author":"J Hu","year":"2023","unstructured":"Hu, J. et al. Microglial Piezo1 senses A\u03b2 fibril stiffness to restrict Alzheimer\u2019s disease. Neuron 111, 15\u201329.e8 (2023).","journal-title":"Neuron"},{"key":"1104_CR250","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.neuron.2021.02.010","volume":"109","author":"SH Lee","year":"2021","unstructured":"Lee, S. H. et al. Trem2 restrains the enhancement of tau accumulation and neurodegeneration by \u03b2-amyloid pathology. Neuron 109, 1283\u20131301.e6 (2021).","journal-title":"Neuron"},{"key":"1104_CR251","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20212479","volume":"219","author":"N Zhao","year":"2022","unstructured":"Zhao, N. et al. Elevating microglia TREM2 reduces amyloid seeding and suppresses disease-associated microglia. J. Exp. Med. 219, e20212479 (2022).","journal-title":"J. Exp. Med."},{"key":"1104_CR252","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200785","volume":"217","author":"S Wang","year":"2020","unstructured":"Wang, S. et al. Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer\u2019s disease model. J. Exp. Med. 217, e20200785 (2020).","journal-title":"J. Exp. Med."},{"key":"1104_CR253","doi-asserted-by":"publisher","first-page":"eaba3239","DOI":"10.1126\/sciadv.aba3239","volume":"6","author":"EC Damisah","year":"2020","unstructured":"Damisah, E. C. et al. Astrocytes and microglia play orchestrated roles and respect phagocytic territories during neuronal corpse removal in vivo. Sci. Adv. 6, eaba3239 (2020).","journal-title":"Sci. Adv."},{"key":"1104_CR254","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1084\/jem.20171265","volume":"215","author":"JD Ulrich","year":"2018","unstructured":"Ulrich, J. D. et al. ApoE facilitates the microglial response to amyloid plaque pathology. J. Exp. Med. 215, 1047\u20131058 (2018).","journal-title":"J. Exp. Med."},{"key":"1104_CR255","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1093\/brain\/awaa088","volume":"143","author":"M Malpetti","year":"2020","unstructured":"Malpetti, M. et al. Microglial activation and tau burden predict cognitive decline in Alzheimer\u2019s disease. Brain 143, 1588\u20131602 (2020).","journal-title":"Brain"},{"key":"1104_CR256","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0006-8993(94)91779-5","volume":"639","author":"H Akiyama","year":"1994","unstructured":"Akiyama, H. et al. Expression of the receptor for macrophage colony stimulating factor by brain microglia and its upregulation in brains of patients with Alzheimer\u2019s disease and amyotrophic lateral sclerosis. Brain Res. 639, 171\u2013174 (1994).","journal-title":"Brain Res."},{"key":"1104_CR257","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1523\/JNEUROSCI.4440-12.2013","volume":"33","author":"D Gomez-Nicola","year":"2013","unstructured":"Gomez-Nicola, D., Fransen, N. L., Suzzi, S. & Perry, V. H. Regulation of microglial proliferation during chronic neurodegeneration. J. Neurosci. 33, 2481\u20132493 (2013).","journal-title":"J. Neurosci."},{"key":"1104_CR258","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/brain\/awv379","volume":"139","author":"A Olmos-Alonso","year":"2016","unstructured":"Olmos-Alonso, A. et al. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer\u2019s-like pathology. Brain 139, 891\u2013907 (2016).","journal-title":"Brain"},{"key":"1104_CR259","doi-asserted-by":"publisher","first-page":"179.e17","DOI":"10.1016\/j.neurobiolaging.2018.01.015","volume":"66","author":"C Sassi","year":"2018","unstructured":"Sassi, C. et al. Mendelian adult-onset leukodystrophy genes in Alzheimer\u2019s disease: critical influence of CSF1R and NOTCH3. Neurobiol. Aging 66, 179.e17\u2013179.e29 (2018).","journal-title":"Neurobiol. Aging"},{"key":"1104_CR260","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0366-9","volume":"12","author":"NN Dagher","year":"2015","unstructured":"Dagher, N. N. et al. Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice. J. Neuroinflammation 12, 139 (2015).","journal-title":"J. Neuroinflammation"},{"key":"1104_CR261","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13024-018-0244-x","volume":"13","author":"J Sosna","year":"2018","unstructured":"Sosna, J. et al. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer\u2019s disease. Mol. Neurodegener. 13, 11 (2018).","journal-title":"Mol. Neurodegener."},{"key":"1104_CR262","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1093\/brain\/aww016","volume":"139","author":"EE Spangenberg","year":"2016","unstructured":"Spangenberg, E. E. et al. Eliminating microglia in Alzheimer\u2019s mice prevents neuronal loss without modulating amyloid-\u03b2 pathology. Brain 139, 1265\u20131281 (2016).","journal-title":"Brain"},{"key":"1104_CR263","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.bbi.2022.10.009","volume":"107","author":"MSJ Kater","year":"2023","unstructured":"Kater, M. S. J. et al. Prevention of microgliosis halts early memory loss in a mouse model of Alzheimer\u2019s disease. Brain Behav. Immun. 107, 225\u2013241 (2023).","journal-title":"Brain Behav. Immun."},{"key":"1104_CR264","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1093\/brain\/awz241","volume":"142","author":"R Mancuso","year":"2019","unstructured":"Mancuso, R. et al. CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice. Brain 142, 3243\u20133264 (2019).","journal-title":"Brain"},{"key":"1104_CR265","doi-asserted-by":"publisher","first-page":"109228","DOI":"10.1016\/j.celrep.2021.109228","volume":"35","author":"Y Hu","year":"2021","unstructured":"Hu, Y. et al. Replicative senescence dictates the emergence of disease-associated microglia and contributes to A\u03b2 pathology. Cell Rep. 35, 109228 (2021).","journal-title":"Cell Rep."},{"key":"1104_CR266","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3389\/fncel.2020.00149","volume":"14","author":"M Martin-Estebane","year":"2020","unstructured":"Martin-Estebane, M. & Gomez-Nicola, D. Targeting microglial population dynamics in Alzheimer\u2019s disease: are we ready for a potential impact on immune function? Front. Cell Neurosci. 14, 149 (2020).","journal-title":"Front. Cell Neurosci."},{"key":"1104_CR267","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.cmet.2019.06.005","volume":"30","author":"SH Baik","year":"2019","unstructured":"Baik, S. H. et al. A breakdown in metabolic reprogramming causes microglia dysfunction in Alzheimer\u2019s disease. Cell Metab. 30, 493\u2013507.e6 (2019).","journal-title":"Cell Metab."},{"key":"1104_CR268","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/bpa.12704","volume":"29","author":"A McIntosh","year":"2019","unstructured":"McIntosh, A. et al. Iron accumulation in microglia triggers a cascade of events that leads to altered metabolism and compromised function in APP\/PS1 mice. Brain Pathol. 29, 606\u2013621 (2019).","journal-title":"Brain Pathol."},{"key":"1104_CR269","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s42003-021-02259-y","volume":"4","author":"MV Guillot-Sestier","year":"2021","unstructured":"Guillot-Sestier, M. V. et al. Microglial metabolism is a pivotal factor in sexual dimorphism in Alzheimer\u2019s disease. Commun. Biol. 4, 711 (2021).","journal-title":"Commun. Biol."},{"key":"1104_CR270","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15267-z","volume":"11","author":"LP Bernier","year":"2020","unstructured":"Bernier, L. P. et al. Microglial metabolic flexibility supports immune surveillance of the brain parenchyma. Nat. Commun. 11, 1559 (2020).","journal-title":"Nat. Commun."},{"key":"1104_CR271","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41590-018-0255-3","volume":"20","author":"PS Minhas","year":"2019","unstructured":"Minhas, P. S. et al. Macrophage de novo NAD+ synthesis specifies immune function in aging and inflammation. Nat. Immunol. 20, 50\u201363 (2019).","journal-title":"Nat. Immunol."},{"key":"1104_CR272","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41586-020-03160-0","volume":"590","author":"PS Minhas","year":"2021","unstructured":"Minhas, P. S. et al. Restoring metabolism of myeloid cells reverses cognitive decline in ageing. Nature 590, 122\u2013128 (2021).","journal-title":"Nature"},{"key":"1104_CR273","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0022-2275(20)39619-X","volume":"6","author":"JS O\u2019Brien","year":"1965","unstructured":"O\u2019Brien, J. S. & Sampson, E. L. Lipid composition of the normal human brain: gray matter, white matter, and myelin. J. Lipid Res. 6, 537\u2013544 (1965).","journal-title":"J. Lipid Res."},{"key":"1104_CR274","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1161\/01.ATV.0000120374.59826.1b","volume":"24","author":"I Bjorkhem","year":"2004","unstructured":"Bjorkhem, I. & Meaney, S. Brain cholesterol: long secret life behind a barrier. Arterioscler. Thromb. Vasc. Biol. 24, 806\u2013815 (2004).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1104_CR275","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1146\/annurev-neuro-091922-034237","volume":"46","author":"G Saher","year":"2023","unstructured":"Saher, G. Cholesterol metabolism in aging and age-related disorders. Annu. Rev. Neurosci. 46, 59\u201378 (2023).","journal-title":"Annu. Rev. Neurosci."},{"key":"1104_CR276","doi-asserted-by":"publisher","first-page":"1259012","DOI":"10.3389\/fnagi.2023.1259012","volume":"15","author":"NS Tobeh","year":"2023","unstructured":"Tobeh, N. S. & Bruce, K. D. Emerging Alzheimer\u2019s disease therapeutics: promising insights from lipid metabolism and microglia-focused interventions. Front. Aging Neurosci. 15, 1259012 (2023).","journal-title":"Front. Aging Neurosci."},{"key":"1104_CR277","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0197-4580(97)00108-5","volume":"18","author":"MA Lovell","year":"1997","unstructured":"Lovell, M. A., Ehmann, W. D., Mattson, M. P. & Markesbery, W. R. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer\u2019s disease. Neurobiol. Aging 18, 457\u2013461 (1997).","journal-title":"Neurobiol. Aging"},{"key":"1104_CR278","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3233\/JAD-2010-100405","volume":"21","author":"M Singh","year":"2010","unstructured":"Singh, M., Dang, T. N., Arseneault, M. & Ramassamy, C. Role of by-products of lipid oxidation in Alzheimer\u2019s disease brain: a focus on acrolein. J. Alzheimers Dis. 21, 741\u2013756 (2010).","journal-title":"J. Alzheimers Dis."},{"key":"1104_CR279","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2112095118","volume":"118","author":"MJ Moulton","year":"2021","unstructured":"Moulton, M. J. et al. Neuronal ROS-induced glial lipid droplet formation is altered by loss of Alzheimer\u2019s disease-associated genes. Proc. Natl Acad. Sci. USA 118, e2112095118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1104_CR280","doi-asserted-by":"publisher","first-page":"101648","DOI":"10.1016\/j.redox.2020.101648","volume":"36","author":"G Ates","year":"2020","unstructured":"Ates, G., Goldberg, J., Currais, A. & Maher, P. CMS121, a fatty acid synthase inhibitor, protects against excess lipid peroxidation and inflammation and alleviates cognitive loss in a transgenic mouse model of Alzheimer\u2019s disease. Redox Biol. 36, 101648 (2020).","journal-title":"Redox Biol."},{"key":"1104_CR281","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41593-019-0566-1","volume":"23","author":"J Marschallinger","year":"2020","unstructured":"Marschallinger, J. et al. Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain. Nat. Neurosci. 23, 194\u2013208 (2020).","journal-title":"Nat. Neurosci."},{"key":"1104_CR282","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41586-024-07185-7","volume":"628","author":"MS Haney","year":"2024","unstructured":"Haney, M. S. et al. APOE4\/4 is linked to damaging lipid droplets in Alzheimer\u2019s disease microglia. Nature 628, 154\u2013161 (2024).","journal-title":"Nature"},{"key":"1104_CR283","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-4407146\/v1","author":"A Kozlova","year":"2024","unstructured":"Kozlova, A. et al. Alzheimer\u2019s disease risk allele of PICALM causes detrimental lipid droplets in microglia. Preprint at Res. Sq. https:\/\/doi.org\/10.21203\/rs.3.rs-4407146\/v1 (2024).","journal-title":"Res. Sq."},{"key":"1104_CR284","first-page":"268","volume":"37","author":"CF Sing","year":"1985","unstructured":"Sing, C. F. & Davignon, J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am. J. Hum. Genet. 37, 268\u2013285 (1985).","journal-title":"Am. J. Hum. Genet."},{"key":"1104_CR285","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.stem.2022.07.001","volume":"29","author":"JE Young","year":"2022","unstructured":"Young, J. E. & Jayadev, S. Neighborhood matters: altered lipid metabolism in APOE4 microglia causes problems for neurons. Cell Stem Cell 29, 1159\u20131160 (2022).","journal-title":"Cell Stem Cell"},{"key":"1104_CR286","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.cmet.2024.03.014","volume":"36","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Microglial lipid droplet accumulation in tauopathy brain is regulated by neuronal AMPK. Cell Metab. 36, 1351\u20131370.e8 (2024).","journal-title":"Cell Metab."},{"key":"1104_CR287","doi-asserted-by":"publisher","first-page":"912","DOI":"10.3390\/biom13060912","volume":"13","author":"N Bresgen","year":"2023","unstructured":"Bresgen, N., Kovacs, M., Lahnsteiner, A., Felder, T. K. & Rinnerthaler, M. The janus-faced role of lipid droplets in aging: insights from the cellular perspective. Biomolecules 13, 912 (2023).","journal-title":"Biomolecules"},{"key":"1104_CR288","doi-asserted-by":"publisher","first-page":"195","DOI":"10.5582\/bst.2024.01092","volume":"18","author":"X Hu","year":"2024","unstructured":"Hu, X., Ma, Y. N. & Xia, Y. Association between abnormal lipid metabolism and Alzheimer\u2019s disease: new research has revealed significant findings on the APOE4 genotype in microglia. Biosci. Trends 18, 195\u2013197 (2024).","journal-title":"Biosci. Trends"},{"key":"1104_CR289","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00401-023-02568-y","volume":"145","author":"F Filipello","year":"2023","unstructured":"Filipello, F. et al. Defects in lysosomal function and lipid metabolism in human microglia harboring a TREM2 loss of function mutation. Acta Neuropathol. 145, 749\u2013772 (2023).","journal-title":"Acta Neuropathol."},{"key":"1104_CR290","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00232-024-00314-3","volume":"257","author":"L Mirdha","year":"2024","unstructured":"Mirdha, L. Aggregation behavior of amyloid beta peptide depends upon the membrane lipid composition. J. Membr. Biol. 257, 151\u2013164 (2024).","journal-title":"J. Membr. Biol."},{"key":"1104_CR291","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1074\/jbc.M111.295451","volume":"287","author":"CY Lee","year":"2012","unstructured":"Lee, C. Y., Tse, W., Smith, J. D. & Landreth, G. E. Apolipoprotein E promotes \u03b2-amyloid trafficking and degradation by modulating microglial cholesterol levels. J. Biol. Chem. 287, 2032\u20132044 (2012).","journal-title":"J. Biol. Chem."},{"key":"1104_CR292","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202300669","volume":"68","author":"Z Liang","year":"2024","unstructured":"Liang, Z. et al. Long-term high-fat diet consumption aggravates \u03b2-amyloid deposition and tau pathology accompanied by microglial activation in an Alzheimer\u2019s disease model. Mol. Nutr. Food Res. 68, e2300669 (2024).","journal-title":"Mol. Nutr. Food Res."},{"key":"1104_CR293","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20232000","volume":"221","author":"D Toral-Rios","year":"2024","unstructured":"Toral-Rios, D. et al. Cholesterol 25-hydroxylase mediates neuroinflammation and neurodegeneration in a mouse model of tauopathy. J. Exp. Med. 221, e20232000 (2024).","journal-title":"J. Exp. Med."},{"key":"1104_CR294","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1002\/alz.12849","volume":"19","author":"PB Lin","year":"2023","unstructured":"Lin, P. B. et al. INPP5D deficiency attenuates amyloid pathology in a mouse model of Alzheimer\u2019s disease. Alzheimers Dement. 19, 2528\u20132537 (2023).","journal-title":"Alzheimers Dement."},{"key":"1104_CR295","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46315-7","volume":"15","author":"A Podlesny-Drabiniok","year":"2024","unstructured":"Podlesny-Drabiniok, A. et al. BHLHE40\/41 regulate microglia and peripheral macrophage responses associated with Alzheimer\u2019s disease and other disorders of lipid-rich tissues. Nat. Commun. 15, 2058 (2024).","journal-title":"Nat. Commun."},{"key":"1104_CR296","doi-asserted-by":"publisher","DOI":"10.1101\/2023.02.06.23285545","author":"S-F You","year":"2023","unstructured":"You, S.-F. et al. MS4A4A modifies the risk of Alzheimer disease by regulating lipid metabolism and immune response in a unique microglia state. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2023.02.06.23285545 (2023).","journal-title":"medRxiv"},{"key":"1104_CR297","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s12276-023-00935-z","volume":"55","author":"C Wang","year":"2023","unstructured":"Wang, C. et al. TRPV1 regulates ApoE4-disrupted intracellular lipid homeostasis and decreases synaptic phagocytosis by microglia. Exp. Mol. Med. 55, 347\u2013363 (2023).","journal-title":"Exp. Mol. Med."},{"key":"1104_CR298","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/s42255-022-00643-4","volume":"4","author":"L Leng","year":"2022","unstructured":"Leng, L. et al. Microglial hexokinase 2 deficiency increases ATP generation through lipid metabolism leading to \u03b2-amyloid clearance. Nat. Metab. 4, 1287\u20131305 (2022).","journal-title":"Nat. Metab."},{"key":"1104_CR299","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.tcb.2018.02.001","volume":"28","author":"A Hernandez-Segura","year":"2018","unstructured":"Hernandez-Segura, A., Nehme, J. & Demaria, M. Hallmarks of cellular senescence. Trends Cell Biol. 28, 436\u2013453 (2018).","journal-title":"Trends Cell Biol."},{"key":"1104_CR300","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0304-3940(95)12192-7","volume":"202","author":"D Blum-Degen","year":"1995","unstructured":"Blum-Degen, D. et al. Interleukin-1\u03b2 and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer\u2019s and de novo Parkinson\u2019s disease patients. Neurosci. Lett. 202, 17\u201320 (1995).","journal-title":"Neurosci. Lett."},{"key":"1104_CR301","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3233\/JAD-130497","volume":"37","author":"D Gezen-Ak","year":"2013","unstructured":"Gezen-Ak, D. et al. BDNF, TNF\u03b1, HSP90, CFH, and IL-10 serum levels in patients with early or late onset Alzheimer\u2019s disease or mild cognitive impairment. J. Alzheimers Dis. 37, 185\u2013195 (2013).","journal-title":"J. Alzheimers Dis."},{"key":"1104_CR302","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.tins.2006.07.001","volume":"29","author":"WJ Streit","year":"2006","unstructured":"Streit, W. J. Microglial senescence: does the brain\u2019s immune system have an expiration date? Trends Neurosci. 29, 506\u2013510 (2006).","journal-title":"Trends Neurosci."},{"key":"1104_CR303","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0006-8993(93)91327-O","volume":"629","author":"JA Wood","year":"1993","unstructured":"Wood, J. A. et al. Cytokine indices in Alzheimer\u2019s temporal cortex: no changes in mature IL-1\u03b2 or IL-1RA but increases in the associated acute phase proteins IL-6, \u03b12-macroglobulin and C-reactive protein. Brain Res. 629, 245\u2013252 (1993).","journal-title":"Brain Res."},{"key":"1104_CR304","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/glia.20468","volume":"55","author":"A Sierra","year":"2007","unstructured":"Sierra, A., Gottfried-Blackmore, A. C., McEwen, B. S. & Bulloch, K. Microglia derived from aging mice exhibit an altered inflammatory profile. Glia 55, 412\u2013424 (2007).","journal-title":"Glia"},{"key":"1104_CR305","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1093\/brain\/awv081","volume":"138","author":"N Maphis","year":"2015","unstructured":"Maphis, N. et al. Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain. Brain 138, 1738\u20131755 (2015).","journal-title":"Brain"},{"key":"1104_CR306","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00401-018-01957-y","volume":"137","author":"IC Stancu","year":"2019","unstructured":"Stancu, I. C. et al. Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo. Acta Neuropathol. 137, 599\u2013617 (2019).","journal-title":"Acta Neuropathol."},{"key":"1104_CR307","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41586-018-0543-y","volume":"562","author":"TJ Bussian","year":"2018","unstructured":"Bussian, T. J. et al. Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline. Nature 562, 578\u2013582 (2018).","journal-title":"Nature"},{"key":"1104_CR308","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/rej.2006.9096","volume":"10","author":"BE Flanary","year":"2007","unstructured":"Flanary, B. E., Sammons, N. W., Nguyen, C., Walker, D. & Streit, W. J. Evidence that aging and amyloid promote microglial cell senescence. Rejuvenation Res. 10, 61\u201374 (2007).","journal-title":"Rejuvenation Res."},{"key":"1104_CR309","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3233\/JAD-230109","volume":"95","author":"PY Ng","year":"2023","unstructured":"Ng, P. Y., Zhang, C., Li, H. & Baker, D. J. Senescent microglia represent a subset of disease-associated microglia in P301S mice. J. Alzheimers Dis. 95, 493\u2013507 (2023).","journal-title":"J. Alzheimers Dis."},{"key":"1104_CR310","doi-asserted-by":"publisher","first-page":"eabg4980","DOI":"10.1126\/sciadv.abg4980","volume":"7","author":"JH Brelstaff","year":"2021","unstructured":"Brelstaff, J. H. et al. Microglia become hypofunctional and release metalloproteases and tau seeds when phagocytosing live neurons with P301S tau aggregates. Sci. Adv. 7, eabg4980 (2021).","journal-title":"Sci. Adv."},{"key":"1104_CR311","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/jnc.15866","volume":"166","author":"D Karabag","year":"2023","unstructured":"Karabag, D. et al. Characterizing microglial senescence: Tau as a key player. J. Neurochem. 166, 517\u2013533 (2023).","journal-title":"J. Neurochem."},{"key":"1104_CR312","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.immuni.2021.01.013","volume":"54","author":"RT Han","year":"2021","unstructured":"Han, R. T., Kim, R. D., Molofsky, A. V. & Liddelow, S. A. Astrocyte-immune cell interactions in physiology and pathology. Immunity 54, 211\u2013224 (2021).","journal-title":"Immunity"},{"key":"1104_CR313","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1152\/physrev.00042.2016","volume":"98","author":"A Verkhratsky","year":"2018","unstructured":"Verkhratsky, A. & Nedergaard, M. Physiology of astroglia. Physiol. Rev. 98, 239\u2013389 (2018).","journal-title":"Physiol. Rev."},{"key":"1104_CR314","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/s41593-021-00905-6","volume":"24","author":"P Hasel","year":"2021","unstructured":"Hasel, P., Rose, I. V. L., Sadick, J. S., Kim, R. D. & Liddelow, S. A. Neuroinflammatory astrocyte subtypes in the mouse brain. Nat. Neurosci. 24, 1475\u20131487 (2021).","journal-title":"Nat. Neurosci."},{"key":"1104_CR315","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","volume":"24","author":"C Escartin","year":"2021","unstructured":"Escartin, C. et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat. Neurosci. 24, 312\u2013325 (2021).","journal-title":"Nat. Neurosci."},{"key":"1104_CR316","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41591-019-0695-9","volume":"26","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y. et al. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer\u2019s disease. Nat. Med. 26, 131\u2013142 (2020).","journal-title":"Nat. Med."},{"key":"1104_CR317","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41392-023-01628-9","volume":"8","author":"A Verkhratsky","year":"2023","unstructured":"Verkhratsky, A. et al. Astrocytes in human central nervous system diseases: a frontier for new therapies. Signal. Transduct. Target. Ther. 8, 396 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"1104_CR318","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow, S. A. et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481\u2013487 (2017).","journal-title":"Nature"},{"key":"1104_CR319","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/s41593-020-00735-y","volume":"23","author":"H Chun","year":"2020","unstructured":"Chun, H. et al. Severe reactive astrocytes precipitate pathological hallmarks of Alzheimer\u2019s disease via H2O2- production. Nat. Neurosci. 23, 1555\u20131566 (2020).","journal-title":"Nat. Neurosci."},{"key":"1104_CR320","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cmet.2022.05.011","volume":"34","author":"YH Ju","year":"2022","unstructured":"Ju, Y. H. et al. Astrocytic urea cycle detoxifies A\u03b2-derived ammonia while impairing memory in Alzheimer\u2019s disease. Cell Metab. 34, 1104\u20131120.e8 (2022).","journal-title":"Cell Metab."},{"key":"1104_CR321","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.it.2020.07.007","volume":"41","author":"F Giovannoni","year":"2020","unstructured":"Giovannoni, F. & Quintana, F. J. The role of astrocytes in CNS inflammation. Trends Immunol. 41, 805\u2013819 (2020).","journal-title":"Trends Immunol."},{"key":"1104_CR322","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.neurobiolaging.2014.09.027","volume":"36","author":"S Sekar","year":"2015","unstructured":"Sekar, S. et al. Alzheimer\u2019s disease is associated with altered expression of genes involved in immune response and mitochondrial processes in astrocytes. Neurobiol. Aging 36, 583\u2013591 (2015).","journal-title":"Neurobiol. Aging"},{"key":"1104_CR323","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s00424-019-02310-2","volume":"471","author":"A Verkhratsky","year":"2019","unstructured":"Verkhratsky, A., Rodrigues, J. J., Pivoriunas, A., Zorec, R. & Semyanov, A. Astroglial atrophy in Alzheimer\u2019s disease. Pflug. Arch. 471, 1247\u20131261 (2019).","journal-title":"Pflug. Arch."},{"key":"1104_CR324","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1523\/JNEUROSCI.4707-08.2009","volume":"29","author":"NA Oberheim","year":"2009","unstructured":"Oberheim, N. A. et al. Uniquely hominid features of adult human astrocytes. J. Neurosci. 29, 3276\u20133287 (2009).","journal-title":"J. Neurosci."},{"key":"1104_CR325","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41586-021-03960-y","volume":"599","author":"KA Guttenplan","year":"2021","unstructured":"Guttenplan, K. A. et al. Neurotoxic reactive astrocytes induce cell death via saturated lipids. Nature 599, 102\u2013107 (2021).","journal-title":"Nature"},{"key":"1104_CR326","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39046-8","volume":"14","author":"I Molina-Gonzalez","year":"2023","unstructured":"Molina-Gonzalez, I. et al. Astrocyte-oligodendrocyte interaction regulates central nervous system regeneration. Nat. Commun. 14, 3372 (2023).","journal-title":"Nat. Commun."},{"key":"1104_CR327","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.cell.2022.05.017","volume":"185","author":"J Tcw","year":"2022","unstructured":"Tcw, J. et al. Cholesterol and matrisome pathways dysregulated in astrocytes and microglia. Cell 185, 2213\u20132233 (2022).","journal-title":"Cell"},{"key":"1104_CR328","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1016\/j.cell.2023.08.039","volume":"186","author":"H Mathys","year":"2023","unstructured":"Mathys, H. et al. Single-cell atlas reveals correlates of high cognitive function, dementia, and resilience to Alzheimer\u2019s disease pathology. Cell 186, 4365\u20134385.e27 (2023).","journal-title":"Cell"},{"key":"1104_CR329","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/s41593-022-01104-7","volume":"25","author":"M Kenigsbuch","year":"2022","unstructured":"Kenigsbuch, M. et al. A shared disease-associated oligodendrocyte signature among multiple CNS pathologies. Nat. Neurosci. 25, 876\u2013886 (2022).","journal-title":"Nat. Neurosci."},{"key":"1104_CR330","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/s41593-022-01183-6","volume":"25","author":"T Kaya","year":"2022","unstructured":"Kaya, T. et al. CD8+ T cells induce interferon-responsive oligodendrocytes and microglia in white matter aging. Nat. Neurosci. 25, 1446\u20131457 (2022).","journal-title":"Nat. Neurosci."},{"key":"1104_CR331","doi-asserted-by":"publisher","first-page":"111189","DOI":"10.1016\/j.celrep.2022.111189","volume":"40","author":"S Pandey","year":"2022","unstructured":"Pandey, S. et al. Disease-associated oligodendrocyte responses across neurodegenerative diseases. Cell Rep. 40, 111189 (2022).","journal-title":"Cell Rep."},{"key":"1104_CR332","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.cell.2020.06.038","volume":"182","author":"WT Chen","year":"2020","unstructured":"Chen, W. T. et al. Spatial transcriptomics and in situ sequencing to study Alzheimer\u2019s disease. Cell 182, 976\u2013991.e19 (2020).","journal-title":"Cell"},{"key":"1104_CR333","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev-cellbio-100913-013101","volume":"30","author":"KA Nave","year":"2014","unstructured":"Nave, K. A. & Werner, H. B. Myelination of the nervous system: mechanisms and functions. Annu. Rev. Cell Dev. Biol. 30, 503\u2013533 (2014).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"1104_CR334","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.73827","volume":"11","author":"M Dubey","year":"2022","unstructured":"Dubey, M. et al. Myelination synchronizes cortical oscillations by consolidating parvalbumin-mediated phasic inhibition. eLife 11, e73827 (2022).","journal-title":"eLife"},{"key":"1104_CR335","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.neurobiolaging.2003.03.001","volume":"25","author":"G Bartzokis","year":"2004","unstructured":"Bartzokis, G. Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer\u2019s disease. Neurobiol. Aging 25, 5\u201318 (2004).","journal-title":"Neurobiol. Aging"},{"key":"1104_CR336","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neurobiolaging.2003.04.001","volume":"25","author":"H Braak","year":"2004","unstructured":"Braak, H. & Del Tredici, K. Poor and protracted myelination as a contributory factor to neurodegenerative disorders. Neurobiol. Aging 25, 19\u201323 (2004).","journal-title":"Neurobiol. Aging"},{"key":"1104_CR337","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/cne.10099","volume":"442","author":"A Peters","year":"2002","unstructured":"Peters, A. & Sethares, C. Aging and the myelinated fibers in prefrontal cortex and corpus callosum of the monkey. J. Comp. Neurol. 442, 277\u2013291 (2002).","journal-title":"J. Comp. Neurol."},{"key":"1104_CR338","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1111\/joa.13577","volume":"239","author":"JM Edgar","year":"2021","unstructured":"Edgar, J. M. et al. Rio-Hortega\u2019s drawings revisited with fluorescent protein defines a cytoplasm-filled channel system of CNS myelin. J. Anat. 239, 1241\u20131255 (2021).","journal-title":"J. Anat."},{"key":"1104_CR339","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.celrep.2016.12.053","volume":"18","author":"N Snaidero","year":"2017","unstructured":"Snaidero, N. et al. Antagonistic functions of MBP and CNP establish cytosolic channels in CNS myelin. Cell Rep. 18, 314\u2013323 (2017).","journal-title":"Cell Rep."},{"key":"1104_CR340","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nature11007","volume":"485","author":"U Funfschilling","year":"2012","unstructured":"Funfschilling, U. et al. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485, 517\u2013521 (2012).","journal-title":"Nature"},{"key":"1104_CR341","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/cne.10859","volume":"466","author":"JH Sandell","year":"2003","unstructured":"Sandell, J. H. & Peters, A. Disrupted myelin and axon loss in the anterior commissure of the aged rhesus monkey. J. Comp. Neurol. 466, 14\u201330 (2003).","journal-title":"J. Comp. Neurol."},{"key":"1104_CR342","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1038\/s41593-024-01682-8","volume":"27","author":"S Kedia","year":"2024","unstructured":"Kedia, S. et al. T cell-mediated microglial activation triggers myelin pathology in a mouse model of amyloidosis. Nat. Neurosci. 27, 1468\u20131474 (2024).","journal-title":"Nat. Neurosci."},{"key":"1104_CR343","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.neuron.2021.01.027","volume":"109","author":"S Safaiyan","year":"2021","unstructured":"Safaiyan, S. et al. White matter aging drives microglial diversity. Neuron 109, 1100\u20131117.e10 (2021).","journal-title":"Neuron"},{"key":"1104_CR344","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/nn.4325","volume":"19","author":"S Safaiyan","year":"2016","unstructured":"Safaiyan, S. et al. Age-related myelin degradation burdens the clearance function of microglia during aging. Nat. Neurosci. 19, 995\u2013998 (2016).","journal-title":"Nat. Neurosci."},{"key":"1104_CR345","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41586-023-06120-6","volume":"618","author":"C Depp","year":"2023","unstructured":"Depp, C. et al. Myelin dysfunction drives amyloid-\u03b2 deposition in models of Alzheimer\u2019s disease. Nature 618, 349\u2013357 (2023).","journal-title":"Nature"},{"key":"1104_CR346","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","volume":"57","author":"BV Zlokovic","year":"2008","unstructured":"Zlokovic, B. V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57, 178\u2013201 (2008).","journal-title":"Neuron"},{"key":"1104_CR347","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22479-4","volume":"12","author":"K Kim","year":"2021","unstructured":"Kim, K. et al. Therapeutic B-cell depletion reverses progression of Alzheimer\u2019s disease. Nat. Commun. 12, 2185 (2021).","journal-title":"Nat. Commun."},{"key":"1104_CR348","doi-asserted-by":"publisher","first-page":"eaaw8330","DOI":"10.1126\/sciadv.aaw8330","volume":"5","author":"Y Elyahu","year":"2019","unstructured":"Elyahu, Y. et al. Aging promotes reorganization of the CD4 T cell landscape toward extreme regulatory and effector phenotypes. Sci. Adv. 5, eaaw8330 (2019).","journal-title":"Sci. Adv."},{"key":"1104_CR349","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.immuni.2017.03.010","volume":"46","author":"JJ Goronzy","year":"2017","unstructured":"Goronzy, J. J. & Weyand, C. M. Successful and maladaptive T cell aging. Immunity 46, 364\u2013378 (2017).","journal-title":"Immunity"},{"key":"1104_CR350","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41590-017-0006-x","volume":"19","author":"J Nikolich-Zugich","year":"2018","unstructured":"Nikolich-Zugich, J. The twilight of immunity: emerging concepts in aging of the immune system. Nat. Immunol. 19, 10\u201319 (2018).","journal-title":"Nat. Immunol."},{"key":"1104_CR351","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","volume":"14","author":"C Franceschi","year":"2018","unstructured":"Franceschi, C., Garagnani, P., Parini, P., Giuliani, C. & Santoro, A. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat. Rev. Endocrinol. 14, 576\u2013590 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1104_CR352","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1126\/science.aax0860","volume":"368","author":"G Desdin-Mico","year":"2020","unstructured":"Desdin-Mico, G. et al. T cells with dysfunctional mitochondria induce multimorbidity and premature senescence. Science 368, 1371\u20131376 (2020).","journal-title":"Science"},{"key":"1104_CR353","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41586-019-1895-7","volume":"577","author":"D Gate","year":"2020","unstructured":"Gate, D. et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer\u2019s disease. Nature 577, 399\u2013404 (2020).","journal-title":"Nature"},{"key":"1104_CR354","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41586-023-05788-0","volume":"615","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy. Nature 615, 668\u2013677 (2023).","journal-title":"Nature"},{"key":"1104_CR355","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/brain\/aww270","volume":"140","author":"C Laurent","year":"2017","unstructured":"Laurent, C. et al. Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy. Brain 140, 184\u2013200 (2017).","journal-title":"Brain"},{"key":"1104_CR356","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jneuroim.2011.11.005","volume":"242","author":"M Pellicano","year":"2012","unstructured":"Pellicano, M. et al. Immune profiling of Alzheimer patients. J. Neuroimmunol. 242, 52\u201359 (2012).","journal-title":"J. Neuroimmunol."},{"key":"1104_CR357","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001106","volume":"9","author":"C Joshi","year":"2022","unstructured":"Joshi, C. et al. CSF-derived CD4+ T-cell diversity is reduced in patients with Alzheimer clinical syndrome. Neurol. Neuroimmunol. Neuroinflamm. 9, e1106 (2022).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"1104_CR358","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1172\/JCI200318104","volume":"112","author":"A Monsonego","year":"2003","unstructured":"Monsonego, A. et al. Increased T cell reactivity to amyloid \u03b2 protein in older humans and patients with Alzheimer disease. J. Clin. Invest. 112, 415\u2013422 (2003).","journal-title":"J. Clin. Invest."},{"key":"1104_CR359","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.4049\/jimmunol.2100737","volume":"209","author":"B Altendorfer","year":"2022","unstructured":"Altendorfer, B. et al. Transcriptomic profiling identifies CD8+ T cells in the brain of aged and Alzheimer\u2019s disease transgenic mice as tissue-resident memory T cells. J. Immunol. 209, 1272\u20131285 (2022).","journal-title":"J. Immunol."},{"key":"1104_CR360","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jalz.2018.02.017","volume":"14","author":"MS Unger","year":"2018","unstructured":"Unger, M. S. et al. Doublecortin expression in CD8+ T-cells and microglia at sites of amyloid-\u03b2 plaques: a potential role in shaping plaque pathology? Alzheimers Dement. 14, 1022\u20131037 (2018).","journal-title":"Alzheimers Dement."},{"key":"1104_CR361","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1038\/s41590-023-01604-z","volume":"24","author":"W Su","year":"2023","unstructured":"Su, W. et al. CXCR6 orchestrates brain CD8+ T cell residency and limits mouse Alzheimer\u2019s disease pathology. Nat. Immunol. 24, 1735\u20131747 (2023).","journal-title":"Nat. Immunol."},{"key":"1104_CR362","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1038\/s41593-023-01415-3","volume":"26","author":"M Jorfi","year":"2023","unstructured":"Jorfi, M. et al. Infiltrating CD8+ T cells exacerbate Alzheimer\u2019s disease pathology in a 3D human neuroimmune axis model. Nat. Neurosci. 26, 1489\u20131504 (2023).","journal-title":"Nat. Neurosci."},{"key":"1104_CR363","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08352-5","volume":"10","author":"N Rosenzweig","year":"2019","unstructured":"Rosenzweig, N. et al. PD-1\/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model. Nat. Commun. 10, 465 (2019).","journal-title":"Nat. Commun."},{"key":"1104_CR364","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45433-3","volume":"9","author":"F Ciccocioppo","year":"2019","unstructured":"Ciccocioppo, F. et al. The characterization of regulatory T-cell profiles in Alzheimer\u2019s disease and multiple sclerosis. Sci. Rep. 9, 8788 (2019).","journal-title":"Sci. Rep."},{"key":"1104_CR365","doi-asserted-by":"publisher","first-page":"fcaa112","DOI":"10.1093\/braincomms\/fcaa112","volume":"2","author":"A Faridar","year":"2020","unstructured":"Faridar, A. et al. Restoring regulatory T-cell dysfunction in Alzheimer\u2019s disease through ex vivo expansion. Brain Commun. 2, fcaa112 (2020).","journal-title":"Brain Commun."},{"key":"1104_CR366","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.4049\/jimmunol.1003953","volume":"187","author":"C Toly-Ndour","year":"2011","unstructured":"Toly-Ndour, C. et al. MHC-independent genetic factors control the magnitude of CD4+ T cell responses to amyloid-\u03b2 peptide in mice through regulatory T cell-mediated inhibition. J. Immunol. 187, 4492\u20134500 (2011).","journal-title":"J. Immunol."},{"key":"1104_CR367","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1093\/brain\/awv408","volume":"139","author":"C Dansokho","year":"2016","unstructured":"Dansokho, C. et al. Regulatory T cells delay disease progression in Alzheimer-like pathology. Brain 139, 1237\u20131251 (2016).","journal-title":"Brain"},{"key":"1104_CR368","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02702-3","volume":"20","author":"G Stym-Popper","year":"2023","unstructured":"Stym-Popper, G. et al. Regulatory T cells decrease C3-positive reactive astrocytes in Alzheimer-like pathology. J. Neuroinflammation 20, 64 (2023).","journal-title":"J. Neuroinflammation"},{"key":"1104_CR369","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.isci.2019.05.039","volume":"16","author":"K Mittal","year":"2019","unstructured":"Mittal, K. et al. CD4 T cells induce a subset of MHCII-expressing microglia that attenuates Alzheimer pathology. iScience 16, 298\u2013311 (2019).","journal-title":"iScience"},{"key":"1104_CR370","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.ebiom.2019.04.019","volume":"43","author":"E Eremenko","year":"2019","unstructured":"Eremenko, E. et al. BDNF-producing, amyloid \u03b2-specific CD4 T cells as targeted drug-delivery vehicles in Alzheimer\u2019s disease. EBioMedicine 43, 424\u2013434 (2019).","journal-title":"EBioMedicine"},{"key":"1104_CR371","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nm.3913","volume":"21","author":"E Zenaro","year":"2015","unstructured":"Zenaro, E. et al. Neutrophils promote Alzheimer\u2019s disease-like pathology and cognitive decline via LFA-1 integrin. Nat. Med. 21, 880\u2013886 (2015).","journal-title":"Nat. Med."},{"key":"1104_CR372","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41593-018-0329-4","volume":"22","author":"JC Cruz Hernandez","year":"2019","unstructured":"Cruz Hernandez, J. C. et al. Neutrophil adhesion in brain capillaries reduces cortical blood flow and impairs memory function in Alzheimer\u2019s disease mouse models. Nat. Neurosci. 22, 413\u2013420 (2019).","journal-title":"Nat. Neurosci."},{"key":"1104_CR373","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.neurobiolaging.2014.01.003","volume":"35","author":"SH Baik","year":"2014","unstructured":"Baik, S. H. et al. Migration of neutrophils targeting amyloid plaques in Alzheimer\u2019s disease mouse model. Neurobiol. Aging 35, 1286\u20131292 (2014).","journal-title":"Neurobiol. Aging"},{"key":"1104_CR374","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00441-017-2626-8","volume":"369","author":"S Gellhaar","year":"2017","unstructured":"Gellhaar, S., Sunnemark, D., Eriksson, H., Olson, L. & Galter, D. Myeloperoxidase-immunoreactive cells are significantly increased in brain areas affected by neurodegeneration in Parkinson\u2019s and Alzheimer\u2019s disease. Cell Tissue Res. 369, 445\u2013454 (2017).","journal-title":"Cell Tissue Res."},{"key":"1104_CR375","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40478-022-01347-2","volume":"10","author":"LCD Smyth","year":"2022","unstructured":"Smyth, L. C. D. et al. Neutrophil-vascular interactions drive myeloperoxidase accumulation in the brain in Alzheimer\u2019s disease. Acta Neuropathol. Commun. 10, 38 (2022).","journal-title":"Acta Neuropathol. Commun."},{"key":"1104_CR376","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/ana.25159","volume":"83","author":"Y Dong","year":"2018","unstructured":"Dong, Y. et al. Neutrophil hyperactivation correlates with Alzheimer\u2019s disease progression. Ann. Neurol. 83, 387\u2013405 (2018).","journal-title":"Ann. Neurol."},{"key":"1104_CR377","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3233\/JAD-2005-7304","volume":"7","author":"M Fiala","year":"2005","unstructured":"Fiala, M. et al. Ineffective phagocytosis of amyloid-\u03b2 by macrophages of Alzheimer\u2019s disease patients. J. Alzheimers Dis. 7, 221\u2013232 (2005).","journal-title":"J. Alzheimers Dis."},{"key":"1104_CR378","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3233\/JAD-170124","volume":"60","author":"A Le Page","year":"2017","unstructured":"Le Page, A. et al. Polymorphonuclear neutrophil functions are differentially altered in amnestic mild cognitive impairment and mild Alzheimer\u2019s disease patients. J. Alzheimers Dis. 60, 23\u201342 (2017).","journal-title":"J. Alzheimers Dis."},{"key":"1104_CR379","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0197-4580(01)00346-3","volume":"23","author":"C Scali","year":"2002","unstructured":"Scali, C. et al. Neutrophils CD11b and fibroblasts PGE(2) are elevated in Alzheimer\u2019s disease. Neurobiol. Aging 23, 523\u2013530 (2002).","journal-title":"Neurobiol. Aging"},{"key":"1104_CR380","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/nm1555","volume":"13","author":"J El Khoury","year":"2007","unstructured":"El Khoury, J. et al. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat. Med. 13, 432\u2013438 (2007).","journal-title":"Nat. Med."},{"key":"1104_CR381","doi-asserted-by":"publisher","first-page":"6208","DOI":"10.1523\/JNEUROSCI.0299-11.2011","volume":"31","author":"G Naert","year":"2011","unstructured":"Naert, G. & Rivest, S. CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer\u2019s disease. J. Neurosci. 31, 6208\u20136220 (2011).","journal-title":"J. Neurosci."},{"key":"1104_CR382","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1084\/jem.20150479","volume":"212","author":"S Prokop","year":"2015","unstructured":"Prokop, S. et al. Impact of peripheral myeloid cells on amyloid-\u03b2 pathology in Alzheimer\u2019s disease-like mice. J. Exp. Med. 212, 1811\u20131818 (2015).","journal-title":"J. Exp. Med."},{"key":"1104_CR383","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1084\/jem.20150478","volume":"212","author":"NH Varvel","year":"2015","unstructured":"Varvel, N. H. et al. Replacement of brain-resident myeloid cells does not alter cerebral amyloid-\u03b2 deposition in mouse models of Alzheimer\u2019s disease. J. Exp. Med. 212, 1803\u20131809 (2015).","journal-title":"J. Exp. Med."},{"key":"1104_CR384","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13024-018-0293-1","volume":"13","author":"AD Thome","year":"2018","unstructured":"Thome, A. D. et al. Functional alterations of myeloid cells during the course of Alzheimer\u2019s disease. Mol. Neurodegener. 13, 61 (2018).","journal-title":"Mol. Neurodegener."},{"key":"1104_CR385","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0301-0082(00)00068-X","volume":"64","author":"E Farkas","year":"2001","unstructured":"Farkas, E. & Luiten, P. G. Cerebral microvascular pathology in aging and Alzheimer\u2019s disease. Prog. Neurobiol. 64, 575\u2013611 (2001).","journal-title":"Prog. Neurobiol."},{"key":"1104_CR386","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrn3114","volume":"12","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic, B. V. Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders. Nat. Rev. Neurosci. 12, 723\u2013738 (2011).","journal-title":"Nat. Rev. Neurosci."},{"key":"1104_CR387","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nm0603-653","volume":"9","author":"P Carmeliet","year":"2003","unstructured":"Carmeliet, P. Angiogenesis in health and disease. Nat. Med. 9, 653\u2013660 (2003).","journal-title":"Nat. Med."},{"key":"1104_CR388","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-8-26","volume":"8","author":"P Grammas","year":"2011","unstructured":"Grammas, P. Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer\u2019s disease. J. Neuroinflammation 8, 26 (2011).","journal-title":"J. Neuroinflammation"},{"key":"1104_CR389","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.neulet.2004.05.017","volume":"366","author":"D Paris","year":"2004","unstructured":"Paris, D. et al. Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis. Neurosci. Lett. 366, 80\u201385 (2004).","journal-title":"Neurosci. Lett."},{"key":"1104_CR390","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1023\/B:AGEN.0000037335.17717.bf","volume":"7","author":"D Paris","year":"2004","unstructured":"Paris, D. et al. Inhibition of angiogenesis by Abeta peptides. Angiogenesis 7, 75\u201385 (2004).","journal-title":"Angiogenesis"},{"key":"1104_CR391","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney, M. D., Sagare, A. P. & Zlokovic, B. V. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat. Rev. Neurol. 14, 133\u2013150 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"1104_CR392","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23337-z","volume":"12","author":"MI Alvarez-Vergara","year":"2021","unstructured":"Alvarez-Vergara, M. I. et al. Non-productive angiogenesis disassembles Ass plaque-associated blood vessels. Nat. Commun. 12, 3098 (2021).","journal-title":"Nat. Commun."},{"key":"1104_CR393","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0169-328X(98)00190-9","volume":"62","author":"RN Kalaria","year":"1998","unstructured":"Kalaria, R. N. et al. Vascular endothelial growth factor in Alzheimer\u2019s disease and experimental cerebral ischemia. Brain Res. Mol. Brain Res. 62, 101\u2013105 (1998).","journal-title":"Brain Res. Mol. Brain Res."},{"key":"1104_CR394","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s43587-021-00054-2","volume":"1","author":"R March-Diaz","year":"2021","unstructured":"March-Diaz, R. et al. Hypoxia compromises the mitochondrial metabolism of Alzheimer\u2019s disease microglia via HIF1. Nat. Aging 1, 385\u2013399 (2021).","journal-title":"Nat. Aging"},{"key":"1104_CR395","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/j.neurobiolaging.2012.10.029","volume":"34","author":"H Tang","year":"2013","unstructured":"Tang, H., Mao, X., Xie, L., Greenberg, D. A. & Jin, K. Expression level of vascular endothelial growth factor in hippocampus is associated with cognitive impairment in patients with Alzheimer\u2019s disease. Neurobiol. Aging 34, 1412\u20131415 (2013).","journal-title":"Neurobiol. Aging"},{"key":"1104_CR396","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/brain\/awv025","volume":"138","author":"T Thomas","year":"2015","unstructured":"Thomas, T., Miners, S. & Love, S. Post-mortem assessment of hypoperfusion of cerebral cortex in Alzheimer\u2019s disease and vascular dementia. Brain 138, 1059\u20131069 (2015).","journal-title":"Brain"},{"key":"1104_CR397","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0197-4580(03)00111-8","volume":"25","author":"SP Yang","year":"2004","unstructured":"Yang, S. P. et al. Co-accumulation of vascular endothelial growth factor with \u03b2-amyloid in the brain of patients with Alzheimer\u2019s disease. Neurobiol. Aging 25, 283\u2013290 (2004).","journal-title":"Neurobiol. Aging"},{"key":"1104_CR398","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1749-6632.1997.tb48478.x","volume":"826","author":"RN Kalaria","year":"1997","unstructured":"Kalaria, R. N. Cerebrovascular degeneration is related to amyloid-\u03b2 protein deposition in Alzheimer\u2019s disease. Ann. N. Y. Acad. Sci. 826, 263\u2013271 (1997).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"1104_CR399","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/0006-8993(92)91686-9","volume":"592","author":"M Kawai","year":"1992","unstructured":"Kawai, M., Cras, P. & Perry, G. Serial reconstruction of \u03b2-protein amyloid plaques: relationship to microvessels and size distribution. Brain Res. 592, 278\u2013282 (1992).","journal-title":"Brain Res."},{"key":"1104_CR400","first-page":"1435","volume":"137","author":"M Kawai","year":"1990","unstructured":"Kawai, M., Kalaria, R. N., Harik, S. I. & Perry, G. The relationship of amyloid plaques to cerebral capillaries in Alzheimer\u2019s disease. Am. J. Pathol. 137, 1435\u20131446 (1990).","journal-title":"Am. J. Pathol."},{"key":"1104_CR401","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/bpa.12004","volume":"23","author":"JD Sengillo","year":"2013","unstructured":"Sengillo, J. D. et al. Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer\u2019s disease. Brain Pathol. 23, 303\u2013310 (2013).","journal-title":"Brain Pathol."},{"key":"1104_CR402","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ijdevneu.2005.11.011","volume":"24","author":"E Kouznetsova","year":"2006","unstructured":"Kouznetsova, E. et al. Developmental and amyloid plaque-related changes in cerebral cortical capillaries in transgenic Tg2576 Alzheimer mice. Int. J. Dev. Neurosci. 24, 187\u2013193 (2006).","journal-title":"Int. J. Dev. Neurosci."},{"key":"1104_CR403","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.brainresbull.2004.11.024","volume":"65","author":"GD Lee","year":"2005","unstructured":"Lee, G. D. et al. Stereological analysis of microvascular parameters in a double transgenic model of Alzheimer\u2019s disease. Brain Res. Bull. 65, 317\u2013322 (2005).","journal-title":"Brain Res. Bull."},{"key":"1104_CR404","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1073\/pnas.0709788105","volume":"105","author":"EP Meyer","year":"2008","unstructured":"Meyer, E. P., Ulmann-Schuler, A., Staufenbiel, M. & Krucker, T. Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer\u2019s disease. Proc. Natl Acad. Sci. USA 105, 3587\u20133592 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1104_CR405","doi-asserted-by":"publisher","first-page":"7250","DOI":"10.1128\/AAC.03728-14","volume":"58","author":"E Sugawara","year":"2014","unstructured":"Sugawara, E. & Nikaido, H. Properties of AdeABC and AdeIJK efflux systems of Acinetobacter baumannii compared with those of the AcrAB-TolC system of Escherichia coli. Antimicrob. Agents Chemother. 58, 7250\u20137257 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1104_CR406","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/s41586-021-04369-3","volume":"603","author":"AC Yang","year":"2022","unstructured":"Yang, A. C. et al. A human brain vascular atlas reveals diverse mediators of Alzheimer\u2019s risk. Nature 603, 885\u2013892 (2022).","journal-title":"Nature"},{"key":"1104_CR407","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nrn.2017.48","volume":"18","author":"K Kisler","year":"2017","unstructured":"Kisler, K., Nelson, A. R., Montagne, A. & Zlokovic, B. V. Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease. Nat. Rev. Neurosci. 18, 419\u2013434 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"1104_CR408","doi-asserted-by":"publisher","first-page":"eaav9518","DOI":"10.1126\/science.aav9518","volume":"365","author":"R Nortley","year":"2019","unstructured":"Nortley, R. et al. Amyloid \u03b2 oligomers constrict human capillaries in Alzheimer\u2019s disease via signaling to pericytes. Science 365, eaav9518 (2019).","journal-title":"Science"},{"key":"1104_CR409","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13024-018-0284-2","volume":"13","author":"W Cao","year":"2018","unstructured":"Cao, W. & Zheng, H. Peripheral immune system in aging and Alzheimer\u2019s disease. Mol. Neurodegener. 13, 51 (2018).","journal-title":"Mol. Neurodegener."},{"key":"1104_CR410","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/ni.3102","volume":"16","author":"MT Heneka","year":"2015","unstructured":"Heneka, M. T., Golenbock, D. T. & Latz, E. Innate immunity in Alzheimer\u2019s disease. Nat. Immunol. 16, 229\u2013236 (2015).","journal-title":"Nat. Immunol."},{"key":"1104_CR411","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1146\/annurev-med-050715-104343","volume":"69","author":"LI Labzin","year":"2018","unstructured":"Labzin, L. I., Heneka, M. T. & Latz, E. Innate immunity and neurodegeneration. Annu. Rev. Med. 69, 437\u2013449 (2018).","journal-title":"Annu. Rev. Med."},{"key":"1104_CR412","doi-asserted-by":"publisher","first-page":"S335","DOI":"10.3233\/JAD-221064","volume":"94","author":"W Huang","year":"2023","unstructured":"Huang, W. et al. Microglia-mediated neurovascular unit dysfunction in Alzheimer\u2019s disease. J. Alzheimers Dis. 94, S335\u2013S354 (2023).","journal-title":"J. Alzheimers Dis."},{"key":"1104_CR413","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","volume":"85","author":"A Montagne","year":"2015","unstructured":"Montagne, A. et al. Blood-brain barrier breakdown in the aging human hippocampus. Neuron 85, 296\u2013302 (2015).","journal-title":"Neuron"},{"key":"1104_CR414","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/s41590-023-01522-0","volume":"24","author":"AS Mendiola","year":"2023","unstructured":"Mendiola, A. S. et al. Defining blood-induced microglia functions in neurodegeneration through multiomic profiling. Nat. Immunol. 24, 1173\u20131187 (2023).","journal-title":"Nat. Immunol."},{"key":"1104_CR415","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrn1387","volume":"5","author":"C Iadecola","year":"2004","unstructured":"Iadecola, C. Neurovascular regulation in the normal brain and in Alzheimer\u2019s disease. Nat. Rev. Neurosci. 5, 347\u2013360 (2004).","journal-title":"Nat. Rev. Neurosci."},{"key":"1104_CR416","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1161\/CIRCRESAHA.117.311054","volume":"121","author":"L Park","year":"2017","unstructured":"Park, L. et al. Brain perivascular macrophages initiate the neurovascular dysfunction of Alzheimer A\u03b2 peptides. Circ. Res. 121, 258\u2013269 (2017).","journal-title":"Circ. Res."},{"key":"1104_CR417","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/s41593-020-0686-7","volume":"23","author":"L Park","year":"2020","unstructured":"Park, L. et al. Tau induces PSD95-neuronal NOS uncoupling and neurovascular dysfunction independent of neurodegeneration. Nat. Neurosci. 23, 1079\u20131089 (2020).","journal-title":"Nat. Neurosci."},{"key":"1104_CR418","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1084\/jem.20171406","volume":"214","author":"A Montagne","year":"2017","unstructured":"Montagne, A., Zhao, Z. & Zlokovic, B. V. Alzheimer\u2019s disease: a matter of blood-brain barrier dysfunction? J. Exp. Med. 214, 3151\u20133169 (2017).","journal-title":"J. Exp. Med."},{"key":"1104_CR419","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature14432","volume":"523","author":"A Louveau","year":"2015","unstructured":"Louveau, A. et al. Structural and functional features of central nervous system lymphatic vessels. Nature 523, 337\u2013341 (2015).","journal-title":"Nature"},{"key":"1104_CR420","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/s41593-018-0227-9","volume":"21","author":"A Louveau","year":"2018","unstructured":"Louveau, A. et al. CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature. Nat. Neurosci. 21, 1380\u20131391 (2018).","journal-title":"Nat. Neurosci."},{"key":"1104_CR421","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1172\/JCI90603","volume":"127","author":"A Louveau","year":"2017","unstructured":"Louveau, A. et al. Understanding the functions and relationships of the glymphatic system and meningeal lymphatics. J. Clin. Invest. 127, 3210\u20133219 (2017).","journal-title":"J. Clin. Invest."},{"key":"1104_CR422","doi-asserted-by":"publisher","first-page":"7698","DOI":"10.1523\/JNEUROSCI.0619-21.2021","volume":"41","author":"LM Hablitz","year":"2021","unstructured":"Hablitz, L. M. & Nedergaard, M. The glymphatic system: a novel component of fundamental neurobiology. J. Neurosci. 41, 7698\u20137711 (2021).","journal-title":"J. Neurosci."},{"key":"1104_CR423","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1126\/science.abb8739","volume":"370","author":"M Nedergaard","year":"2020","unstructured":"Nedergaard, M. & Goldman, S. A. Glymphatic failure as a final common pathway to dementia. Science 370, 50\u201356 (2020).","journal-title":"Science"},{"key":"1104_CR424","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.cell.2020.12.040","volume":"184","author":"J Rustenhoven","year":"2021","unstructured":"Rustenhoven, J. et al. Functional characterization of the dural sinuses as a neuroimmune interface. Cell 184, 1000\u20131016.e27 (2021).","journal-title":"Cell"},{"key":"1104_CR425","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14195-x","volume":"11","author":"G Ringstad","year":"2020","unstructured":"Ringstad, G. & Eide, P. K. Cerebrospinal fluid tracer efflux to parasagittal dura in humans. Nat. Commun. 11, 354 (2020).","journal-title":"Nat. Commun."},{"key":"1104_CR426","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41586-022-05474-7","volume":"612","author":"J Rustenhoven","year":"2022","unstructured":"Rustenhoven, J. & Kipnis, J. Brain borders at the central stage of neuroimmunology. Nature 612, 417\u2013429 (2022).","journal-title":"Nature"},{"key":"1104_CR427","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41586-018-0368-8","volume":"560","author":"S Da Mesquita","year":"2018","unstructured":"Da Mesquita, S. et al. Functional aspects of meningeal lymphatics in ageing and Alzheimer\u2019s disease. Nature 560, 185\u2013191 (2018).","journal-title":"Nature"},{"key":"1104_CR428","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3233\/JAD-190013","volume":"69","author":"S Kwon","year":"2019","unstructured":"Kwon, S. et al. Impaired peripheral lymphatic function and cerebrospinal fluid outflow in a mouse model of Alzheimer\u2019s disease. J. Alzheimers Dis. 69, 585\u2013593 (2019).","journal-title":"J. Alzheimers Dis."},{"key":"1104_CR429","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.nbd.2014.07.012","volume":"71","author":"M Pappolla","year":"2014","unstructured":"Pappolla, M. et al. Evidence for lymphatic A\u03b2 clearance in Alzheimer\u2019s transgenic mice. Neurobiol. Dis. 71, 215\u2013219 (2014).","journal-title":"Neurobiol. Dis."},{"key":"1104_CR430","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/bpa.12656","volume":"29","author":"L Wang","year":"2019","unstructured":"Wang, L. et al. Deep cervical lymph node ligation aggravates AD-like pathology of APP\/PS1 mice. Brain Pathol. 29, 176\u2013192 (2019).","journal-title":"Brain Pathol."},{"key":"1104_CR431","doi-asserted-by":"publisher","first-page":"709","DOI":"10.4103\/1673-5374.230299","volume":"13","author":"YR Wen","year":"2018","unstructured":"Wen, Y. R., Yang, J. H., Wang, X. & Yao, Z. B. Induced dural lymphangiogenesis facilities soluble amyloid-beta clearance from brain in a transgenic mouse model of Alzheimer\u2019s disease. Neural Regen. Res. 13, 709\u2013716 (2018).","journal-title":"Neural Regen. Res."},{"key":"1104_CR432","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41586-021-03489-0","volume":"593","author":"S Da Mesquita","year":"2021","unstructured":"Da Mesquita, S. et al. Meningeal lymphatics affect microglia responses and anti-A\u03b2 immunotherapy. Nature 593, 255\u2013260 (2021).","journal-title":"Nature"},{"key":"1104_CR433","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka, M. T. et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 14, 388\u2013405 (2015).","journal-title":"Lancet Neurol."},{"key":"1104_CR434","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/ni.1836","volume":"11","author":"CR Stewart","year":"2010","unstructured":"Stewart, C. R. et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 11, 155\u2013161 (2010).","journal-title":"Nat. Immunol."},{"key":"1104_CR435","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1096\/fj.03-0364fje","volume":"18","author":"K Fassbender","year":"2004","unstructured":"Fassbender, K. et al. The LPS receptor (CD14) links innate immunity with Alzheimer\u2019s disease. FASEB J. 18, 203\u2013205 (2004).","journal-title":"FASEB J."},{"key":"1104_CR436","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.4049\/jimmunol.1101121","volume":"188","author":"S Liu","year":"2012","unstructured":"Liu, S. et al. TLR2 is a primary receptor for Alzheimer\u2019s amyloid \u03b2 peptide to trigger neuroinflammatory activation. J. Immunol. 188, 1098\u20131107 (2012).","journal-title":"J. Immunol."},{"key":"1104_CR437","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1159\/000110455","volume":"20","author":"S Walter","year":"2007","unstructured":"Walter, S. et al. Role of the Toll-like receptor 4 in neuroinflammation in Alzheimer\u2019s disease. Cell Physiol. Biochem. 20, 947\u2013956 (2007).","journal-title":"Cell Physiol. Biochem."},{"key":"1104_CR438","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka, M. T. et al. NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature 493, 674\u2013678 (2013).","journal-title":"Nature"},{"key":"1104_CR439","doi-asserted-by":"publisher","first-page":"13075","DOI":"10.1096\/fj.201900439","volume":"33","author":"C Venegas","year":"2019","unstructured":"Venegas, C. & Heneka, M. T. Inflammasome-mediated innate immunity in Alzheimer\u2019s disease. FASEB J. 33, 13075\u201313084 (2019).","journal-title":"FASEB J."},{"key":"1104_CR440","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1146\/annurev-med-041316-085215","volume":"69","author":"BI Hudson","year":"2018","unstructured":"Hudson, B. I. & Lippman, M. E. Targeting RAGE signaling in inflammatory disease. Annu. Rev. Med. 69, 349\u2013364 (2018).","journal-title":"Annu. Rev. Med."},{"key":"1104_CR441","doi-asserted-by":"publisher","first-page":"26043","DOI":"10.1074\/jbc.M115.679043","volume":"290","author":"Y Atagi","year":"2015","unstructured":"Atagi, Y. et al. Apolipoprotein E is a ligand for triggering receptor expressed on myeloid cells 2 (TREM2). J. Biol. Chem. 290, 26043\u201326050 (2015).","journal-title":"J. Biol. Chem."},{"key":"1104_CR442","doi-asserted-by":"publisher","first-page":"26033","DOI":"10.1074\/jbc.M115.677286","volume":"290","author":"CC Bailey","year":"2015","unstructured":"Bailey, C. C., DeVaux, L. B. & Farzan, M. The triggering receptor expressed on myeloid cells 2 binds apolipoprotein E. J. Biol. Chem. 290, 26033\u201326042 (2015).","journal-title":"J. Biol. Chem."},{"key":"1104_CR443","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jalz.2016.07.004","volume":"13","author":"W Song","year":"2017","unstructured":"Song, W. et al. Alzheimer\u2019s disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation. Alzheimers Dement. 13, 381\u2013387 (2017).","journal-title":"Alzheimers Dement."},{"key":"1104_CR444","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","volume":"160","author":"Y Wang","year":"2015","unstructured":"Wang, Y. et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model. Cell 160, 1061\u20131071 (2015).","journal-title":"Cell"},{"key":"1104_CR445","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.celrep.2019.03.099","volume":"27","author":"C Sala Frigerio","year":"2019","unstructured":"Sala Frigerio, C. et al. The major risk factors for Alzheimer\u2019s disease: age, sex, and genes modulate the microglia response to A\u03b2 plaques. Cell Rep. 27, 1293\u20131306.e6 (2019).","journal-title":"Cell Rep."},{"key":"1104_CR446","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","volume":"570","author":"H Mathys","year":"2019","unstructured":"Mathys, H. et al. Single-cell transcriptomic analysis of Alzheimer\u2019s disease. Nature 570, 332\u2013337 (2019).","journal-title":"Nature"},{"key":"1104_CR447","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1084\/jem.20171529","volume":"215","author":"WM Song","year":"2018","unstructured":"Song, W. M. et al. Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism. J. Exp. Med. 215, 745\u2013760 (2018).","journal-title":"J. Exp. Med."},{"key":"1104_CR448","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1006\/exnr.1996.0043","volume":"138","author":"A Afagh","year":"1996","unstructured":"Afagh, A., Cummings, B. J., Cribbs, D. H., Cotman, C. W. & Tenner, A. J. Localization and cell association of C1q in Alzheimer\u2019s disease brain. Exp. Neurol. 138, 22\u201332 (1996).","journal-title":"Exp. Neurol."},{"key":"1104_CR449","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0002-9440(10)64753-0","volume":"156","author":"SE Stoltzner","year":"2000","unstructured":"Stoltzner, S. E. et al. Temporal accrual of complement proteins in amyloid plaques in Down\u2019s syndrome with Alzheimer\u2019s disease. Am. J. Pathol. 156, 489\u2013499 (2000).","journal-title":"Am. J. Pathol."},{"key":"1104_CR450","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/alz.12389","volume":"18","author":"D Boche","year":"2022","unstructured":"Boche, D. & Gordon, M. N. Diversity of transcriptomic microglial phenotypes in aging and Alzheimer\u2019s disease. Alzheimers Dement. 18, 360\u2013376 (2022).","journal-title":"Alzheimers Dement."},{"key":"1104_CR451","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.neuron.2018.10.031","volume":"100","author":"A Litvinchuk","year":"2018","unstructured":"Litvinchuk, A. et al. Complement C3aR inactivation attenuates tau pathology and reverses an immune network deregulated in tauopathy models and Alzheimer\u2019s disease. Neuron 100, 1337\u20131353.e5 (2018).","journal-title":"Neuron"},{"key":"1104_CR452","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/j.celrep.2019.07.060","volume":"28","author":"T Wu","year":"2019","unstructured":"Wu, T. et al. Complement C3 is activated in human AD brain and is required for neurodegeneration in mouse models of amyloidosis and tauopathy. Cell Rep. 28, 2111\u20132123.e6 (2019).","journal-title":"Cell Rep."},{"key":"1104_CR453","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3389\/fimmu.2020.00724","volume":"11","author":"J Yang","year":"2020","unstructured":"Yang, J., Wise, L. & Fukuchi, K. I. TLR4 cross-talk with NLRP3 inflammasome and complement signaling pathways in Alzheimer\u2019s disease. Front. Immunol. 11, 724 (2020).","journal-title":"Front. Immunol."},{"key":"1104_CR454","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1182\/blood-2006-12-063636","volume":"110","author":"X Zhang","year":"2007","unstructured":"Zhang, X. et al. Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Blood 110, 228\u2013236 (2007).","journal-title":"Blood"},{"key":"1104_CR455","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1523\/JNEUROSCI.1734-20.2020","volume":"41","author":"A Alawieh","year":"2021","unstructured":"Alawieh, A. et al. Complement drives synaptic degeneration and progressive cognitive decline in the chronic phase after traumatic brain injury. J. Neurosci. 41, 1830\u20131843 (2021).","journal-title":"J. Neurosci."},{"key":"1104_CR456","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr.","year":"2018","unstructured":"Jack, C. R. Jr. et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 14, 535\u2013562 (2018).","journal-title":"Alzheimers Dement."},{"key":"1104_CR457","doi-asserted-by":"publisher","first-page":"3680","DOI":"10.1096\/fj.11-202382","volume":"26","author":"D Pavlovski","year":"2012","unstructured":"Pavlovski, D. et al. Generation of complement component C5a by ischemic neurons promotes neuronal apoptosis. FASEB J. 26, 3680\u20133690 (2012).","journal-title":"FASEB J."},{"key":"1104_CR458","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/archneurol.2010.147","volume":"67","author":"MM Carrasquillo","year":"2010","unstructured":"Carrasquillo, M. M. et al. Replication of CLU, CR1, and PICALM associations with Alzheimer disease. Arch. Neurol. 67, 961\u2013964 (2010).","journal-title":"Arch. Neurol."},{"key":"1104_CR459","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"JC Lambert","year":"2009","unstructured":"Lambert, J. C. et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease. Nat. Genet. 41, 1094\u20131099 (2009).","journal-title":"Nat. Genet."},{"key":"1104_CR460","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/bs.ai.2021.09.003","volume":"152","author":"TJ Petrisko","year":"2021","unstructured":"Petrisko, T. J., Gomez-Arboledas, A. & Tenner, A. J. Complement as a powerful \u201cinfluencer\u201d in the brain during development, adulthood and neurological disorders. Adv. Immunol. 152, 157\u2013222 (2021).","journal-title":"Adv. Immunol."},{"key":"1104_CR461","doi-asserted-by":"publisher","first-page":"eaaf6295","DOI":"10.1126\/scitranslmed.aaf6295","volume":"9","author":"Q Shi","year":"2017","unstructured":"Shi, Q. et al. Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP\/PS1 mice. Sci. Transl. Med. 9, eaaf6295 (2017).","journal-title":"Sci. Transl. Med."},{"key":"1104_CR462","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13024-020-0357-x","volume":"15","author":"F El Gaamouch","year":"2020","unstructured":"El Gaamouch, F. et al. VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice. Mol. Neurodegener. 15, 4 (2020).","journal-title":"Mol. Neurodegener."},{"key":"1104_CR463","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1471-4159.2010.06595.x","volume":"113","author":"RR Ager","year":"2010","unstructured":"Ager, R. R. et al. Microglial C5aR (CD88) expression correlates with amyloid-\u03b2 deposition in murine models of Alzheimer\u2019s disease. J. Neurochem. 113, 389\u2013401 (2010).","journal-title":"J. Neurochem."},{"key":"1104_CR464","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02539-2","volume":"19","author":"K Carvalho","year":"2022","unstructured":"Carvalho, K. et al. Modulation of C5a-C5aR1 signaling alters the dynamics of AD progression. J. Neuroinflammation 19, 178 (2022).","journal-title":"J. Neuroinflammation"},{"key":"1104_CR465","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s40478-022-01416-6","volume":"10","author":"A Gomez-Arboledas","year":"2022","unstructured":"Gomez-Arboledas, A. et al. C5aR1 antagonism alters microglial polarization and mitigates disease progression in a mouse model of Alzheimer\u2019s disease. Acta Neuropathol. Commun. 10, 116 (2022).","journal-title":"Acta Neuropathol. Commun."},{"key":"1104_CR466","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13024-017-0210-z","volume":"12","author":"MX Hernandez","year":"2017","unstructured":"Hernandez, M. X. et al. Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss. Mol. Neurodegener. 12, 66 (2017).","journal-title":"Mol. Neurodegener."},{"key":"1104_CR467","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0369-6","volume":"12","author":"C Landlinger","year":"2015","unstructured":"Landlinger, C. et al. Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer\u2019s disease. J. Neuroinflammation 12, 150 (2015).","journal-title":"J. Neuroinflammation"},{"key":"1104_CR468","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s40478-022-01404-w","volume":"10","author":"SM Carpanini","year":"2022","unstructured":"Carpanini, S. M. et al. Terminal complement pathway activation drives synaptic loss in Alzheimer\u2019s disease models. Acta Neuropathol. Commun. 10, 99 (2022).","journal-title":"Acta Neuropathol. Commun."},{"key":"1104_CR469","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong, S. et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352, 712\u2013716 (2016).","journal-title":"Science"},{"key":"1104_CR470","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2147\/ITT.S305420","volume":"10","author":"A Gomez-Arboledas","year":"2021","unstructured":"Gomez-Arboledas, A., Acharya, M. M. & Tenner, A. J. The role of complement in synaptic pruning and neurodegeneration. Immunotargets Ther. 10, 373\u2013386 (2021).","journal-title":"Immunotargets Ther."},{"key":"1104_CR471","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.molimm.2017.05.025","volume":"89","author":"NM Thielens","year":"2017","unstructured":"Thielens, N. M., Tedesco, F., Bohlson, S. S., Gaboriaud, C. & Tenner, A. J. C1q: a fresh look upon an old molecule. Mol. Immunol. 89, 73\u201383 (2017).","journal-title":"Mol. Immunol."},{"key":"1104_CR472","doi-asserted-by":"publisher","first-page":"eabi8593","DOI":"10.1126\/scitranslmed.abi8593","volume":"14","author":"J Spurrier","year":"2022","unstructured":"Spurrier, J. et al. Reversal of synapse loss in Alzheimer mouse models by targeting mGluR5 to prevent synaptic tagging by C1Q. Sci. Transl. Med. 14, eabi8593 (2022).","journal-title":"Sci. Transl. Med."},{"key":"1104_CR473","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1523\/JNEUROSCI.18-08-02974.1998","volume":"18","author":"CA Murray","year":"1998","unstructured":"Murray, C. A. & Lynch, M. A. Evidence that increased hippocampal expression of the cytokine interleukin-1\u03b2 is a common trigger for age- and stress-induced impairments in long-term potentiation. J. Neurosci. 18, 2974\u20132981 (1998).","journal-title":"J. Neurosci."},{"key":"1104_CR474","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0304-3940(95)12252-4","volume":"203","author":"AJ Cunningham","year":"1996","unstructured":"Cunningham, A. J., Murray, C. A., O\u2019Neill, L. A., Lynch, M. A. & O\u2019Connor, J. J. Interleukin-1\u03b2 (IL-1\u03b2) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci. Lett. 203, 17\u201320 (1996).","journal-title":"Neurosci. Lett."},{"key":"1104_CR475","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1046\/j.1471-4159.2000.0750634.x","volume":"75","author":"V Tancredi","year":"2000","unstructured":"Tancredi, V. et al. The inhibitory effects of interleukin-6 on synaptic plasticity in the rat hippocampus are associated with an inhibition of mitogen-activated protein kinase ERK. J. Neurochem. 75, 634\u2013643 (2000).","journal-title":"J. Neurochem."},{"key":"1104_CR476","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/0304-3940(92)90071-E","volume":"146","author":"V Tancredi","year":"1992","unstructured":"Tancredi, V. et al. Tumor necrosis factor alters synaptic transmission in rat hippocampal slices. Neurosci. Lett. 146, 176\u2013178 (1992).","journal-title":"Neurosci. Lett."},{"key":"1104_CR477","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0006-8993(90)91331-A","volume":"525","author":"V Tancredi","year":"1990","unstructured":"Tancredi, V., Zona, C., Velotti, F., Eusebi, F. & Santoni, A. Interleukin-2 suppresses established long-term potentiation and inhibits its induction in the rat hippocampus. Brain Res. 525, 149\u2013151 (1990).","journal-title":"Brain Res."},{"key":"1104_CR478","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature25158","volume":"552","author":"C Venegas","year":"2017","unstructured":"Venegas, C. et al. Microglia-derived ASC specks cross-seed amyloid-\u03b2 in Alzheimer\u2019s disease. Nature 552, 355\u2013361 (2017).","journal-title":"Nature"},{"key":"1104_CR479","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41586-023-06373-1","volume":"620","author":"MF Gulen","year":"2023","unstructured":"Gulen, M. F. et al. cGAS-STING drives ageing-related inflammation and neurodegeneration. Nature 620, 374\u2013380 (2023).","journal-title":"Nature"},{"key":"1104_CR480","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26851-2","volume":"12","author":"M Jin","year":"2021","unstructured":"Jin, M. et al. Tau activates microglia via the PQBP1-cGAS-STING pathway to promote brain inflammation. Nat. Commun. 12, 6565 (2021).","journal-title":"Nat. Commun."},{"key":"1104_CR481","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s43587-022-00337-2","volume":"3","author":"X Xie","year":"2023","unstructured":"Xie, X. et al. Activation of innate immune cGAS-STING pathway contributes to Alzheimer\u2019s pathogenesis in 5xFAD mice. Nat. Aging 3, 202\u2013212 (2023).","journal-title":"Nat. Aging"},{"key":"1104_CR482","doi-asserted-by":"publisher","first-page":"949340","DOI":"10.3389\/fncel.2022.949340","volume":"16","author":"SAI Sanford","year":"2022","unstructured":"Sanford, S. A. I. & McEwan, W. A. Type-I interferons in Alzheimer\u2019s disease and other tauopathies. Front. Cell Neurosci. 16, 949340 (2022).","journal-title":"Front. Cell Neurosci."},{"key":"1104_CR483","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02789-8","volume":"20","author":"YL Chai","year":"2023","unstructured":"Chai, Y. L. et al. Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer\u2019s disease but not Lewy body dementias. J. Neuroinflammation 20, 111 (2023).","journal-title":"J. Neuroinflammation"},{"key":"1104_CR484","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.tins.2022.10.007","volume":"45","author":"O Kann","year":"2022","unstructured":"Kann, O., Almouhanna, F. & Chausse, B. Interferon \u03b3: a master cytokine in microglia-mediated neural network dysfunction and neurodegeneration. Trends Neurosci. 45, 913\u2013927 (2022).","journal-title":"Trends Neurosci."},{"key":"1104_CR485","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.neuron.2014.12.068","volume":"85","author":"MV Guillot-Sestier","year":"2015","unstructured":"Guillot-Sestier, M. V. et al. Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology. Neuron 85, 534\u2013548 (2015).","journal-title":"Neuron"},{"key":"1104_CR486","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1038\/nm.2965","volume":"18","author":"J Vom Berg","year":"2012","unstructured":"Vom Berg, J. et al. Inhibition of IL-12\/IL-23 signaling reduces Alzheimer\u2019s disease-like pathology and cognitive decline. Nat. Med. 18, 1812\u20131819 (2012).","journal-title":"Nat. Med."},{"key":"1104_CR487","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.142","volume":"7","author":"C Carlock","year":"2017","unstructured":"Carlock, C. et al. Interleukin33 deficiency causes tau abnormality and neurodegeneration with Alzheimer-like symptoms in aged mice. Transl. Psychiatry 7, e1164 (2017).","journal-title":"Transl. Psychiatry"},{"key":"1104_CR488","doi-asserted-by":"publisher","first-page":"E2705","DOI":"10.1073\/pnas.1604032113","volume":"113","author":"AK Fu","year":"2016","unstructured":"Fu, A. K. et al. IL-33 ameliorates Alzheimer\u2019s disease-like pathology and cognitive decline. Proc. Natl Acad. Sci. USA 113, E2705\u2013E2713 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1104_CR489","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.neurobiolaging.2006.03.013","volume":"28","author":"PL McGeer","year":"2007","unstructured":"McGeer, P. L. & McGeer, E. G. NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies. Neurobiol. Aging 28, 639\u2013647 (2007).","journal-title":"Neurobiol. Aging"},{"key":"1104_CR490","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1212\/01.wnl.0000311269.57716.63","volume":"70","author":"SC Vlad","year":"2008","unstructured":"Vlad, S. C., Miller, D. R., Kowall, N. W. & Felson, D. T. Protective effects of NSAIDs on the development of Alzheimer disease. Neurology 70, 1672\u20131677 (2008).","journal-title":"Neurology"},{"key":"1104_CR491","first-page":"CD011459","volume":"4","author":"F Jordan","year":"2020","unstructured":"Jordan, F. et al. Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia. Cochrane Database Syst. Rev. 4, CD011459 (2020).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1104_CR492","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1097\/00005072-199911000-00003","volume":"58","author":"AV Yermakova","year":"1999","unstructured":"Yermakova, A. V., Rollins, J., Callahan, L. M., Rogers, J. & O\u2019Banion, M. K. Cyclooxygenase-1 in human Alzheimer and control brain: quantitative analysis of expression by microglia and CA3 hippocampal neurons. J. Neuropathol. Exp. Neurol. 58, 1135\u20131146 (1999).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1104_CR493","doi-asserted-by":"publisher","first-page":"15248","DOI":"10.1523\/JNEUROSCI.6361-11.2013","volume":"33","author":"EW Griffin","year":"2013","unstructured":"Griffin, E. W., Skelly, D. T., Murray, C. L. & Cunningham, C. Cyclooxygenase-1-dependent prostaglandins mediate susceptibility to systemic inflammation-induced acute cognitive dysfunction. J. Neurosci. 33, 15248\u201315258 (2013).","journal-title":"J. Neurosci."},{"key":"1104_CR494","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1471-4159.2010.06759.x","volume":"114","author":"SB Matousek","year":"2010","unstructured":"Matousek, S. B. et al. Cyclooxygenase-1 mediates prostaglandin E(2) elevation and contextual memory impairment in a model of sustained hippocampal interleukin-1\u03b2 expression. J. Neurochem. 114, 247\u2013258 (2010).","journal-title":"J. Neurochem."},{"key":"1104_CR495","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/jnc.12059","volume":"124","author":"SH Choi","year":"2013","unstructured":"Choi, S. H. et al. Cyclooxygenase-1 inhibition reduces amyloid pathology and improves memory deficits in a mouse model of Alzheimer\u2019s disease. J. Neurochem. 124, 59\u201368 (2013).","journal-title":"J. Neurochem."},{"key":"1104_CR496","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.1523\/JNEUROSCI.3846-16.2017","volume":"37","author":"A Eskilsson","year":"2017","unstructured":"Eskilsson, A. et al. Immune-induced fever is dependent on local but not generalized prostaglandin E(2) synthesis in the brain. J. Neurosci. 37, 5035\u20135044 (2017).","journal-title":"J. Neurosci."},{"key":"1104_CR497","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13024-023-00627-2","volume":"18","author":"KA Walker","year":"2023","unstructured":"Walker, K. A. et al. The role of peripheral inflammatory insults in Alzheimer\u2019s disease: a review and research roadmap. Mol. Neurodegener. 18, 37 (2023).","journal-title":"Mol. Neurodegener."},{"key":"1104_CR498","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1172\/JCI77487","volume":"125","author":"JU Johansson","year":"2015","unstructured":"Johansson, J. U. et al. Prostaglandin signaling suppresses beneficial microglial function in Alzheimer\u2019s disease models. J. Clin. Invest. 125, 350\u2013364 (2015).","journal-title":"J. Clin. Invest."},{"key":"1104_CR499","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ajpath.2014.09.016","volume":"185","author":"X Li","year":"2015","unstructured":"Li, X. et al. Prostaglandin E2 receptor subtype 2 regulation of scavenger receptor CD36 modulates microglial A\u03b242 phagocytosis. Am. J. Pathol. 185, 230\u2013239 (2015).","journal-title":"Am. J. Pathol."},{"key":"1104_CR500","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nm1362","volume":"12","author":"T Kawano","year":"2006","unstructured":"Kawano, T. et al. Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat. Med. 12, 225\u2013229 (2006).","journal-title":"Nat. Med."},{"key":"1104_CR501","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.neurobiolaging.2011.09.017","volume":"33","author":"G Zhen","year":"2012","unstructured":"Zhen, G. et al. PGE2 EP1 receptor exacerbated neurotoxicity in a mouse model of cerebral ischemia and Alzheimer\u2019s disease. Neurobiol. Aging 33, 2215\u20132219 (2012).","journal-title":"Neurobiol. Aging"},{"key":"1104_CR502","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1046\/j.0022-3042.2001.00675.x","volume":"80","author":"A Bal-Price","year":"2002","unstructured":"Bal-Price, A., Matthias, A. & Brown, G. C. Stimulation of the NADPH oxidase in activated rat microglia removes nitric oxide but induces peroxynitrite production. J. Neurochem. 80, 73\u201380 (2002).","journal-title":"J. Neurochem."},{"key":"1104_CR503","doi-asserted-by":"publisher","first-page":"eaaw0843","DOI":"10.1126\/science.aaw0843","volume":"371","author":"T Nakamura","year":"2021","unstructured":"Nakamura, T. et al. Noncanonical transnitrosylation network contributes to synapse loss in Alzheimer\u2019s disease. Science 371, eaaw0843 (2021).","journal-title":"Science"},{"key":"1104_CR504","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.freeradbiomed.2021.07.002","volume":"172","author":"T Nakamura","year":"2021","unstructured":"Nakamura, T., Oh, C. K., Zhang, X. & Lipton, S. A. Protein S-nitrosylation and oxidation contribute to protein misfolding in neurodegeneration. Free Radic. Biol. Med. 172, 562\u2013577 (2021).","journal-title":"Free Radic. Biol. Med."},{"key":"1104_CR505","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nature04782","volume":"441","author":"T Uehara","year":"2006","unstructured":"Uehara, T. et al. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 441, 513\u2013517 (2006).","journal-title":"Nature"},{"key":"1104_CR506","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/jnc.14870","volume":"152","author":"TS Wijasa","year":"2020","unstructured":"Wijasa, T. S. et al. Quantitative proteomics of synaptosome S-nitrosylation in Alzheimer\u2019s disease. J. Neurochem. 152, 710\u2013726 (2020).","journal-title":"J. Neurochem."},{"key":"1104_CR507","doi-asserted-by":"publisher","first-page":"11693","DOI":"10.1523\/JNEUROSCI.1081-16.2016","volume":"36","author":"B Guivernau","year":"2016","unstructured":"Guivernau, B. et al. Amyloid-\u03b2 peptide nitrotyrosination stabilizes oligomers and enhances NMDAR-mediated toxicity. J. Neurosci. 36, 11693\u201311703 (2016).","journal-title":"J. Neurosci."},{"key":"1104_CR508","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1093\/brain\/awp023","volume":"132","author":"FX Guix","year":"2009","unstructured":"Guix, F. X. et al. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation. Brain 132, 1335\u20131345 (2009).","journal-title":"Brain"},{"key":"1104_CR509","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/emmm.201200243","volume":"4","author":"FX Guix","year":"2012","unstructured":"Guix, F. X. et al. Modification of \u03b3-secretase by nitrosative stress links neuronal ageing to sporadic Alzheimer\u2019s disease. EMBO Mol. Med. 4, 660\u2013673 (2012).","journal-title":"EMBO Mol. Med."},{"key":"1104_CR510","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.neuron.2011.07.001","volume":"71","author":"MP Kummer","year":"2011","unstructured":"Kummer, M. P. et al. Nitration of tyrosine 10 critically enhances amyloid \u03b2 aggregation and plaque formation. Neuron 71, 833\u2013844 (2011).","journal-title":"Neuron"},{"key":"1104_CR511","doi-asserted-by":"publisher","first-page":"10636","DOI":"10.1523\/JNEUROSCI.2143-06.2006","volume":"26","author":"MR Reynolds","year":"2006","unstructured":"Reynolds, M. R. et al. Tau nitration occurs at tyrosine 29 in the fibrillar lesions of Alzheimer\u2019s disease and other tauopathies. J. Neurosci. 26, 10636\u201310645 (2006).","journal-title":"J. Neurosci."},{"key":"1104_CR512","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.expneurol.2017.01.013","volume":"291","author":"CF Lourenco","year":"2017","unstructured":"Lourenco, C. F., Ledo, A., Barbosa, R. M. & Laranjinha, J. Neurovascular uncoupling in the triple transgenic model of Alzheimer\u2019s disease: impaired cerebral blood flow response to neuronal-derived nitric oxide signaling. Exp. Neurol. 291, 36\u201343 (2017).","journal-title":"Exp. Neurol."},{"key":"1104_CR513","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12754","volume":"17","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. nNOS-CAPON interaction mediates amyloid-\u03b2-induced neurotoxicity, especially in the early stages. Aging Cell 17, e12754 (2018).","journal-title":"Aging Cell"},{"key":"1104_CR514","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10278-x","volume":"10","author":"S Hashimoto","year":"2019","unstructured":"Hashimoto, S. et al. Tau binding protein CAPON induces tau aggregation and neurodegeneration. Nat. Commun. 10, 2394 (2019).","journal-title":"Nat. Commun."},{"key":"1104_CR515","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/nrd1958","volume":"5","author":"SA Lipton","year":"2006","unstructured":"Lipton, S. A. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nat. Rev. Drug Discov. 5, 160\u2013170 (2006).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1104_CR516","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1042\/BST0351119","volume":"35","author":"GC Brown","year":"2007","unstructured":"Brown, G. C. Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase. Biochem. Soc. Trans. 35, 1119\u20131121 (2007).","journal-title":"Biochem. Soc. Trans."},{"key":"1104_CR517","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s12035-019-01805-4","volume":"57","author":"X Geng","year":"2020","unstructured":"Geng, X. et al. Effects of docosahexaenoic acid and its peroxidation product on amyloid-\u03b2 peptide-stimulated microglia. Mol. Neurobiol. 57, 1085\u20131098 (2020).","journal-title":"Mol. Neurobiol."},{"issue":"Suppl. 2","key":"1104_CR518","first-page":"S13","volume":"52","author":"DT Weldon","year":"1997","unstructured":"Weldon, D. T., Maggio, J. E. & Mantyh, P. W. New insights into the neuropathology and cell biology of Alzheimer\u2019s disease. Geriatrics 52 (Suppl. 2), S13\u2013S16 (1997).","journal-title":"Geriatrics"},{"key":"1104_CR519","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2009579118","volume":"118","author":"JM Bourgognon","year":"2021","unstructured":"Bourgognon, J. M. et al. Inhibition of neuroinflammatory nitric oxide signaling suppresses glycation and prevents neuronal dysfunction in mouse prion disease. Proc. Natl Acad. Sci. USA 118, e2009579118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1104_CR520","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1084\/jem.20051529","volume":"202","author":"C Nathan","year":"2005","unstructured":"Nathan, C. et al. Protection from Alzheimer\u2019s-like disease in the mouse by genetic ablation of inducible nitric oxide synthase. J. Exp. Med. 202, 1163\u20131169 (2005).","journal-title":"J. Exp. Med."},{"key":"1104_CR521","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1172\/JCI11916","volume":"107","author":"MP Mattson","year":"2001","unstructured":"Mattson, M. P. & Camandola, S. NF-\u03baB in neuronal plasticity and neurodegenerative disorders. J. Clin. Invest. 107, 247\u2013254 (2001).","journal-title":"J. Clin. Invest."},{"key":"1104_CR522","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13195-015-0119-0","volume":"7","author":"HB Nygaard","year":"2015","unstructured":"Nygaard, H. B. et al. A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer\u2019s disease. Alzheimers Res. Ther. 7, 35 (2015).","journal-title":"Alzheimers Res. Ther."},{"key":"1104_CR523","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1001\/jamaneurol.2019.2050","volume":"76","author":"CH van Dyck","year":"2019","unstructured":"van Dyck, C. H. et al. Effect of AZD0530 on cerebral metabolic decline in Alzheimer disease: a randomized clinical trial. JAMA Neurol. 76, 1219\u20131229 (2019).","journal-title":"JAMA Neurol."},{"key":"1104_CR524","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40263-020-00787-5","volume":"35","author":"MC Gage","year":"2021","unstructured":"Gage, M. C. & Thippeswamy, T. Inhibitors of src family kinases, inducible nitric oxide synthase, and NADPH oxidase as potential CNS drug targets for neurological diseases. CNS Drugs 35, 1\u201320 (2021).","journal-title":"CNS Drugs"},{"key":"1104_CR525","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10753-022-01721-1","volume":"46","author":"S Thakur","year":"2023","unstructured":"Thakur, S., Dhapola, R., Sarma, P., Medhi, B. & Reddy, D. H. Neuroinflammation in Alzheimer\u2019s disease: current progress in molecular signaling and therapeutics. Inflammation 46, 1\u201317 (2023).","journal-title":"Inflammation"},{"key":"1104_CR526","doi-asserted-by":"publisher","first-page":"609073","DOI":"10.3389\/fnmol.2020.609073","volume":"13","author":"MR Brown","year":"2020","unstructured":"Brown, M. R., Radford, S. E. & Hewitt, E. W. Modulation of \u03b2-amyloid fibril formation in Alzheimer\u2019s 33ion. Front. Mol. Neurosci. 13, 609073 (2020).","journal-title":"Front. Mol. Neurosci."},{"key":"1104_CR527","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ijdevneu.2005.11.014","volume":"24","author":"M Sastre","year":"2006","unstructured":"Sastre, M., Klockgether, T. & Heneka, M. T. Contribution of inflammatory processes to Alzheimer\u2019s disease: molecular mechanisms. Int. J. Dev. Neurosci. 24, 167\u2013176 (2006).","journal-title":"Int. J. Dev. Neurosci."},{"key":"1104_CR528","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-5-25","volume":"5","author":"M Sastre","year":"2008","unstructured":"Sastre, M., Walter, J. & Gentleman, S. M. Interactions between APP secretases and inflammatory mediators. J. Neuroinflammation 5, 25 (2008).","journal-title":"J. Neuroinflammation"},{"key":"1104_CR529","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0006-291X(02)00725-8","volume":"295","author":"T Burton","year":"2002","unstructured":"Burton, T., Liang, B., Dibrov, A. & Amara, F. Transforming growth factor-\u03b2-induced transcription of the Alzheimer \u03b2-amyloid precursor protein gene involves interaction between the CTCF-complex and Smads. Biochem. Biophys. Res. Commun. 295, 713\u2013723 (2002).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1104_CR530","doi-asserted-by":"publisher","first-page":"9796","DOI":"10.1523\/JNEUROSCI.23-30-09796.2003","volume":"23","author":"M Sastre","year":"2003","unstructured":"Sastre, M. et al. Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-\u03b3 agonists modulate immunostimulated processing of amyloid precursor protein through regulation of \u03b2-secretase. J. Neurosci. 23, 9796\u20139804 (2003).","journal-title":"J. Neurosci."},{"key":"1104_CR531","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1002\/jcb.22382","volume":"108","author":"G Sommer","year":"2009","unstructured":"Sommer, G. et al. Amyloid precursor protein expression is induced by tumor necrosis factor \u03b1 in 3T3-L1 adipocytes. J. Cell Biochem. 108, 1418\u20131422 (2009).","journal-title":"J. Cell Biochem."},{"key":"1104_CR532","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1006\/nbdi.2002.0515","volume":"10","author":"E Tamagno","year":"2002","unstructured":"Tamagno, E. et al. Oxidative stress increases expression and activity of BACE in NT2 neurons. Neurobiol. Dis. 10, 279\u2013288 (2002).","journal-title":"Neurobiol. Dis."},{"key":"1104_CR533","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00702-003-0095-6","volume":"111","author":"I Blasko","year":"2004","unstructured":"Blasko, I. et al. Experimental traumatic brain injury in rats stimulates the expression, production and activity of Alzheimer\u2019s disease \u03b2-secretase (BACE-1). J. Neural Transm. 111, 523\u2013536 (2004).","journal-title":"J. Neural Transm."},{"key":"1104_CR534","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/glia.10178","volume":"41","author":"M Hartlage-Rubsamen","year":"2003","unstructured":"Hartlage-Rubsamen, M. et al. Astrocytic expression of the Alzheimer\u2019s disease \u03b2-secretase (BACE1) is stimulus-dependent. Glia 41, 169\u2013179 (2003).","journal-title":"Glia"},{"key":"1104_CR535","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.3390\/biom12101457","volume":"12","author":"S Naseer","year":"2022","unstructured":"Naseer, S. et al. Traumatic brain injury leads to alterations in contusional cortical miRNAs involved in dementia. Biomolecules 12, 1457 (2022).","journal-title":"Biomolecules"},{"key":"1104_CR536","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3233\/JAD-2011-111148","volume":"28","author":"C Pottier","year":"2012","unstructured":"Pottier, C. et al. Amyloid-\u03b2 protein precursor gene expression in Alzheimer\u2019s disease and other conditions. J. Alzheimers Dis. 28, 561\u2013566 (2012).","journal-title":"J. Alzheimers Dis."},{"key":"1104_CR537","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41586-020-2681-2","volume":"586","author":"JY Hur","year":"2020","unstructured":"Hur, J. Y. et al. The innate immunity protein IFITM3 modulates \u03b3-secretase in Alzheimer\u2019s disease. Nature 586, 735\u2013740 (2020).","journal-title":"Nature"},{"key":"1104_CR538","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.bbi.2009.01.017","volume":"23","author":"LB Jaeger","year":"2009","unstructured":"Jaeger, L. B. et al. Lipopolysaccharide alters the blood-brain barrier transport of amyloid \u03b2 protein: a mechanism for inflammation in the progression of Alzheimer\u2019s disease. Brain Behav. Immun. 23, 507\u2013517 (2009).","journal-title":"Brain Behav. Immun."},{"key":"1104_CR539","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s40478-021-01253-z","volume":"9","author":"J Xie","year":"2021","unstructured":"Xie, J. et al. Low-grade peripheral inflammation affects brain pathology in the App(NL-G-F)mouse model of Alzheimer\u2019s disease. Acta Neuropathol. Commun. 9, 163 (2021).","journal-title":"Acta Neuropathol. Commun."},{"key":"1104_CR540","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1073\/pnas.92.7.3032","volume":"92","author":"B Brugg","year":"1995","unstructured":"Brugg, B. et al. Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain. Proc. Natl Acad. Sci. USA 92, 3032\u20133035 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1104_CR541","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-5-37","volume":"5","author":"JW Lee","year":"2008","unstructured":"Lee, J. W. et al. Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation. J. Neuroinflammation 5, 37 (2008).","journal-title":"J. Neuroinflammation"},{"key":"1104_CR542","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s11481-007-9069-z","volume":"2","author":"DL Herber","year":"2007","unstructured":"Herber, D. L. et al. Microglial activation is required for A\u03b2 clearance after intracranial injection of lipopolysaccharide in APP transgenic mice. J. Neuroimmune Pharmacol. 2, 222\u2013231 (2007).","journal-title":"J. Neuroimmune Pharmacol."},{"key":"1104_CR543","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.expneurol.2004.07.007","volume":"190","author":"DL Herber","year":"2004","unstructured":"Herber, D. L. et al. Time-dependent reduction in A\u03b2 levels after intracranial LPS administration in APP transgenic mice. Exp. Neurol. 190, 245\u2013253 (2004).","journal-title":"Exp. Neurol."},{"key":"1104_CR544","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/jnr.21252","volume":"85","author":"KZ Bourne","year":"2007","unstructured":"Bourne, K. Z. et al. Differential regulation of BACE1 promoter activity by nuclear factor-\u03baB in neurons and glia upon exposure to \u03b2-amyloid peptides. J. Neurosci. Res. 85, 1194\u20131204 (2007).","journal-title":"J. Neurosci. Res."},{"key":"1104_CR545","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.pneurobio.2006.06.001","volume":"79","author":"S Rossner","year":"2006","unstructured":"Rossner, S., Sastre, M., Bourne, K. & Lichtenthaler, S. F. Transcriptional and translational regulation of BACE1 expression \u2014 implications for Alzheimer\u2019s disease. Prog. Neurobiol. 79, 95\u2013111 (2006).","journal-title":"Prog. Neurobiol."},{"key":"1104_CR546","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1073\/pnas.0503839103","volume":"103","author":"M Sastre","year":"2006","unstructured":"Sastre, M. et al. Nonsteroidal anti-inflammatory drugs repress \u03b2-secretase gene promoter activity by the activation of PPAR\u03b3. Proc. Natl Acad. Sci. USA 103, 443\u2013448 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1104_CR547","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1172\/JCI124619","volume":"129","author":"K Placek","year":"2019","unstructured":"Placek, K., Schultze, J. L. & Aschenbrenner, A. C. Epigenetic reprogramming of immune cells in injury, repair, and resolution. J. Clin. Invest. 129, 2994\u20133005 (2019).","journal-title":"J. Clin. Invest."},{"key":"1104_CR548","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.neuron.2011.11.033","volume":"73","author":"A de Calignon","year":"2012","unstructured":"de Calignon, A. et al. Propagation of tau pathology in a model of early Alzheimer\u2019s disease. Neuron 73, 685\u2013697 (2012).","journal-title":"Neuron"},{"key":"1104_CR549","doi-asserted-by":"publisher","first-page":"12845","DOI":"10.1074\/jbc.M808759200","volume":"284","author":"B Frost","year":"2009","unstructured":"Frost, B., Jacks, R. L. & Diamond, M. I. Propagation of tau misfolding from the outside to the inside of a cell. J. Biol. Chem. 284, 12845\u201312852 (2009).","journal-title":"J. Biol. Chem."},{"key":"1104_CR550","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1084\/jem.20131685","volume":"211","author":"K Yamada","year":"2014","unstructured":"Yamada, K. et al. Neuronal activity regulates extracellular tau in vivo. J. Exp. Med. 211, 387\u2013393 (2014).","journal-title":"J. Exp. Med."},{"key":"1104_CR551","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nn.4132","volume":"18","author":"H Asai","year":"2015","unstructured":"Asai, H. et al. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat. Neurosci. 18, 1584\u20131593 (2015).","journal-title":"Nat. Neurosci."},{"key":"1104_CR552","doi-asserted-by":"publisher","first-page":"109720","DOI":"10.1016\/j.celrep.2021.109720","volume":"36","author":"S Jiang","year":"2021","unstructured":"Jiang, S. et al. Proteopathic tau primes and activates interleukin-1\u03b2 via myeloid-cell-specific MyD88- and NLRP3-ASC-inflammasome pathway. Cell Rep. 36, 109720 (2021).","journal-title":"Cell Rep."},{"key":"1104_CR553","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/glia.22389","volume":"61","author":"DP Schafer","year":"2013","unstructured":"Schafer, D. P., Lehrman, E. K. & Stevens, B. The \u201cquad-partite\u201d synapse: microglia-synapse interactions in the developing and mature CNS. Glia 61, 24\u201336 (2013).","journal-title":"Glia"},{"key":"1104_CR554","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.neuron.2012.12.023","volume":"77","author":"H Kettenmann","year":"2013","unstructured":"Kettenmann, H., Kirchhoff, F. & Verkhratsky, A. Microglia: new roles for the synaptic stripper. Neuron 77, 10\u201318 (2013).","journal-title":"Neuron"},{"key":"1104_CR555","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/dneu.22777","volume":"81","author":"S De Schepper","year":"2021","unstructured":"De Schepper, S., Crowley, G. & Hong, S. Understanding microglial diversity and implications for neuronal function in health and disease. Dev. Neurobiol. 81, 507\u2013523 (2021).","journal-title":"Dev. Neurobiol."},{"key":"1104_CR556","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.neuron.2012.03.026","volume":"74","author":"DP Schafer","year":"2012","unstructured":"Schafer, D. P. et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 74, 691\u2013705 (2012).","journal-title":"Neuron"},{"key":"1104_CR557","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.cell.2007.10.036","volume":"131","author":"B Stevens","year":"2007","unstructured":"Stevens, B. et al. The classical complement cascade mediates CNS synapse elimination. Cell 131, 1164\u20131178 (2007).","journal-title":"Cell"},{"key":"1104_CR558","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.neuron.2018.10.014","volume":"100","author":"B Dejanovic","year":"2018","unstructured":"Dejanovic, B. et al. Changes in the synaptic proteome in tauopathy and rescue of tau-induced synapse loss by C1q antibodies. Neuron 100, 1322\u20131336.e7 (2018).","journal-title":"Neuron"},{"key":"1104_CR559","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.cell.2016.04.001","volume":"165","author":"H Lui","year":"2016","unstructured":"Lui, H. et al. Progranulin deficiency promotes circuit-specific synaptic pruning by microglia via complement activation. Cell 165, 921\u2013935 (2016).","journal-title":"Cell"},{"key":"1104_CR560","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nature18283","volume":"534","author":"MJ Vasek","year":"2016","unstructured":"Vasek, M. J. et al. A complement-microglial axis drives synapse loss during virus-induced memory impairment. Nature 534, 538\u2013543 (2016).","journal-title":"Nature"},{"key":"1104_CR561","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1016\/j.celrep.2019.11.013","volume":"29","author":"A Vukojicic","year":"2019","unstructured":"Vukojicic, A. et al. The classical complement pathway mediates microglia-dependent remodeling of spinal motor circuits during development and in SMA. Cell Rep. 29, 3087\u20133100.e7 (2019).","journal-title":"Cell Rep."},{"key":"1104_CR562","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1038\/s41591-023-02566-3","volume":"29","author":"DK Wilton","year":"2023","unstructured":"Wilton, D. K. et al. Microglia and complement mediated early corticostriatal synapse loss and cognitive dysfunction in Huntington\u2019s disease. Nat. Med. 29, 2866\u20132884 (2023).","journal-title":"Nat. Med."},{"key":"1104_CR563","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1038\/s41591-023-02566-3","volume":"29","author":"DK Wilton","year":"2023","unstructured":"Wilton, D. K. et al. Microglia and complement mediate early corticostriatal synapse loss and cognitive dysfunction in Huntington\u2019s disease. Nat. Med. 29, 2866\u20132884 (2023).","journal-title":"Nat. Med."},{"key":"1104_CR564","doi-asserted-by":"publisher","first-page":"13460","DOI":"10.1523\/JNEUROSCI.1333-13.2013","volume":"33","author":"AH Stephan","year":"2013","unstructured":"Stephan, A. H. et al. A dramatic increase of C1q protein in the CNS during normal aging. J. Neurosci. 33, 13460\u201313474 (2013).","journal-title":"J. Neurosci."},{"key":"1104_CR565","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1683-1","volume":"17","author":"D Datta","year":"2020","unstructured":"Datta, D. et al. Classical complement cascade initiating C1q protein within neurons in the aged rhesus macaque dorsolateral prefrontal cortex. J. Neuroinflammation 17, 8 (2020).","journal-title":"J. Neuroinflammation"},{"key":"1104_CR566","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41593-023-01257-z","volume":"26","author":"S De Schepper","year":"2023","unstructured":"De Schepper, S. et al. Perivascular cells induce microglial phagocytic states and synaptic engulfment via SPP1 in mouse models of Alzheimer\u2019s disease. Nat. Neurosci. 26, 406\u2013415 (2023).","journal-title":"Nat. Neurosci."},{"key":"1104_CR567","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13108","volume":"33","author":"A Fracassi","year":"2023","unstructured":"Fracassi, A. et al. TREM2-induced activation of microglia contributes to synaptic integrity in cognitively intact aged individuals with Alzheimer\u2019s neuropathology. Brain Pathol. 33, e13108 (2023).","journal-title":"Brain Pathol."},{"key":"1104_CR568","doi-asserted-by":"publisher","first-page":"eadf0141","DOI":"10.1126\/scitranslmed.adf0141","volume":"15","author":"J Zhou","year":"2023","unstructured":"Zhou, J. et al. The neuronal pentraxin Nptx2 regulates complement activity and restrains microglia-mediated synapse loss in neurodegeneration. Sci. Transl. Med. 15, eadf0141 (2023).","journal-title":"Sci. Transl. Med."},{"key":"1104_CR569","doi-asserted-by":"publisher","first-page":"19","DOI":"10.12703\/r\/10-19","volume":"10","author":"D Sokolova","year":"2021","unstructured":"Sokolova, D., Childs, T. & Hong, S. Insight into the role of phosphatidylserine in complement-mediated synapse loss in Alzheimer\u2019s disease. Fac. Rev. 10, 19 (2021).","journal-title":"Fac. Rev."},{"key":"1104_CR570","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022113246","volume":"42","author":"J Rueda-Carrasco","year":"2023","unstructured":"Rueda-Carrasco, J. et al. Microglia-synapse engulfment via PtdSer-TREM2 ameliorates neuronal hyperactivity in Alzheimer\u2019s disease models. EMBO J. 42, e113246 (2023).","journal-title":"EMBO J."},{"key":"1104_CR571","doi-asserted-by":"publisher","first-page":"106263","DOI":"10.1016\/j.nbd.2023.106263","volume":"186","author":"M Das","year":"2023","unstructured":"Das, M. et al. Alzheimer risk-increasing TREM2 variant causes aberrant cortical synapse density and promotes network hyperexcitability in mouse models. Neurobiol. Dis. 186, 106263 (2023).","journal-title":"Neurobiol. Dis."},{"key":"1104_CR572","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","volume":"12","author":"J Hardy","year":"1991","unstructured":"Hardy, J. & Allsop, D. Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease. Trends Pharmacol. Sci. 12, 383\u2013388 (1991).","journal-title":"Trends Pharmacol. Sci."},{"key":"1104_CR573","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jalz.2008.09.004","volume":"5","author":"ADAPT Research Group","year":"2009","unstructured":"ADAPT Research Group; Meinert, C. L., McCaffrey, L. D. & Breitner, J. C. Alzheimer\u2019s disease anti-inflammatory prevention trial: design, methods, and baseline results. Alzheimers Dement. 5, 93\u2013104 (2009).","journal-title":"Alzheimers Dement."},{"key":"1104_CR574","doi-asserted-by":"publisher","first-page":"e2070","DOI":"10.1212\/WNL.0000000000007232","volume":"92","author":"PF Meyer","year":"2019","unstructured":"Meyer, P. F. et al. INTREPAD: a randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease. Neurology 92, e2070\u2013e2080 (2019).","journal-title":"Neurology"},{"key":"1104_CR575","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3233\/JAD-221026","volume":"94","author":"S Karima","year":"2023","unstructured":"Karima, S. et al. Boswellic acids improve clinical cognitive scores and reduce systemic inflammation in patients with mild to moderate Alzheimer\u2019s disease. J. Alzheimers Dis. 94, 359\u2013370 (2023).","journal-title":"J. Alzheimers Dis."},{"key":"1104_CR576","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3233\/JAD-221007","volume":"93","author":"F Rahmani","year":"2023","unstructured":"Rahmani, F. et al. Twelve weeks of intermittent caloric restriction diet mitigates neuroinflammation in midlife individuals with multiple sclerosis: a pilot study with implications for prevention of Alzheimer\u2019s disease. J. Alzheimers Dis. 93, 263\u2013273 (2023).","journal-title":"J. Alzheimers Dis."},{"key":"1104_CR577","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.gerinurse.2022.09.005","volume":"48","author":"L Chen","year":"2022","unstructured":"Chen, L. et al. Effects of oral health intervention strategies on cognition and microbiota alterations in patients with mild Alzheimer\u2019s disease: a randomized controlled trial. Geriatr. Nurs. 48, 103\u2013110 (2022).","journal-title":"Geriatr. Nurs."},{"key":"1104_CR578","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/alz.12651","volume":"19","author":"M Brody","year":"2023","unstructured":"Brody, M. et al. Results and insights from a phase I clinical trial of Lomecel-B for Alzheimer\u2019s disease. Alzheimers Dement. 19, 261\u2013273 (2023).","journal-title":"Alzheimers Dement."},{"key":"1104_CR579","first-page":"1645","volume":"18","author":"RGJ Goncalves","year":"2023","unstructured":"Goncalves, R. G. J., Vasques, J. F., da Silva-Junior, A. J., Gubert, F. & Mendez-Otero, R. Mesenchymal stem cell- and extracellular vesicle-based therapies for Alzheimer\u2019s disease: progress, advantages, and challenges. Neural Regen. Res. 18, 1645\u20131651 (2023).","journal-title":"Neural Regen. Res."},{"key":"1104_CR580","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1002\/sctm.17-0051","volume":"6","author":"AI Caplan","year":"2017","unstructured":"Caplan, A. I. Mesenchymal stem cells: time to change the name! Stem Cell Transl. Med. 6, 1445\u20131451 (2017).","journal-title":"Stem Cell Transl. Med."},{"key":"1104_CR581","unstructured":"Hansen, L. Denali Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights https:\/\/investors.denalitherapeutics.com\/news-releases\/news-release-details\/denali-therapeutics-reports-second-quarter-2023-financial (2023)."},{"key":"1104_CR582","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/s41593-023-01356-x","volume":"26","author":"A Cain","year":"2023","unstructured":"Cain, A. et al. Multicellular communities are perturbed in the aging human brain and Alzheimer\u2019s disease. Nat. Neurosci. 26, 1267\u20131280 (2023).","journal-title":"Nat. Neurosci."},{"key":"1104_CR583","doi-asserted-by":"publisher","first-page":"5390","DOI":"10.1038\/s41380-023-02147-3","volume":"28","author":"S Lomoio","year":"2023","unstructured":"Lomoio, S. et al. 3D bioengineered neural tissue generated from patient-derived iPSCs mimics time-dependent phenotypes and transcriptional features of Alzheimer\u2019s disease.Mol. Psychiatry 28, 5390\u20135401 (2023).","journal-title":"Mol. Psychiatry"},{"key":"1104_CR584","doi-asserted-by":"publisher","first-page":"e2264","DOI":"10.1212\/WNL.0000000000201120","volume":"99","author":"L Yu","year":"2022","unstructured":"Yu, L. et al. Association of AK4 protein from stem cell-derived neurons with cognitive reserve: an autopsy study. Neurology 99, e2264\u2013e2274 (2022).","journal-title":"Neurology"},{"key":"1104_CR585","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1038\/s41590-023-01558-2","volume":"24","author":"MJ Dolan","year":"2023","unstructured":"Dolan, M. J. et al. Exposure of iPSC-derived human microglia to brain substrates enables the generation and manipulation of diverse transcriptional states in vitro. Nat. Immunol. 24, 1382\u20131390 (2023).","journal-title":"Nat. Immunol."},{"key":"1104_CR586","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41596-020-00447-4","volume":"16","author":"N Fattorelli","year":"2021","unstructured":"Fattorelli, N. et al. Stem-cell-derived human microglia transplanted into mouse brain to study human disease. Nat. Protoc. 16, 1013\u20131033 (2021).","journal-title":"Nat. Protoc."},{"key":"1104_CR587","doi-asserted-by":"publisher","DOI":"10.1101\/2022.07.07.499139","author":"R Mancuso","year":"2022","unstructured":"Mancuso, R. et al. A multi-pronged human microglia response to Alzheimer\u2019s disease A\u03b2 pathology. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2022.07.07.499139 (2022).","journal-title":"bioRxiv"},{"key":"1104_CR588","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/s41593-024-01600-y","volume":"27","author":"R Mancuso","year":"2024","unstructured":"Mancuso, R. et al. Xenografted human microglia display diverse transcriptomic states in response to Alzheimer\u2019s disease-related amyloid-\u03b2 pathology. Nat. Neurosci. 27, 886\u2013900 (2024).","journal-title":"Nat. Neurosci."},{"key":"1104_CR589","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/ni.3703","volume":"18","author":"M Prinz","year":"2017","unstructured":"Prinz, M., Erny, D. & Hagemeyer, N. Ontogeny and homeostasis of CNS myeloid cells. Nat. Immunol. 18, 385\u2013392 (2017).","journal-title":"Nat. Immunol."},{"key":"1104_CR590","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1194637","volume":"330","author":"F Ginhoux","year":"2010","unstructured":"Ginhoux, F. et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330, 841\u2013845 (2010).","journal-title":"Science"},{"key":"1104_CR591","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nn.3318","volume":"16","author":"K Kierdorf","year":"2013","unstructured":"Kierdorf, K. et al. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat. Neurosci. 16, 273\u2013280 (2013).","journal-title":"Nat. Neurosci."},{"key":"1104_CR592","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/nn.4631","volume":"20","author":"P Fuger","year":"2017","unstructured":"Fuger, P. et al. Microglia turnover with aging and in an Alzheimer\u2019s model via long-term in vivo single-cell imaging. Nat. Neurosci. 20, 1371\u20131376 (2017).","journal-title":"Nat. Neurosci."},{"key":"1104_CR593","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.celrep.2017.07.004","volume":"20","author":"P Reu","year":"2017","unstructured":"Reu, P. et al. The lifespan and turnover of microglia in the human brain. Cell Rep. 20, 779\u2013784 (2017).","journal-title":"Cell Rep."},{"key":"1104_CR594","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nn.4547","volume":"20","author":"TL Tay","year":"2017","unstructured":"Tay, T. L. et al. A new fate mapping system reveals context-dependent random or clonal expansion of microglia. Nat. Neurosci. 20, 793\u2013803 (2017).","journal-title":"Nat. Neurosci."},{"key":"1104_CR595","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1038\/nn2014","volume":"10","author":"B Ajami","year":"2007","unstructured":"Ajami, B., Bennett, J. L., Krieger, C., Tetzlaff, W. & Rossi, F. M. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat. Neurosci. 10, 1538\u20131543 (2007).","journal-title":"Nat. Neurosci."},{"key":"1104_CR596","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1038\/nn2015","volume":"10","author":"A Mildner","year":"2007","unstructured":"Mildner, A. et al. Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat. Neurosci. 10, 1544\u20131553 (2007).","journal-title":"Nat. Neurosci."},{"key":"1104_CR597","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.celrep.2020.01.010","volume":"30","author":"T Masuda","year":"2020","unstructured":"Masuda, T., Sankowski, R., Staszewski, O. & Prinz, M. Microglia heterogeneity in the single-cell era. Cell Rep. 30, 1271\u20131281 (2020).","journal-title":"Cell Rep."},{"key":"1104_CR598","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.immuni.2018.11.004","volume":"50","author":"TR Hammond","year":"2019","unstructured":"Hammond, T. R. et al. Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes. Immunity 50, 253\u2013271.e6 (2019).","journal-title":"Immunity"},{"key":"1104_CR599","doi-asserted-by":"publisher","first-page":"eaat7554","DOI":"10.1126\/science.aat7554","volume":"363","author":"MJC Jordao","year":"2019","unstructured":"Jordao, M. J. C. et al. Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation. Science 363, eaat7554 (2019).","journal-title":"Science"},{"key":"1104_CR600","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.neuron.2018.12.006","volume":"101","author":"Q Li","year":"2019","unstructured":"Li, Q. et al. Developmental heterogeneity of microglia and brain myeloid cells revealed by deep single-cell RNA sequencing. Neuron 101, 207\u2013223.e10 (2019).","journal-title":"Neuron"},{"key":"1104_CR601","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.immuni.2021.06.002","volume":"54","author":"M Schwabenland","year":"2021","unstructured":"Schwabenland, M. et al. Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions. Immunity 54, 1594\u20131610.e11 (2021).","journal-title":"Immunity"}],"container-title":["Nature Reviews Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41577-024-01104-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41577-024-01104-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41577-024-01104-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T08:03:48Z","timestamp":1746173028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41577-024-01104-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,9]]},"references-count":601,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["1104"],"URL":"https:\/\/doi.org\/10.1038\/s41577-024-01104-7","relation":{},"ISSN":["1474-1733","1474-1741"],"issn-type":[{"value":"1474-1733","type":"print"},{"value":"1474-1741","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,9]]},"assertion":[{"value":"9 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.J.T. serves\/served on scientific advisory boards and\/or as a consultant with Alnylam, Apellis, and Montis and has a research contract from Visterra. C.Cruchaga has received research support from GSK and EISAI. C.Cruchaga is a member of the scientific advisory board of Circular Genomics and owns stocks. C.Cruchaga is a member of the scientific advisory board of Admit. D.J.B. has a financial interest related to this research. He is a co-inventor on patents held by Mayo Clinic, patent applications licensed to or filed by Unity Biotechnology, and a Unity Biotechnology shareholder. Research in the Baker Laboratory has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic Conflict of Interest policies. D.M. serves on the advisory board of Mindimmune, InMed and SynapsDx. He collaborates with Hesperos Inc. C.Cunningham has acted on the advisory board for Exalys Therapeutics and has received a small research grant from IONIS Therapeutics. C.T. has research contracts with Acumen, ADx Neurosciences, AC-Immune, Alamar, Aribio, Axon Neurosciences, Beckman-Coulter, BioConnect, Bioorchestra, Brainstorm Therapeutics, Celgene, Cognition Therapeutics, EIP Pharma, Eisai, Eli Lilly, Fujirebio, Instant Nano Biosensors, Novo Nordisk, Olink, PeopleBio, Quanterix, Roche, Toyama and Vivoryon. She is editor in chief of\n                      Alzheimer Research and Therapy\n                      , and serves on editorial boards of\n                      Molecular Neurodegeneration\n                      ,\n                      Neurology: Neuroimmunology & Neuroinflammation\n                      ,\n                      Medidact Neurologie\n                      Springer, and serves on committee to define guidelines for cognitive disturbances and one for acute neurology in the Netherlands. She had consultancy\/speaker contracts for Aribio, Biogen, Beckman-Coulter, Cognition Therapeutics, Eli Lilly, Merck, Novo Nordisk, Olink, Roche and Veravas. D.B. has served as a consultant for Biogen. D.R.T. collaborated with Novartis Pharma AG (Switzerland) and GE-Healthcare (UK). G.D. holds two patents on immunomodulatory treatments in Alzheimer disease and tauopathies, has served on the scientific advisory board of Coya Therapeutics, and received lecturer fees from Eisai and research support from Institut Roche. H.Z. has served at scientific advisory boards and\/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZPath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, LabCorp, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures sponsored by Alzecure, BioArctic, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk, Roche, and WebMD, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). K.A. is co-founder and member of the SAB for Willow Neuroscience, Inc. L.A. has been consultant for Intelgenx. M.C. is a member of the scientific advisory board of Vigil, NGMBio, Cell Signalling Technology, Cartesian, and Halyard; receives research support from Ono Pharmaceutical; and has patents pending on LILRB4 and TREM2. O.B. co-founded and is on the scientific advisory board of Glial Therapeutics and GliaX. O.B. collaborates with GSK and Regulus Therapeutics and received research funding from Sanofi, GSK, honoraria for lectures, and consultancy for UCB, Camp4, Ono Pharma USA, and General Biophysics. R.Mancuso has or had scientific collaborations with Alector, Nodthera, Alchemab and Roche, and has been consultant for Sanofi. R.R. is a full time employee at Third Rock Ventures, a firm that creates new biotech companies, including those addressing neurodegeneration. He is also Co-Founder and holds equity at Abata Therapeutics. S.A.L. maintains a financial interest in AstronauTx Ltd. and Synapticure, and sits on the SAB of the Global BioAccess Fund. S.H. has received speaking fees from Eisai Ltd, Novo Nordisk, and Alnylam, receives research funding from Eisai Ltd., and has a collaborative project with Ionis Ltd. W.M.vdF. receives or has received funding by ZonMW, NWO, EU-JPND, EU-IHI, Alzheimer Nederland, Hersenstichting CardioVascular Onderzoek Nederland, Health Holland, Topsector Life Sciences & Health, stichting Dioraphte, Gieskes-Strijbis fonds, stichting Equilibrio, Edwin Bouw fonds, Pasman stichting, stichting Alzheimer & Neuropsychiatrie Foundation, Philips, Biogen MA Inc., Novartis-NL, Life-MI, AVID, Roche BV, Eli Lilly-NL, Fujifilm, Eisai, Combinostics. W.M.vdF. has been an invited speaker at Biogen MA Inc., Danone, Eisai, WebMD Neurology (Medscape), NovoNordisk, Springer Healthcare, and European Brain Council; consultant to Oxford Health Policy Forum CIC, Roche, Biogen MA Inc., and Eisai; all funding paid to her institution. W.M.vdF. participated in advisory boards of Biogen MA Inc., Roche, and Eli Lilly. W.M.vdF. is a member of the steering committee of EVOKE\/EVOKE+ (NovoNordisk); all funding paid to her institution. W.M.vdF. is a member of the steering committee of PAVE and Think Brain Health. W.M.vdF. was an Associate Editor of\n                      Alzheimer\u2019s Research & Therapy\n                      in 2020\/2021 and is an Associate Editor at\n                      Brain\n                      .\u00a0P.E. was funded by the Medical Research Council and now by Higher Education Funding Council for England (HEFCE). He has also received grants from Alzheimer\u2019s Research, UK, Alzheimer\u2019s Drug Discovery Foundation, Alzheimer\u2019s Society, UK, Medical Research Council, Alzheimer\u2019s Association US, Van-Geest foundation, and European Union grants. P.E. is a consultant to Roche, Pfizer, and Novo Nordisk. He has received educational and research grants from GE Healthcare, Novo Nordisk, Piramal Life Science\/Life Molecular Imaging, Avid Radiopharmaceuticals and Eli Lilly. He was a member of the Scientific Advisory Board at Novo Nordisk. All other authors have no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}